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This report presents the findings from a large-scale bio-behavioural survey implemented across 13 Euro-
pean countries. The survey was implemented in the context of the European Commission co-funded Sialon II 
project (see www.sialon.eu). The overall objective of the Sialon II project (2011-2014) was to carry out and pro-
mote combined and targeted prevention, complemented by meaningful surveillance, among MSM. The Sialon II 
project follows on from its predecessor Sialon (2008-2010); both projects were set within a context of rising HIV 
infections among MSM in many countries across Europe as indicated by both the ECDC and the other scientific 
literature. 
The Sialon II survey employed two different probability sampling procedures, namely Time-Location Sam-
pling (TLS) and Respondent-Driven Sampling (RDS). These two methods allowed researchers to enrol hetero-
geneous populations and to collect reliable information on behaviour patterns, prevention needs and sexual 
health in the MSM population. The survey is without precedence in Europe in terms of its size and from the point 
of view of the practical implementation of the WHO – Joint United Nations Programme on HIV/AIDS (UNAIDS) 
Second Generation Surveillance System (SGSS) approach and behavioural surveillance recommendations from 
the ECDC.
The TLS method was adopted in Belgium, Bulgaria, Germany, Poland, Portugal, Slovenia, Spain, Sweden, 
and the UK whereas the RDS method was employed in Italy, Lithuania, Romania, and the Slovak Republic. The 
choice of sampling procedure was dependent both on the cultural and social characteristics of the participating 
cities and taking into consideration the activities of the previous Sialon project where only the TLS method was 
employed. 
Data from the Sialon II survey have provided a wealth and diversity of insights regarding: access to preven-
tion programs and testing in each partner country; results on sexual behaviour in the last six months (with 
steady and non-steady partners) including condom use; as well as findings relating to commercial sex, ‘fisting’, 
treatment and viral load, substance (mis)use, and sexual health (sexual satisfaction, sexual safety, and sexual 
autonomy). In terms of HIV prevalence, data suggested a range between 2% and 20%, with higher prevalence 
among individuals older than 25 years of age. A relevant proportion (ranging between 12% and 88%) of partici-
pants were unaware of being HIV-positive. 
On the one hand, the findings confirm the already identified trend of rising infection among MSM in Europe. 
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One the other hand, the data reveal some alarming findings with regard to prevention, treatment and support to 
MSM and underline the disparities within Europe. 
The high number of MSM who were tested for the first time in the context of this survey, in particular in the 
Eastern European survey cities and the high estimates of HIV positive participants unaware of their real se-
rum-status, seem to suggest critical conditions in terms of future increase of the HIV epidemic. The situation 
seems to be particularly concerning in Eastern European cities, where a low level of condom use is reported, as 
well as a high level of perceived discrimination. 
The lack and/or delay in diagnosis is also a crucial factor in general. In several cities, the treatment coverage 
is less than optimal among individuals who know they are HIV positive indicating potential challenges in linkage 
to care and continuity of care. 
This scenario reflects the marked diversity of the societal and political contexts of the countries involved, in 
particular with respect to the social and legal conditions for sexual minority emancipation. This will obviously 
have an impact on both surveillance and prevention activities and needs to be taken into consideration in the 
definition of policy in this area. This means that in addition to concrete measures such as increased condom 
distribution networks and promotion of testing and treatment, policy actions must also address the social de-
terminants of high risk behaviour and low uptake of testing for HIV and other STIs such as homophobia and 
stigma. 
Similarly, the segmentation and the complexity of the MSM population which this survey has contributed 
to identifying, point to the need to design targeted HIV prevention and health promotion interventions by sub-
groups. For example, young MSM (<25 years) presented a particularly vulnerable subgroup of MSM engaging in 
high risk behaviour and experiencing a high perception of homonegativity. Another main subgroup identified in 
Sialon II are MSM attending venues from other European countries including migrants (non-native or non-res-
ident MSM) and tourists, raising issues of increased vulnerability due to multiple marginalization in the case of 
migrants or limited access to prevention activities in the case of tourists. 
To conclude, the findings of Sialon II survey represent a valid contribution to the pool of epidemiological 
research that has been has undertaken to date in the area of HIV/STI prevention among MSM. However, at the 
same time, the results also point to the urgent need for continued and more widespread data collection (in line 
with the SGGS) to better understand the marked differences in prevention needs across Europe and among 
sub-populations of MSM and hence to better define more effective and efficient prevention strategies.
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General introduction to the report
This document is a key deliverable of the European Sialon II project co-funded by the European Commission 
(see www.sialon.eu). It presents the main results of the Sialon II project and focuses specifically on the findings 
from a large-scale bio-behavioural survey implemented across 13 European countries. 
In Chapter 2, the background to the Sialon II project is outlined including a summary of the relevant liter-
ature and an overview of the current debates regarding the HIV/STI epidemic within Europe. In Chapter 3, the 
methodology of the Sialon II bio-behavioural survey is presented, summarising the main procedural and tech-
nical issues involved. Ethical considerations relating to implementation from initial data collection to delivery of 
the test results and data analysis are then explored in Chapter 4. 
The main results from the Sialon II survey are presented in Chapter 5 which includes a series of related sub-
sections as follows: in Section 5.1, a detailed description of the sample including socio-demographic character-
istics is provided. Data on access to prevention programmes and testing are explored in Section 5.2; Section 5.3 
presents findings on sexual behaviour in the last six months with male non-steady partners, whereas Section 
5.4 presents data on sexual behaviour in the last six months with male steady partners. Insights on sexual be-
haviour with female partners are provided in Section 5.5. Data on sexual behaviour during the last episode of 
sexual intercourse and on commercial sex are presented in Sections 5.6 and 5.7 respectively. Details on high 
risk behaviour (fisting) are reported in Section 5.8. Estimates on HIV and other STIs are provided in Section 5.9, 
whilst Section 5.10 focuses on treatment and viral load data. A comprehensive presentation of the project’s 
main results is completed by final sections on sexual health (5.11) and substance (mis)use (5.12).
In Chapter 6, the main findings and potential implications of the Sialon II data are discussed. Finally, in Chap-
ter 7, the project’s key conclusions are presented followed by a series of recommendations for future action in 
the area of HIV/STI prevention. 
Notes on the presentation of findings and other issues
During data analysis, the two different sampling methods used by the Sialon II survey (TLS and RDS) were 
1. Introduction
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taken into account1. However, in order to provide the reader with clear and easy-to-read tables and graphs, data 
are presented at city level independently from the actual sampling method used. In other words, data related 
to the cities are listed in alphabetical order (in both graphs and tables) without separating into TLS and RDS 
recruitment sites. 
As final remark, this report is based on data from the Sialon II project, co-funded by CHAFEA under the 2008-
2013 Second Health Programme (Work Plan 2010). The sole responsibility lies with the authors of this report, 
and the Commission is not responsible for any use that may be made of the information contained therein.
Massimo Mirandola, Lorenzo Gios, Nigel Sherriff 
1 Details of all data analysis procedures and protocols will be made available in future publications
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Summary
The HIV epidemic among MSM continues to represent a pressing public health issue in Europe. The need of 
structured surveillance initiatives where both biological (e.g. oral fluid) and behavioural data (e.g. from ques-
tionnaires) are collected, is evident. The use of a common set of indicators adopted across Europe is also a key 
factor in monitoring the epidemic. 
The Sialon II project, in line with the international literature (e.g. UNAIDS, WHO and ECDC reports and 
guidelines), includes the use of GARPR indicators and WHO-UNAIDS guidelines on testing in the framework of 
epidemiological studies. The project has contributed significantly to the harmonisation of surveillance methods 
across participating countries, delivering comparable data from behavioural and epidemiological indicators for 
MSM communities. 
Introduction
This chapter provides an overview of the current situation with regard to MSM and HIV in Europe. In particu-
lar, attention is drawn to some of the pressing issues relating to the monitoring of the epidemic and the urgent 
need for reliable and comparable data across European countries. Details of the first Sialon project are provided 
followed by a description of the subsequent SIALON II project including the survey objectives and an overview of 
the participating countries. In the final part of the chapter, a number of conclusions are highlighted relating to 
the contribution of the Sialon II research. 
HIV and MSM in Europe
The HIV epidemic continues to represent a critical public health issue in Europe and elsewhere (ECDC/WHO, 
2013). Data and documents from the ECDC show that for the WHO European Region, 136.235 new HIV diagnoses 
2. Background
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were reported in 2014, with a rate of 15.7 per 100.000. Therefore, the cumulative number of infections diagnosed 
in the WHO European Region increased to a total of 1,715,434.
With regard to the mode of transmission in the EU/EEA countries in 2013, the highest proportion of new HIV 
diagnoses was reported in men who have sex with men (MSM) accounting for 42% of all new infections (com-
pared to 40.4% in 2012) (ECDC / WHO, 2014). 
Mode of transmission of newly-diagnosed HIV cases reported in the EU/EEA 2013 (ECDC / WHO, 2013)
Number of new HIV diagnoses among MSM EU/EEA 2004-2013 (ECDCl / WHO, 2013)
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In EU/EEA countries where data are available, since 2004 HIV diagnoses have increased by 33% among MSM, 
confirming that this specific sub-population continues to represent a majority of the new HIV infected people 
across Europe. Consequently, this sub-population is considered as a population at high risk for acquiring HIV.
Moreover, according to the most recent data available from the ECDC (2015), HIV prevalence among MSM 
appears to be 5% or above in more than half of all EU/EEA countries. According to the Global AIDS Response 
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Progress Reporting (GARPR) disaggregation, reported prevalence is lower for MSM under 25 years old (roughly 
2.9%) than for MSM over 25 years old (roughly 7.7%) (ECDC, 2015). In general, new diagnoses have increased 
dramatically in younger MSM in the EU/EEA area: between 2004 and 2013, the number of new HIV-positive MSM 
aged 20-24yrs almost doubled, whereas in adult MSM (30-39 years old) the estimates remain relatively stable. 
 Whilst these levels of new diagnoses and HIV prevalence could be due to increasing HIV testing, it is also 
likely that new diagnoses in the younger age groups represent ongoing transmission in this specific population. 
Indeed, with regard to the latter, according to the current scientific literature an increase of high risk sexual 
practices (such as unprotected anal intercourse) has been reported among MSM across Europe (ECDC / WHO, 
2014; ECDC, 2012). Almost one third of all HIV infected MSM in Europe are estimated to be unaware of their 
seropositive status. 
Monitoring the epidemic: GARPR indicators
HIV diagnosis represents a key surveillance activity for monitoring the HIV epidemic especially in ‘hard-to-
reach’ populations such as MSM. Reliable and comparable data, including trends in risk behaviours over time, 
are of crucial importance in order to monitor the outbreak of infections, and to understand whether and by how 
much rates are increasing and which populations (or sub-populations) are affected the most. 
Consequently, the international literature has stressed the need for public health to embrace three main ap-
proaches in monitoring and controlling the epidemic: (i) a structured surveillance system method, the so-called 
Second Generation Surveillance System; (ii) the use a of common set of indicators adopted across Europe, and; 
(iii) specific prevention campaigns targeting MSM and testing promotion. 
In terms of structured surveillance initiatives and in response to the growing awareness of the urgency for a 
comprehensive and effective response, a number of European countries have implemented surveys specifically 
targeting MSM (Elford, 2009) focusing primarily on the monitoring of risk behaviours. A SGSS approach (UN-
AIDS, 2002), where both biological (e.g. oral fluid) and behavioural data (e.g. from questionnaires) are collected 
and triangulated, has unfortunately only been adopted in a limited number of studies (Dubois-Arber, 2010). This 
represents a challenging issue and limits the value of such targeted initiatives due to, amongst others, a lack 
of comparability of data across European countries (UNAIDS Joint United Nations Programme on HIV/AIDS 
and WHO, 2000). A SGSS approach is defined by the WHO as the “regular, systematic collection, analysis and 
interpretation of information for use in tracking and describing changes in the HIV/AIDS epidemic over time”. 
This approach is central not only because it allows the public health sector to monitor the spread of infections 
in a given population and to analyse trends over time, but also as it can facilitate countries in improving their 
planning of prevention initiatives.
With regard to the use of common indicators across Europe to monitor and control the epidemic, imple-
mentation is not systematic. Often considerable variations across countries are reported both in terms of the 
specific indicators used and the way in which such indicators are calculated and used for reporting. Conse-
quently, the implementation of harmonised HIV-STI surveillance systems across Europe could be a crucial tool 
in monitoring the HIV epidemic effectively in high-risk populations including MSM (Elford J, 2009). 
In 2001 the United Nations General Assembly, in a Special Session on HIV/AIDS, proposed the construction of 
a set of core indicators, namely the UNGASS indicators to boost the harmonisation of data at the international 
level (UNAIDS, 2008; WHO/UNAIDS, 2009). These UNGASS indicators have been revised and updated periodi-
cally, becoming in 2012 “the Global AIDS Response Progress Reporting (GARPR) indicators”. The most recent 
version of the indicators guidelines were released in 2014 by UNAIDS, UNICEF and the WHO (UNAIDS, 2014). 
Through the framework of monitoring the Dublin Declaration in Europe and Central Asia, ECDC and WHO have 
harmonised its indicators on HIV testing, condom use and HIV prevalence among MSM (UNAIDS/WHO working 
group on global HIV/AIDS and STI surveillance, 2011).
GARPR indicators represent a unique tool that can assist countries in evaluating the effectiveness of their 
HIV-STIs programmes, providing policy makers, scientific communities, civil societies and other stakeholders 
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with clear and direct markers on the status of the epidemic across different target-groups. Moreover, when 
GARPR data are collected and investigated across several countries, such indicators can provide crucial in-
sights from a regional perspective, also providing a general overview of prevention needs or areas where the 
implementation of specific actions or campaigns is urgently needed. 
The first Sialon project (2008-2010)
The first Sialon project (Sialon: Capacity building in HIV/Syphilis prevalence estimation using non-invasive 
methods among MSM in Southern and Eastern Europe) was funded under the 2003-2008 Public Health Pro-
gramme (work plan 2007) (Mirandola, 2009). The project was designed to obtain reliable and valid data on HIV 
and Syphilis prevalence, as well as explore associated risk behaviours including cultural factors among MSM. 
Non-invasive outreach testing was used based on oral fluid sample collections and an anonymous question-
naire was administered for collecting behavioural data. Time-Location Sampling (TLS) was adopted with the 
active involvement of gay associations in each data collection site. The study was a descriptive multi-centre 
biological and behavioural cross-sectional survey carried out in seven Southern and Eastern European cities 
including: Athens (Greece); Barcelona (Spain); Bratislava (Slovakia); Bucharest (Romania); Ljubljana (Slove-
nia), Prague (Czech Republic); and Verona (Italy). International core indicators (called UNGASS indicators at 
that time, now GARPR indicators) were utilised in order to collect reliable and comparable data across partic-
ipating countries. 
The Sialon results (Mirandola, 2009) highlighted primarily the need for health promotion and prevention 
messages to be focused particularly on sexual behaviour, as well as raising the importance of testing promotion 
especially among young MSM, and highlighting the urgency of collecting additional and reliable information for 
STIs other than HIV. Data generated through the first Sialon project were used not only to monitor the respective 
HIV epidemics in partner countries, but also to harmonise the data collection process across the participating 
countries. In doing so, the study’s protocols proved to be an effective tool in planning and implementing large 
scale bio-behavioural surveys. As a result, a second Sialon II project was developed and submitted for funding 
to the EC’s 2008-2013 Public Health Programme. 
The Sialon II project 
Building on the successes and experiences of the first Sialon project (Mirandola, 2009), and in line with the 
2009-2013 European Commission (EC) Communication on combating HIV/AIDS in the European Union (EU) and 
neighbouring countries (EC, 2009) and with the operational Action Plan which has recently been updated to 
cover the period 2014-2016 (EC, 2014), the overall objective of the Sialon II project was to carry out and promote 
combined and targeted prevention, complemented by meaningful surveillance, among MSM. 
More specifically, the aim was to build capacity, knowledge, and expertise across the participating countries 
in terms of delivering effective prevention actions and of implementing innovative surveillance methodologies 
for MSM. 
Sialon II was funded under the EC Public Health Programme 2008-2013 (Work Plan 2010). The project’s strate-
gic relevance was threefold: i) Sialon II collected behavioural and biological data as well as assessed the preven-
tion needs of MSM in line with the WHO and UNAIDS’ recommendations on SGSS; ii) the project addressed directly 
the need for effective responses in priority regions such as the EU Member States most affected by HIV; and iii) 
complementing the EC’s 2010 Health Programme, Sialon II targeted MSM specifically as a (sub) population at high 
risk of acquiring HIV and other STIs. 
Sialon II worked in active collaboration with diverse gay communities in all phases of the project actions. 
As examples, this included members of gay communities as project partners, as key collaborators, and as key 
informers in developing and implementing targeted and culturally sensitive strategies of communication for the 
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prevention of HIV and promotion of Voluntary Counselling and Testing (VCT) among MSM. Sialon II also worked 
in partnership with other major stakeholders including the ECDC, the WHO and UNAIDS, particularly during the 
initial development phase of the project. Such collaborations contributed considerably to the development and 
successful application of standard methodologies across the partner countries (including the research proto-
cols, core GARPR/ECDC indicators, and epidemiological algorithms) as well as refining the specific prevention 
strategies to be implemented. Finally, further to collaborations with European institutions and countries, new 
partnerships were also established with EU neighbouring countries including Armenia and Moldova with the 
support of the WHO and UNAIDS. 
Sialon II survey objectives
The Sialon II survey had the following primary objectives:
•	 To	pilot	the	implementation	of	a	bio-behavioural	survey	using	different	sampling	methods,	namely	Time-Lo-
cation Sampling (TLS) and Respondent-Driven Sampling (RDS); 
•	 To	estimate	anti-HIV-Ab	prevalence	among	MSM	in	data	collection	using	the	TLS	method;	
•	 To	estimate	anti-HIV-Ab,	Syphilis,	HBV-HVC	prevalence	among	MSM	in	data	collection	sites	using	the	RDS	
method; 
•	 To	identify,	describe	and	analyse	sexual	risk	behaviour	patterns,	prevention	needs	and	sexual	health	in	the	
MSM population, triangulating the behavioural data (risk behaviours, socio-ecological or contextual fac-
tors) and the biological information. 
As noted earlier, these survey objectives were consistent with the SGSS approach and with the ECDC and 
WHO behavioural surveillance recommendations (UNAIDS/WHO working group on global HIV/AIDS and STI sur-
veillance, 2011). The main GARPR indicators related to MSM which were included in the Sialon II surveys were as 
follows:
•	 Indicator	1.11:	Men	who	have	sex	with	men:	prevention	programmes	(percentage	of	men	who	have	sex	with	
men reached with HIV prevention programmes); 
•	 Indicator	1.12:	Men	who	have	sex	with	men:	condom	use	(percentage	of	men	reporting	the	use	of	a	condom	
the last time they had anal sex with a male partner); 
•	 Indicator	1.13:	HIV	testing	in	men	who	have	sex	with	men	(percentage	of	men	who	have	sex	with	men	who	
received an HIV test in the past 12 months and know their results); 
•	 Indicator	1.14:	HIV	prevalence	in	men	who	have	sex	with	men	(percentage	of	men	who	have	sex	with	men	
risk who are living with HIV). 
In terms of behaviours, the broader scientific literature as well as WHO-UNAIDS specific publications, stress 
the importance of monitoring key behaviours and attitudes connected to the transmission of HIV and STIs, 
namely:
•	 Sexual	behaviour	(condom	use,	sexual	practices,	number	and	type	of	sexual	partners);	
•	 Substance	use/abuse;	
•	 Health	seeking	behaviours	(access	to	VCT);
•	 STI	indicators	(self-reported	past	history	of	STI	testing/STI	(all	sites),	and	biomarkers).	
In addition, given that behaviours are strongly influenced by characteristics of the socio-ecological environ-
ment (e.g. such as public policy on HIV, different types of social venues targeting MSM such as discos, bars, 
clubs, saunas etc. as well as access to, and quality of, local health and care services) (Dahlgren, 1991), Sialon 
II also considered how knowledge about such characteristics might be useful in improving sexual health and 
prevention activities and programmes for MSM. 
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Overview of the Sialon II survey countries
In Sialon II, a total of 13 countries were involved in implementing the bio-behavioural survey including Swe-
den, United Kingdom, Belgium, Germany, Portugal, Spain, Italy, Bulgaria, Lithuania, Poland, Romania, Slovak 
Republic and Slovenia. Such diverse geographical coverage inevitably meant the existence of very different 
cultural and social contexts and thus the choice of methodology to be implemented, namely TLS (Belgium, Bul-
garia, Germany, Poland, Portugal, Slovenia, Spain, Sweden, and the UK) or RDS (Italy, Lithuania, Romania, and 
the Slovak Republic) was dependent on the characteristics of the particular city in question. 
Conclusions
Increases in HIV cases among MSM continue to be reported by the ECDC and in the wider international sci-
entific literature. Effective interventions to monitor and control HIV epidemics among this specific target group 
remain a priority. In this process, it is imperative to gain reliable and comparable data on epidemic patterns 
within and between countries, as well as meaningful assessment, identification, and response to MSM preven-
tion needs. 
The Sialon II project has contributed significantly to the harmonisation of surveillance methods across par-
ticipating countries and in doing so, has increased directly the public health response at country and European 
level. The comparable data on behavioural and epidemiological indicators for MSM communities (ECDC and 
GARPR indicators) presented in this report can be used at local, European, and international levels. 
Through initial formative research, the project has identified unmet prevention needs and built communi-
ty-based capacity to carry out research and prevention in venue-based settings. While the Sialon II prevention 
campaign was designed to take place in the context of the TLS and RDS data collection venues, implemen-
tation of prevention activities went beyond the data collection as such. Sialon II adopted a community-based, 
participatory approach throughout the whole project, which contributed to identify the shortcomings of existing 
prevention policies and measures, and strengthened a Europe-wide network of international (UNAIDS, WHO) 
and European institutions (European Commission, ECDC), National Institutes of Public Health, Universities, and 
civil society organisations (NGOs working with and for MSM).
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Summary
Two different probability sampling procedures were used to sample MSM for the Sialon II survey: Time-Loca-
tion Sampling (TLS) and Respondent-Driven Sampling (RDS). The first procedure is based on venues where the 
target population congregates, whilst the second is based on a peer-to-peer recruitment process. Preliminary 
formative research was carried out as well as dedicated training for data collectors and lab staff. A question-
naire for collecting behavioural data was developed in line with the international indicators (ECDC, GARPR) and 
lab procedures were identified according to both local standards and WHO guidelines. Finally, specific sampling 
weights procedures were followed in line with the two methods adopted. 
Introduction
In this Chapter, details of the sampling methods and procedures are provided for the Sialon II study. Spe-
cifically, a general introduction to TLS and RDS methods is presented including a brief consideration of their 
advantages and disadvantages. This chapter provides Information about formative research, the data collection 
locations, including selection of recruitment sites, and the study design, including the sample size, inclusion/
exclusion criteria, tool development and implementation procedures. A description of the behavioural ques-
tionnaire and laboratory procedures conducted for the biological component of the survey are also presented. 
The Chapter ends with a detailed consideration of the data management and analytical procedures adopted, 
including the weighting systems. 
Introduction to TLS and RDS methods
Two different probability sampling methods were used to sample MSM for the Sialon II survey: Time-Lo-
cation Sampling (TLS) (Williamson, 2007; Stueve, 2001) and Respondent-Driven Sampling (RDS) (Heckathorn, 
3. Methods
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1997). According to the literature, these methods are considered effective in gathering representative samples 
of populations that are considered hard to reach or hidden (Montealegre, 2013; Malekinejad, 2008). 
TLS approximates random cluster sampling whereby everyone attending the cluster (or venue) has an equal 
chance of inclusion but are sampled as a group. The basis for TLS is to construct a ‘universe of venues’ where 
the target population congregates and to select randomly the venue, day of the week, and time of day (venue-
day-time [VDT] units) from this universe. Eligible persons from these units are then sampled randomly. Fol-
lowing data collection, data are analysed to adjust for any cluster effects. A complete venue universe serves as 
the sampling frame and is essential for TLS being considered (at least theoretically) as a probability sampling 
method. The venue universe is also a useful tool for understanding the geography and diversity of the target 
population. 
Respondent Driven Sampling (RDS) is a chain-referral sampling method that incorporates numerous the-
oretical and analytical assumptions to provide representative estimates of the network of the population sam-
pled. RDS recruitment begins with a set number of individuals or ’seeds’, selected purposefully from the target 
population. Seeds are trained to recruit a set number of individuals from their social network of peers. The 
recruits of the seeds who enrol in an RDS survey are also trained to recruit a set number of individuals from 
their social network of peers. Seeds and recruited participants typically receive incentives in return for their 
participation (referred to as primary incentives) and for referring additional recruits (secondary incentives). 
Ideally, this process results in long recruitment chains made up of several ’waves’ of recruits. As recruitment 
chains lengthen, the composition of the sample becomes less dependent on the purposefully selected seeds 
and the sample becomes increasingly similar to the population being sampled. RDS also involves a complex 
analytical component crucial for generating population estimates and confidence intervals using data collected 
about each participant’s social network size and recruitment patterns. 
Pros and cons of TLS and RDS methods
TLS is useful for recruiting MSM who attend different types of gay venues in a given city. The formative 
research stage of TLS is particularly important in the recruitment process as it allows the identification of all 
venues (locations) at which enough persons from the population of interest could be found on some day during a 
period of at least 4 hours to make recruitment feasible (Karon, 2012). However, TLS misses members of the tar-
get population (in this case MSM) who never or rarely attend venues. Therefore, estimates from TLS represent 
only ‘visible’ MSM, that is, MSM who are attending the gay scene (the venues that were selected through the 
formative research in each study site). TLS is prone to systematic bias when a complete and accurate universe 
of the venues cannot be created. This may be because sites change between the mapping and study initiation 
period (e.g. venues closing down or new ones opening), venue owners do not allow access, or venues are too 
hidden or dangerous to map. Implementing TLS requires resources to perform a comprehensive mapping of 
all venues as well as keeping accurate and thorough records of the enumeration and mapping process, and to 
conduct data collection at often unsociable hours. 
RDS is one of the most widely used methods to sample the most hidden and hard to reach populations world-
wide, including those who are not visible at venues (Montealegre, 2013). However, if the population of interest is 
not socially networked, other sampling methods should be considered. Compared to TLS, RDS is better suited for 
allowing researchers to collect blood and serum samples for testing because participants must enrol in the study 
at a fixed site. Having a fixed site also allows for the delivery of counselling and test results and fewer distractions 
for participants completing self-administered questionnaires. RDS is also useful for providing opportunities to de-
liver health promotion or HIV prevention interventions to participants (Latkin, 1999). As RDS relies on participants 
to recruit their peers, research staff are not required to engage with potential participants, thereby conceivably 
increasing accessibility to the study. Nevertheless, like TLS, RDS requires rigorous management by trained staff 
to collect data on who recruited whom and to measure each participant’s social network size, both of which are 
essential to conducting data analysis. Some studies comparing RDS and TLS samples (Kendall, 2008; Zhao, 2014) 
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have shown that each method is prone to sample MSM from dissimilar segments of the population. For instance, 
RDS has been known to over-represent MSM subgroups that are younger and are from lower SES group (Sabin, 
2014) and in the case of the SAILON II study, MSM sampled with RDS in Bucharest comprised a network of MSM 
who injected drugs and sold sex. This can result in different sample characteristics, and the differences may 
persist also after these data are weighted. It is, therefore, important to understand the underlying network struc-
ture of the population to clearly define the final denominator in the sample. As RDS is a network based sampling 
method, analysis is particularly complex and requires the use of open source software such as RDSAT (www.
respondentdrivensampling.org) or RDS Analyst (www.hpmrg.org).
In conclusion, RDS is particularly useful for sampling more hidden segments of the MSM population, includ-
ing those MSM who are not visible at venues. Both TLS and RDS may end up sampling different subsets of the 
total population of MSM. However, this is a minor limitation as long as the subset being sampled is known and 
described when presenting results. Although neither RDS nor TLS is perfect, they are the only probability based 
methods available for sampling hard to reach and hidden populations. For the Sialon II studies, the availability 
of TLS and RDS methods allowed for countries to adapt a rigorous sampling strategy based on the context of 
the region and the population profile of MSM. 
Data collection locations
Data generated through TLS and RDS methods were collected in 13 EU countries: Belgium, Bulgaria, Ger-
many, Italy, Lithuania, Poland, Portugal, Spain, Romania, Slovakia, Sweden, Slovenia, and the United Kingdom. 
Table 3.1. Sampling method, country, city and associated and collaborating partners
Sampling method Country City Associated and Collaborating partners
Time-Location 
Sampling
Belgium Brussels 
Institute of Tropical Medicine (Antwerp); Rainbow House(Brussels); Sen-
soa (Antwerp)
Bulgaria Sofia
NCIPD, National Reference Laboratory of HIV (Sofia); Association Health 
without Borders Bulgaria (Sofia)
Germany Hamburg
Robert	Koch-Institute	 (Berlin);	Hein&Fiete	 (local	HIV-prevention	agency	
in Hamburg) 
Poland Warsaw
National Institute of Public Health – National Institute of Hygiene (War-
saw); Lambda Warsawa Association (Warsaw) 
Portugal Lisbon Instituto Higiene e Medicina Tropical (Lisbon); GAT (Lisbon)
Slovenia Ljubljana National Institute of Public Health (Ljubljana); SKUC Magnus (Ljubljana)
Spain Barcelona
Centre d’Estudis Epidemiològics sobre la Sida de Catalunya - CEEISCAT 
(Barcelona); STOP SIDA (Barcelona)
Sweden Stockholm Swedish Institute for Communicable Disease Control (Stockholm)
UK Brighton
Centre for Health Research, University of Brighton (Brighton); Terrence 
Higgins Trust (Brighton)
Respondent-Driven 
Sampling
Italy Verona
Azienda Universitaria Ospedaliera Integrata, Regione Veneto (Verona); 
Istituto Superiore di Sanità (Rome); Arcigay – Italian LGBT Association 
(Bologna – Verona)
Lithuania Vilnius Centre for Communicable Diseases and AIDS (Vilnius)
Slovakia Bratislava Slovak Medical University (Bratislava)
Romania Bucharest
National Institute of Infectious Diseases “M Bals” (Bucharest); ACCEPT 
(Bucharest); ARAS (Bucharest)
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The bio-behavioural survey was implemented using TLS in nine countries (Belgium, Bulgaria, Germany, Poland, 
Portugal, Spain, Sweden, Slovenia, and United Kingdom) and RDS was implemented in four countries (Italy, 
Lithuania, Romania, and Slovakia). The institutions involved in Sialon II included those also involved in Sialon I 
as well as additional institutions and are listed in Table 3.1. 
With the collaboration of UNAIDS and WHO, the procedures (protocols, UNGASS / GARPR / ECDC indicators, 
epidemiological algorithms) and prevention strategies developed in the context of the Sialon II studies. These 
materials were also shared in Armenia and Moldova who chose not to undertake the Sialon II study since they 
were conducting national biological and behavioural surveillance studies of MSM.
Formative Research
Formative research, conducted in each participating country, involved representatives from the gay commu-
nities in each city and key informants. For both TLS and RDS, formative research was used primarily to provide 
a comprehensive ‘picture’ of each study area, including demographic characteristics, the proportion of MSM 
among the adult male population, the degree of ‘outness’ reported by MSM in the study area, self-reported 
internalised homonegativity, gay-venue attendance, and self-reported HIV and STI history. For TLS, formative 
research involved identifying and mapping MSM venues and time segments and attendance at those venues, 
creating an initial ‘universe’ of venues, exploring and anticipating safety issues for fieldwork, and developing 
relationships with venue owners to secure their participation. For RDS, formative research involved identifying 
the underlying structure of MSM networks and selecting appropriate study sites (e.g. easy for MSM to find, 
quiet, private, safe, and comfortable). 
In line with the approach adopted to conduct the formative research, specific activities were foreseen, such 
as media reviews, interviews, observation, enumeration data, and gathering logistical characteristics. When 
necessary, key informant interviews were conducted with MSM researchers, health providers, venue owners or 
managers and staff of community-based organisations and commercial and social venues. 
Selection of study sites: TLS
During the formative research phase, TLS research teams met with venue owners or managers to solicit 
their approval to conduct the survey on their property. If an owner was unable to provide sufficient information 
regarding attendance patterns for a specific venue (e.g. at cruising settings), with their permission, a member 
of the research team attended the venue in order to count and characterise MSM in attendance. A list of gay 
venues was therefore established in each city participating in the study. 
Information about the different study sites was collected via a combination of a dedicated questionnaire and 
access to secondary data from the European MSM Internet Survey (EMIS) (The EMIS Network, 2013). The ques-
tionnaires were completed by each project partner from the respective study country in partnership with their 
local collaborating partner (e.g. NGO). Each questionnaire explored a number of areas such as: the proposed 
study site; previous experiences with different study methodologies and target groups; data on gay-friendly 
commercial and non-commercial sites; testing opportunities, regulations, and treatment guidelines for HIV, 
STIs, HBV, and HCV; legislation relating to gay issues (e.g. date of homosexuality being legal, possibility of gay 
marriage or officially recognised civil partnerships, protection from discrimination regarding sexual orientation 
etc.) and; stigmatisation.
For the universe of venues to be identified, the questionnaire was divided into different sections for collecting 
information on: who attends the venues; MSM patterns of attendance during specific days and times; special 
events including frequency (e.g. parties, parades); proportion of MSM among venue attendees, safety issues, 
owner’s agreement to participate, logistical characteristics, and other useful contextual information. Together, 
these data were used to estimate the number and proportion of eligible MSM who attended VDTs. 
Any commercial or non-commercial location attended by MSM could be included as a venue in the universe. 
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One exception were venues that specifically served HIV-positive members of the target population given including 
these types of venues would artificially increase the representation of HIV-positive individuals in the final sample.
Venues considered eligible were (if available) commercial (cafés, discos/clubs, bars, sex shops, sex clubs, 
sex cinemas, and saunas) and non-commercial (cruising settings, gay community centres, gay pride events, 
and other special events). Once an initial list of venues had been established through the formative research 
process, MSM venues and VDT units were then defined. This process was completed approximately two months 
before data collection by the respective country TLS researcher in partnership with a specified field coordinator 
from their local gay NGO. 
Selection of study sites: RDS
RDS study sites were selected based on various criteria such as being accessible (easy to find), quiet and 
private (confidential), safe (both for research staff and participants, especially in terms of collecting biological 
specimens), and comfortable. In order to guarantee safety and confidentiality, study site locations were selected 
through the involvement of the local gay communities in each participating city and in partnership with the local 
health services.
Members of the RDS research team ensured participants were eligible, felt relaxed and comfortable, and 
understood and consented to the survey process. Researchers used feedback from participants to identify and 
evaluate necessary improvements to the data collection process. This feedback loop helped in securing the 
enrolment of other participants recruited by peers. All RDS researchers received substantial training to collect 
data and on how to implement the concurrent interactive prevention activities (e.g. distribution of information 
packs containing condoms and lubricant, and relevant information leaflets). 
Study design
The Sialon II studies are cross-sectional studies. For TLS, a three-stage sampling design was adopted in-
cluding the random sampling of venues, venue-day-time locations (VDT), and participants (individuals). For 
RDS, a multi-centre biological and behavioural cross-sectional design was adopted. 
Sample size calculation
TLS and RDS sample sizes were calculated using an estimated HIV prevalence of 15%, which is one of the 
higher estimates among those observed in the former Sialon I study. In addition, a confidence level of 95%, a 
precision of 5% and a design effect of 2 (to account for the sampling method not being a traditional random 
sample) were used to calculate a final sample size of 392, rounded up to 400 at each site. A sample size of 400 
was assessed as being sufficient in order to allow an estimation of HIV prevalence with a 95% confidence inter-
val of +/- 5% if the prevalence is 15%. According to preliminary available data, in many countries the prevalence 
was likely to be lower, with the consequence that the estimate would have had an even broader confidence in-
terval and thus a larger sample size would have been required. Based on experiences of using TLS in the Sialon 
I study, it was estimated that approximately 50% of the persons approached to participate in the study would 
refuse to take part. This means that in each city, data collectors would have to approach around 800 people in 
order to collect data for 400. 
Inclusion and exclusion criteria
The inclusion criteria included male participants who: 
•	 Had	any	kind	of	sex	(penetrative	or	not)	at	least	once	with	a	man	during	the	last	12	months;
•	 Were	18	year	and	older;
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•	 Provided	anonymous	informed	consent	to	take	part	in	the	study;
•	 Agreed	to	answer	the	study	questionnaire;
•	 Agreed	to	donate	an	oral	fluid	sample	(TLS);	
•	 Agreed	to	donate	a	blood	sample	(RDS);
•	 Had	a	valid	coupon	(except	for	the	seeds	in	RDS).
Exclusion criteria were defined as follows:
•	 Having	already	participated	in	the	study;
•	 Not	having	a	coupon	(RDS).
Tools development
Several different research tools were developed specific to TLS and RDS. All tools were developed in collab-
oration with the partner NGOs in order to ensure that they were locally relevant, informed by gay communities, 
and could assist in ensuring data collection uniformity. These main tools were: 
•	 A	training	module	for	TLS	and	RDS	research	teams;	
•	 A	prevention	and	training	manual	(including	findings	from	the	formative	research);	
•	 A	training	module	for	laboratory	technicians	on	virological	procedures;
•	 A	behavioural	questionnaire;
•	 An	HIV/STI	prevention	package.
Training module for TLS and RDS research teams 
The training module included two different training and data collection tools according to the TLS and RDS 
method. 
The TLS module included ten core components as follows:
1. TLS sampling manual for detailing the sampling procedures and on how the sample frames are con-
structed. Two specific forms were provided to assist the completion of the first and second sampling 
frames; 
2. TLS data collection manual describing how to collect bio-behavioural data from participants through 
gay venues according using TLS methods;
3. VDT form for data collectors to summarise the number of collections assigned to every pair of data 
collectors according to the sampling plan;
4. A record form to record the unique barcodes from questionnaires along with the name of the data col-
lector, specific VDT, and date of collection;
5. Oral-fluid sample delivery receipt to manage the delivery procedure of the samples from the data col-
lectors to the laboratory; 
6. Informed consent form to be signed by the participant in order to formalise consent to participate in the 
study;
7. Participant information sheet for participants to keep, setting out the study’s aims and procedures, 
ethical considerations, issues and participant’s rights (e.g. right to withdraw, data protection etc.); 
8. Interactive HIV/STI prevention card including separate barcode: A graphically designed card to be given 
to participants which included a unique barcode necessary to collect personal test results, and a de-
tachable card with an interactive HIV/STI prevention activity to assess the prevention knowledge level of 
the participant and stimulate a prevention conversation with the data collector;
9. Refusal form on which refusals to participate were recorded along with basic contextual information 
(e.g. approximate age, reason for refusal if offered etc.);
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10. Questionnaire manual used as guidance for data collectors when administering the behavioural part of 
the survey.
The RDS module included eight core components as follows:
1. RDS data collection manual describing how to collect bio-behavioural data from participants according 
using RDS methods;
2. RDS software package for the automatic generation and printing of individualised materials (e.g. cou-
pons, result card, barcoded questionnaires, etc.) for each participant as well as the generation of RDS 
record (excel) files;
3. Informed consent form to be signed by the participant in order to formalise consent to participate in the 
study;
4. Participant information sheet for participants to keep regarding the study’s aims and procedures, eth-
ical considerations, issues and participant’s rights (e.g. right to withdraw, data protection etc); 
5. RDS interview questionnaire/grid with specific items on the respondent’s network structure and rela-
tionships (personal network size, number of peers who the respondent knows personally in a specific 
period of time etc.). An additional item measured the relationship between the participant and his re-
cruiter. As an improvement of the RDS methodology, respondents were also requested to indicate the 
last four figures of each potential peer’s mobile number, with their first initial. This helped to map the 
social network more precisely, even if anonymously, allowing a detailed re-construction of the partici-
pant’s personal network;
6. Recruitment coupons (3+1) consisting of three coupons to be given to three other possible participants 
by the recruited person and one coupon (voucher) for the collection of the secondary incentive;
7. Result card (coupon-voucher) for the collection of an individual’s test results;
8. RDS follow up questionnaire/grid measuring the recruitment process in the participant chain.
Prevention and Training Manual 
The prevention and training manual included two core components:
1. Formative research report with information on the study sites in each country including prevention 
issues highlighted through EMIS data;
2. Prevention training manual which included the underpinning conceptual base of the prevention activi-
ties, namely, the minority stress model (Meyer, 2005) and the information-motivation-behavioural skills 
model (Fisher and Fisher, 1992) for the training of the data collectors in prevention, especially for the 
TLS part, and the guidelines for the use of the Sialon II information packs and the interactive prevention 
card.
Training module for laboratory technicians 
This tool provided guidelines for the laboratory technicians involved in the analysis of the biological samples 
for TLS and RDS. Detailed information on the laboratory procedures to be followed for testing oral fluid as well 
as testing on blood were provided. 
Behavioural questionnaire 
The Sialon II behavioural questionnaire was developed by building on existing (and already standardised) 
questionnaires from two previous EU-funded projects, namely Sialon I and EMIS. In line with the UNGASS-GARPR 
and ECDC behavioural indicators, the Sialon II questionnaire was designed to elicit a range of behavioural and 
socio-ecological data including: prevention needs; sexual behaviours; service access; socio-ecological aspects 
of the environment; risk behaviours; HIV testing in the last 12 months; proportions of MSM reached through HIV 
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prevention programmes; condom use at last anal sex, and; estimates of HIV infection. In addition, the question-
naire was also designed to include specific items on sexual health and well-being based on recent recommen-
dations from the WHO (WHO, 2010). These items included sexual satisfaction (TLS and RDS), and safety and 
autonomy (RDS only). 
In order to have a shared and participatory process in designing the questionnaire, the draft version was 
distributed among partners (including partner NGOs) for comments and amendments. The final version of the 
questionnaire was translated into national languages, back-translated and then piloted. As noted above, a com-
panion questionnaire manual was also developed in order to guide data collectors during implementation and 
increase uniformity in procedures with a view to guaranteeing uniformity in data collection across the different 
cities. The manual was a core component of the training module for data collectors. 
Laboratory procedures
Laboratory testing guidelines were developed taking into account both the international ‘gold-standards’ for 
HIV and STI testing and the local laboratory procedures in each participating country, as well as the WHO-STI 
surveillance guidelines. 
With regards to the TLS survey, oral fluids (OF) were collected using Oral Specimen Collection Devices (ORA-
COLE) or swabs at room temperature in gay venues. Each plastic tube containing an OF specimen was labelled 
with the same unique barcode as the questionnaire of each participant. After collection, OF were stored be-
tween 4°C-8°C and transported at room temperature to the laboratory within 72 hours of collection. On receipt 
by the testing laboratory, tubes containing the swab were filled with 1.0 ml of recovering buffer and vortexed for 
20 seconds. 
Swabs were then removed from the tubes, squeezing and twisting the sponge against the plastic wall, in-
verted and placed back inside the tube. Tubes were capped and centrifuged at 805g for 5 minutes at room tem-
perature to extract the OF. OF was then transferred to a sterile microfuge tube (Sarstedt, Numbrecht, Germany) 
and stored at -20° C until needed for testing.
The quality of the HIV-negative oral fluid samples was established by measuring total IgG using Human IgG 
ELISA kit (Immunology Consultants Laboratory, Inc.). Before testing, each sample was diluted 1/250 with the 
buffer provided in the IgG kit. The negative samples with IgG concentration < 3.5 mg/L were considered invalid 
and excluded from the study.
Anonymous and confidential testing of HIV-antibodies from OF was conducted following the testing strategy 
recommended by the WHO (WHO, 2009) using commercial available diagnostic kits: Genscreen HIV ½ version 2 
(BIO-RAD) and Vironostika HIV Ag/Ab (Biomerieux). Usage of both of these kits was done according to standard 
diagnostic procedures with the exception of Vironostika when a double sample volume of oral fluid sample (100 
µl) was used comparing to serum. According to the research protocol, where an OF sample was HIV-reactive 
in one or both tests, participants (if they collected their results using their unique barcode) were provided with 
post-test counselling, and encouraged to re-test on blood via usual care pathways in their city of residence. 
With regards to the RDS component, blood samples were collected according to standard procedures. As 
with TLS, each plastic tube containing a specimen was labelled with the same unique barcode as the question-
naire of each participant. Each sample was then tested for HIV, HBV, HCV and Treponema pallidum infection. 
Anonymous and confidential testing of HIV infection on blood was conducted following WHO guidelines on test-
ing (WHO, 2007, 2009). Serum samples were tested with commercial EC marked 4th generation ELISA tests. An 
HIV positive sero-status was based upon the outcome of two or more tests relying on different antigens or of 
different operating characteristics for newly diagnosed individuals. A positive result was confirmed on a second 
sample using Western Blot. In each site 200 µL of serum were collected for every individual confirmed positive 
for HIV antibodies, stored at –20°C and were shipped to a central laboratory under refrigerated conditions for 
Avidity Index calculations. Participants with HIV-positive results were counselled and referred into local care 
systems for further management of their HIV status. 
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Data management and analysis
For data generated through TLS and RDS, a data entry tool was developed and piloted using the EpiData 
software ( EpiData Data Entry, Data Management and basic Statistical Analysis System. 2000-2008). The specific 
data entry template was adapted to the precise questionnaire format of the country in question (e.g. in terms of 
the precise order of questions, any extra questions, coding etc.). Each Sialon II partner received two data entry 
templates; one for the laboratory and questionnaire data, and one for the refusal form. Extensive instructions 
on the whole data entering process were provided.
All datasets were controlled and quality checked locally by project partners. Up to 10% of the total sam-
ple was double entered. All databases as well as double entry outputs were further cross-checked and then 
merged to form a common (TLS+RDS) dataset for analysis. 
Data management was carried out using DataEntry and R (v.13.1 and v.14.0). Additional cross-checks were 
performed with Stata. Data analysis was carried out using R (v3.1.0), Stata and SPSS. TLS estimates (including 
GARPR indicators) were calculated as proportions. Confidence intervals were calculated using the Normal 
approximation applying a Wald type formula i.e. the mean ± 1.96*standard error. In cases where a confidence 
interval limit went below 0% or above 100%, these were set to 0% or 100%. For RDS, estimates were weighted 
using the successive sampling estimate in RDS Analyst (www.hpmrg.org).
Weighting systems 
For the TLS survey data, incidence and proportion estimates were weighted and corrected using the meth-
ods described by Karon and Wejnert (Karon, 2012). Estimates were adjusted in three different ways simulta-
neously by taking into consideration: the design effect due to clustering of participants at the venue, and; the 
individual participant’s sampling weight.
Design effect (DE) quantifies the departure from a simple random sample design. DE was incorporated into 
the calculation of the standard error (SE) which assumed a simple random sample. The location (venue) was 
defined as the unit of clustering. A DE of one indicates that the sample was equivalent to a simple random sam-
ple, while a DE above one indicates clustering. In the cases where the DE is below one, the conclusion is that the 
sample was more efficient than a simple random sample. Where all or none of the participants were included 
in the numerator of the indicator (i.e. percentage equal to 0% or 100%), the DE was not possible to calculate.
Each TLS participant’s individual weight was calculated as the inverse of the product of three probabilities 
based on: the length of time of the time-location event; the number of sampled individuals during the event 
in relation to the estimated number of visitors during the sampling event, and; the participant’s frequency of 
attendance in the last three months at the particular venue where the participant was sampled. 
Due to many missing values in the variables on attendance at the specific venue, it was not possible to 
calculate directly the TLS sampling weight. Therefore an imputation was carried out for this variable using 
the method of chained equations, also known as the MICE method (van Buren, 2011). Predictors included the 
following: age, city of study, country of birth (study country or not), country of residence (study country or not), 
visitor or local resident, HIV status according to saliva test result, number of visits to the venue in the last 3 
months, and number of visits to venue type in the last 3 months. Ten rounds of imputations were conducted, 
and the median value of those was then calculated. The ceiling (i.e. rounding up to the next whole number) of 
the number of imputed visits was then used in the cases were the number of visits had not been given by the 
participant.
For RDS, data were weighted using the without replacement successive sampling estimator (Gile, 2010). This 
weighting procedure uses information about the recruitment patterns and each participant’s social network 
size to account for biases normally found in chain referral sampling methods. 
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Limitations 
The methodology adopted for the Sialon II study, from data collection to data analysis, incorporated the most 
advanced approaches in implementing bio-behavioural surveys, in line with the indications in scientific liter-
ature and international guidelines from ECDC, UNAIDS and WHO (UNAIDS/WHO, 2002; UNAIDS/WHO, 2000; 
Johnston, 2013). However, in certain specific cases, the Sialon II survey methods and related findings present 
some limitations. Such limitations are related either to the sampling methodology and tools adopted or to the 
characteristics of the data that are analysed and described in the present report. 
Sampling methods
One limitation of the Sialon II methodology related to the sampling methods adopted in the study. As already 
noted, subsets of the population may have been sampled depending on the sampling method used which may 
not represent the entire MSM population (Kendall, 2008; Zhao, 2014). For RDS, we know that some surveys 
have missed younger or older or MSM of particular socio-economic status. For TLS, we know that portions of 
the population that are not visible are missed. How these groups differ from the entire population is not known 
without further qualitative research. 
TLS is extremely useful for recruiting MSM who can be measured based on their attendance at different 
types of gay venues in a given city. As long as a thorough and complete mapping of all venues is conducted, the 
TLS sample should represent those MSM who are visible at these venues, which in many cities may be most 
MSM. In fact, it is assumed that MSM present in each specific VDT have an equal or somehow known chance 
of being enrolled in the study. In addition, it is assumed that a complete map of the VDT units is available in the 
selected sites and venues in the given city (refer to the Formative Research section). In any case, because of 
such assumptions, MSM who never or rarely attend the gay scene (selected venues) are de facto excluded from 
the study. 
RDS is particularly useful for recruiting more hidden and non-visible MSM. However, because RDS samples a 
network, failure to understand the parameters of that network may result in biased estimations when important 
subgroups are excluded from the sample. A thorough formative assessment of the population networks and 
strategic selection of seeds can reduce the chances that important subpopulations are missed in the sampling. 
RDS relies on two different levels of assumptions: functional and analytical. Functional assumptions are 
that MSM (i) should know one another as members of the survey population, and (ii) should be connected by a 
network composed of a single component. Analytical assumptions are that (i) MSM enrolled in the survey can 
accurately assess the number of other MSM (in line with the inclusion criteria) in their personal network size; 
(ii) the recruitment of other participants from the recruiter’s network is performed randomly (Volz, 2008; Heck-
athorn, 2007).
Tools 
The use of different sampling methods impacts the questionnaire development and administration proce-
dures. Due to the characteristics of the participants’ enrolment process through both the RDS and TLS surveys, 
two versions of the Sialon II questionnaire were developed. In both versions, the main core items were included, 
but due to practical constraints of data collection at the TLS venues – which required a shorter questionnaire 
– specific additional questions (e.g., commercial sex, detailed information on sex with female partners, etc.) 
were excluded. In many cases, the use of an explicit slang expression for items focusing on specific sexual be-
haviours was deliberate to disambiguate the question and avoid potential misunderstanding. Despite this, some 
items in the questionnaire could have been misinterpreted by some respondents. To limit questionnaire bias, 
the questionnaire was designed through a participatory process and the draft version was distributed among 
partners (including partner NGOs) for comments and amendments. The final version of the questionnaire was 
translated into national languages, back-translated and then piloted. In addition, a companion questionnaire 
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manual was also developed in order to guide data collectors during implementation and increase uniformity 
in procedures across the different cities. Piloting of items and procedures was carried out in order to ensure 
understanding of the questions and uniformity of the data collection process. In addition, the Sialon II ques-
tionnaires incorporated the main international indicators for bio-behavioural surveys, in line with the WHO and 
ECDC recommendations (UNAIDS/WHO, 2002; WHO, 2010; UNAIDS/WHO working group on global HIV/AIDS 
and STI surveillance, 2011; UNAIDS, 2008). 
Sample composition
The sample compositions differed in some countries. For instance, the proportion of study participants 
younger than 25 years was larger in Central/Eastern European cities than in Western European study sites. 
In very specific cases, the precision of the estimate for the younger age group is questionable as the sample 
sizes were relatively small (<50). This is most likely explained by the different age structure of the MSM popu-
lation approachable by surveillance studies across different cities. It does probably not reflect a more difficult 
access to young MSM in Western Europe, but rather a more difficult access to older MSM in Central/Eastern 
Europe sites. Older MSM in Central/Eastern Europe have grown up in a much more homophobic environment 
with a lack of gay infrastructure like commercial and non-commercial gay venues. Some of the differences in 
the GARPR indicators could be associated with these age differences, and also with the different time-points of 
onset of the HIV epidemic among MSM. 
In some cases confidence intervals are relatively wide and with small sample sizes for some cities, variable 
estimates must therefore be interpreted cautiously. For instance, stratification by age was not possible for cer-
tain variables due to the low numbers of participants who declared engaging in specific sexual behaviour (e.g. 
commercial sex activities).
A closer look at behavioural variables in different TLS cities and a comparison with the samples from the 
same study areas in the EMIS survey (The EMIS Network, 2013) suggests that different segments of the total 
MSM population were reached in the gay venues which were selected for the recruitment of study participants. 
For example, gay bars/cafes where gay couples go out for socialising rather than for seeking sex partners are 
less present in the Central/Eastern European cities than in the Western European cities. This may affect the 
composition of the relatively small younger age groups (<25 years) in Western European cities, but may also 
affect the sample from Sofia. While the high self-reported testing rates and scores for the ‘having been reached 
by prevention’ indicator are indicative of the good work of the NGO which recruited the participants for the study, 
this sample is probably less representative for the general MSM population of the study city/country as com-
pared to the TLS samples from other cities.
Another aspect is the inclusion of tourists from other countries and nationals not residing in the study city in 
the samples. The proportion of tourists varies considerably between TLS cities, and tourists are nearly absent 
in the RDS samples. However, since the weighting procedure was based on the frequency of venue visits (less 
frequent visits are associated with higher weights), tourists may get disproportional high weights which may 
bias weighted estimates according to the proportion of tourists. 
Comparability and generalisability of the samples
In line with the methodology adopted in this multi-centre bio-behavioural cross-sectional design, survey re-
sults cannot be compared across the different study sites (as this was not the purpose of this multi-site project), 
and the generalisation of the estimates to the overall MSM population might be problematic. 
Findings based on the data collected though TLS can be generalised only to the population of MSM attending 
the gay scene in the given study site. Similarly, estimates based on the RDS data can be generalised to the net-
work of MSM who live, work or socialise in the given study city area, in line with the inclusion criteria. Data related 
to RDS surveys refer to networks (and not to individuals) recruited through the survey: this could lead to the 
exclusion of some potential hidden sub-populations that are not well connected with the larger network of MSM. 
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In line with this approach, data are considered, analysed and presented separately, for each study site, with-
out grouping or comparing different cities estimates. 
In some Sections (e.g. those focusing on sexual behaviours), TLS and RDS datasets were combined to pres-
ent aggregated data in circumstances where actual numbers were particularly low, although this detours from 
the strict statistical and epidemiological assumptions behind the Sialon II study. Nevertheless, as long as these 
results are interpreted with caution, combining the datasets offers additional insight into the characteristics 
and behaviours of MSM which may be useful in developing future prevention actions. 
References
EpiData Data Entry, Data Management and basic Statistical Analysis System. 2000-2008. (n.d.). Odense Den-
mark: Lauritsen JM. (Ed.), EpiData Association.
Heckathorn, D. (2007). Extensions of Respondent-Driven Sampling: Analyzing Continuous Variables and 
Controlling for Differential Recruitment. Sociological Methodology, 37(1): 151-207.
Heckathorn, D. (1997). Respondent-Driven Sampling: A New Approach to the Study of Hidden Populations. 
Social Problems, 44(2):174-199.
Johnston, L. (2013). Introduction to HIV/AIDS and sexually transmitted infection surveillance: Module 4: In-
troduction to Respondent Driven Sampling. Geneva: World Health Organization.
Karon, J. (n.d.). Retrieved from www.amstat.org/sections/srms/Proceedings/y2005/Files/JSM2005-000306.pdf
Karon, J. (2012). Statistical Methods for the Analysis of Time–Location Sampling Data. Journal Urban Health, 
89(3): 565–586.
Kendall, C. (2008). An empirical comparison of respondent-driven sampling, time location sampling, and 
snowball sampling for behavioral surveillance in men who have sex with men, Fortaleza, Brazil. AIDS Be-
haviour, Jul;12(4 Suppl):S97-104.
Latkin, C. (1999). Social network approaches to recruitment, HIV prevention, medical care, and medication 
adherence. Journal of acquired immune deficiency syndromes, 63(1):S54.
Malekinejad, M. (2008). Using respondent-driven sampling methodology for HIV biological and behavioral 
surveillance in international settings: a systematic review. AIDS Behavior;12(4 Suppl):S105-30.
Montealegre, JR. (2013). Respondent driven sampling for HIV biological and behavioral surveillance in Latin 
America and the Caribbean. AIDS Behavior;17(7):2313-40.
Sabin, K. (2014). Epidemiological Challenges to the Assessment of HIV Burdens among key populations: 
respondent driven sampling, time location sampling and demographic and health surveys. Current Opinion in 
HIV and AIDS. 9(2):101-6.
Stueve, A. (2001). Time-space sampling in minority communities: results with young Latino men who have 
sex with men. American Journal of Public Health, 91(6): 922-6.
UNAIDS/WHO (2000). Guidelines for second generation surveillance. Geneva: World Health Organization.
UNAIDS/WHO (2002). Initiating Second Generation HIV Surveillance Systems: Practical Guidelines. Geneva: 
World Health Organization.
UNAIDS (2008). Monitoring the Declaration of Commitment on HIVAIDS. Guidelines on construction of core 
indicators – 2008 Reporting UNGASS. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS).
41The Sialon II Project. Report on a Bio-behavioural Survey among MSM in 13 European cities
UNAIDS/WHO working group on global HIV/AIDS and STI surveillance. (2011). Guidelines on surveillance 
among populations most at risk for HIV UNAIDS/WHO working group on global HIV/AIDS and STI surveillance. 
Geneva: World Health Organization.
van Buren, S. (2011). MICE: Multivariate Imputation by Chained Equation in R. Journal of Statistical Software, 
45(3).
Volz, E. (2008). Probability Based Estimation Theory for Respondent Driven Sampling. Journal of Official 
Statistics, 24(1):79-97.
Williamson, LM. (2007). HIV prevalence and undiagnosed infection among a community sample of gay men 
in Scotland. Journal of Acquired Immune Deficiency Syndromes, 45(2): 224-30.
World Health Organization. (2010). Measuring sexual health: conceptual and practical considerations and 
related indicators. Geneva: World Health Organization.
Zhao, J. (2014). A Comparison Between Respondent-Driven Sampling and Time-Location Sampling Among 
Men Who Have Sex with Men in Shenzhen, China. Archives of Sexual Behaviour, 44(7):2055-65..
Authors
Lorenzo Gios
Coordinamento Regionale per il Management e la Progettazione Europea, 
Azienda Ospedaliera Universitaria Integrata, Verona, Italy
Igor Toskin 
Department	of	Reproductive	Health	&	Research	World	Health	Organization,	Geneva,	Switzerland
Massimo Mirandola 
Infectious Diseases Section, Department of Pathology - Verona University Hospital - 
Veneto	Region	&	Coordinamento	Regionale	per	il	Management	e	la	Progettazione	Europea,	
Azienda Ospedaliera Universitaria Integrata, Verona, Italy
nigel Sherriff 
Centre for Health Research CHR, University of Brighton, Brighton, UK
Paolo Guglielmetti 
European Commission, DG SANTE, Policy Officer responsible for Sialon II
Cinthia Menel-Lemos 
European Commission, CHAFEA, Project Officer responsible for Sialon II
We would like to acknowledge the invaluable contribution of Teymur Noori 
of the ECDC for his excellent suggestions and comments during the production of this report
43The Sialon II Project. Report on a Bio-behavioural Survey among MSM in 13 European cities
Summary
Due to the potential sensitivity of a bio-behavioural survey on MSM institutions and gay communities in each 
country were involved in the project from the outset informing all aspects of the project planning, development, 
implementation, and evaluation. Additional stakeholders and experts were also involved technically and to advise 
on ethical issues related to the study protocols (e.g. the WHO and ECDC). In parallel to the partner institutional 
review process, the Sialon II protocols were also submitted to and approved by the WHO Research Project Review 
Panel (RP2) and to the WHO Research Ethics Review Committee (WHO-ERC). 
In line with the principles of anonymity and confidentiality, a specific barcode system was adopted to facili-
tate linkage between an individual’s biological sample and their behavioural survey responses. 
Considerable care was taken in the preparation of all project documentation and dissemination materials to 
minimise the potential for misuse or misinterpretation of survey findings. 
Introduction 
In this Chapter, details are provided of some of the key ethical considerations addressed in the Sialon II 
project. Given the complexity of the research design, attention is paid to a number of different ethical issues re-
lating to recruitment, informed consent, data storage, vulnerability of the study participants and compensation, 
liability for data collectors, and access to treatment and/or counselling. Towards the end of the Chapter, issues 
relating to the environmental impact of the project, monitoring of the survey, and dissemination of the project’s 
results are outlined. 
Overview of ethical considerations
The Sialon II survey collected biological samples and linked behavioural information from MSM through 
complex procedures across 13 different European countries. Such a large-scale undertaking in countries with 
4. Ethical considerations
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sometimes quite different national regulations regarding ethical and governance issues (e.g. relating to privacy, 
confidentiality, and informed consent rules) raised a number of both specific and more general challenges. 
Consequently, very specific and clear ethical and governance procedures were required in order to comply with 
all local, national, and European guidance on ethical and legal conduct in research with human participants, as 
well as to minimise the risks of mistakes (including potential diagnostic mistakes). 
In general, conducting bio-behavioural surveys on sensitive topics such as sexual orientation, sexual be-
haviours, and HIV/STI status can be problematic in that any data or findings can potentially be misused or 
misinterpreted reinforcing MSM related stigma and discrimination. Consequently, as noted in Chapters 2 and 
3, gay communities in each country were involved in the project from the outset informing all aspects of the 
project. Additional stakeholders and experts were also involved technically and to advise on ethical issues (e.g. 
the WHO and ECDC). The Sialon II study protocols were submitted to the local ethics committee (and sometimes 
governance committee depending on requirements) in each participating city by the relevant project partner. In 
all sites, full ethical approval was gained prior to the commencement of any data collection activities. 
In parallel to the partner institutional review process, the Sialon II protocols were also submitted to the 
WHO Research Project Review Panel (RP2). RP2 is tasked with providing a review for research projects proto-
cols, particularly on the technical and methodological components of the survey. The RP2 committee analysed 
the protocols ensuring the rigorous quality of both procedural and methodological issues related to the entire 
survey process. Following feedback and fine tuning, the final Sialon II protocols were approved in 2012.
As an additional step, the RP2 approved protocols were also submitted in 2013 to the WHO Research Ethics 
Review Committee (WHO-ERC). The WHO-ERC is an international ethics committee in charge of evaluating and 
setting high quality and ethical standards in all research supported by the WHO. The WHO-ERC acts in accor-
dance with the World Medical Association’s Declaration of Helsinki on Ethical Principles for Medical Research 
Involving Human Subjects [sic] (World Medical Association Declaration of Helsinki, adopted by the 18th WMA 
General Assembly, Helsinki, Finland, June 1964 and amended by the 59th WMA General Assembly, Seoul, Octo-
ber 2008), the International Ethical Guidelines for Biomedical Research Involving Human Subjects [sic] (Council 
for International Organizations of Medical Sciences (CIOMS), 2002) as well as the International Guidelines for 
Ethical Review of Epidemiological Studies (Council for International Organizations of Medical Sciences (CIOMS), 
2009). The Sialon II protocols were approved by the WHO-ERC in February 2013, and thus became a WHO col-
laborating study. Consequently, periodical monitoring reports on the status of the survey implementation were 
prepared and submitted regularly to the WHO-ERC committee for review and approval. 
A detailed description of some of the key ethical issues in the project is reported in the following sections.
Ethical issues in recruitment, gaining informed consent, and data storage 
Recruitment and informed consent
The Sialon II survey adhered vociferously to principles of anonymity and confidentiality for participants 
throughout the research process. For instance, to adhere to these principles and comply with all ethical and 
legal obligations, in TLS and RDS recruitment and for the entire data collection process, the name of the par-
ticipant was not collected at any time. Instead to facilitate linkage between an individual’s biological sample and 
their behavioural survey responses (as well as other documents), a barcode system was developed. Barcodes 
were unique to each participant and attached adhesively to the biological collection device, the behavioural 
questionnaire, informed consent form, and interactive prevention card with an additional detachable card to 
allow participants to collect their results anonymously. 
To gain informed consent, a precise and staged-consent process was developed to ensure that participants 
had the opportunity to participate anonymously (or refuse participation without explanation), to understand fully 
any risk to participation, the limitations to the project and testing procedures (e.g. highlighting the project was 
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primarily for surveillance rather than diagnostic purposes), and to guarantee the right to withdraw consent at 
any time. 
During data collection, members of the research team approached potential participants and offered them 
prevention materials as means of engagement and as an HIV prevention outreach activity. If initial verbal con-
sent to proceed was received, participants were then offered a detailed participant information sheet (PIS). 
The PIS included a description of the project, provided information on what participation entailed, as well as 
explained issues of confidentiality, anonymity, and how to find out more information about the project even after 
the data collection was complete. If at this point participants were willing to proceed and understood what that 
meant, they were asked by the researcher to complete a consent form. As a further measure to secure the pro-
tection of an individual’s anonymity, the consent forms allowed participants to simply make a mark (such as a 
cross) rather than provide a potentially identifiable signature. At the end of the data collection process, consent 
was checked again by the researcher to ensure participants were still happy for their data to be used. 
Although Sialon II is an epidemiological project, ethically participants should nevertheless be able to receive 
their test results. Thus, results from the TLS arm of the study were made available to participants approxi-
mately one week after the date of the sample collection. Using the unique barcode given to them during data 
collection, participants were able to receive their result in person and receive post-test counselling if desired. In 
compliance with ethical protocols and to minimise the impact of any potential diagnostic mistakes, respondents 
who requested their result were informed that they were not diagnostic and that they should be tested again 
with another test performed on serum according to WHO/UNAIDS and/or national algorithms for HIV testing. 
Additional testing for Syphilis, HBV and HCV were offered where possible depending on the city in question. 
Information on where to access such additional tests or medical checks using local health care service pro-
vision was always provided. For instances of HIV-positive cases, in each country a referral system was agreed 
locally to ensure (i) additional testing for confirmation if needed, (ii) prompt treatment, and; (iii) follow-up ses-
sions. Furthermore, the availability of ARV treatment for those diagnosed HIV-positive was guaranteed as well 
the management of concomitant infections. In case a participant decided to reject the offer of confirmatory 
testing, he was invited to sign a specific consent form to attest this. 
Data storage procedures
All biological samples were stored according to the study protocols before being shipped to the respective 
laboratories. Any samples without a ‘signed’ informed consent form were not sent for testing and destroyed. 
With regard to the behavioural data, paper copies of the completed questionnaires and related forms (e.g. con-
sent forms, refusal forms etc.) were kept by project partners in locked filing cabinets in appropriately secured 
rooms. In terms of data entry, security of data was controlled by having password protected access to project 
computer files. Specific procedures were in place during data entry to prevent loss of data due to technical dif-
ficulties. Supervision of the entire process was provided and assured by the partner responsible at local level. 
Ethical issues regarding vulnerability of the study participants
The vulnerability of participants in Sialon II related mainly to privacy issues given that involuntary disclosure 
of personal information and/or a HIV status can lead to stigmatisation and discrimination.
With regards to the TLS data collection, participants were approached in environments chosen by them (e.g. 
venues such as saunas, bars etc.) meaning that the issue of privacy was generally already addressed. As far as 
the RDS survey was concerned, participants were approached by their peers (i.e. other MSM) through existing 
social contacts who were themselves well aware of issues relating to privacy. However, to ensure all research-
ers (TLS) and peers (RDS) involved in data collection understood the need to protect participant’s privacy, spe-
cific in-person training on this issue was delivered prior to data collection being conducted. 
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Ethical issues regarding data collectors
Issues of personal safety for researchers conducting data collection in TLS and RDS were anticipated and 
addressed during project planning (e.g. via development of a training manual for data collectors which included 
safety issues), formative research (e.g. identifying potential ‘unsafe’ data collection environments during map-
ping), and through ethical and governance approval processes. Exact regulations regarding risk assessments, 
insurance coverage, and liabilities differed from country to country but were assessed, monitored, and overseen 
as appropriate by the local project partner. 
Ethical issues regarding compensation to study participants
No form of reimbursement or compensation for TLS participants was foreseen. However, according to the lit-
erature concerning implementation of the RDS method (Semaan, 2009), a participant should be compensated for 
the time and work involved in the recruitment of his peers. Consequently, for RDS two incentives were foreseen for 
each participant: a primary incentive for taking part in the first instance, and; a secondary incentive representing 
simple remuneration for recruiting additional peers to participate. The amounts and type of compensation for RDS 
participants for each study site were determined according to the results of the formative research.
Ethical issues in access to treatment and/or counselling 
All testing was entirely voluntary following initial discussions with the participant and their receipt of a PIS, 
followed by receipt by the researcher of a signed (mark or signature) informed consent form. As noted earlier in 
this chapter, TLS and RDS participants were able to receive their result in person and receive post-test counsel-
ling. In compliance with the approved ethical protocols, respondents who requested their result were informed 
that they were not diagnostic and that they should be tested again with another test performed on serum. Fur-
thermore, as also noted previously, additional tests for STIs were offered where possible. In TLS and RDS for 
instances of HIV-positive cases, referral systems were agreed with local health care providers. 
Ethical issues regarding the environmental impact of the project
All survey partners involved in TLS and RDS testing took responsibility for collecting and disposing of the 
packaging of the tests in line with local standard guidelines. Moreover, all prevention materials (e.g. information 
pack, PIS etc.) were distributed during the data collection process in quantities that were appropriate for the 
expected number of attendees to avoid unnecessary waste of resources. Any left-over condom and lubricants 
following the end of data collection were donated to the local gay NGO for onward distribution to MSM as part 
of their normal outreach activities. Finally, in laboratories and in clinical settings, appropriate local procedures 
for the disposal of medical devices (e.g. syringes) were followed. 
Ethical issues in monitoring of the survey
During the implementation of the Sialon II survey, the study protocols including ethical procedures were 
monitored regularly and in line with the project Grant Agreement and the ethical approvals received, namely 
the WHO RP2 and WHO-ERC, and individual partner institutional approvals. This process was overseen by the 
Sialon II project coordinators (Azienda Ospedaliera Universitaria Integrata Verona [AOUI-VR]) in collaboration 
with the leaders of the work packages relating to the TLS survey (Fundació Institut d’Investigació en Ciències de 
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la Salut Germans Trias I Pujol [IGTIP]) and the RDS survey (AOUI-VR, Verona, Italy). 
For the duration of the data collection, email exchanges were held on a regular basis in order to cross-check 
whether all the procedures stated in the Sialon II master protocol were being followed appropriately by all the 
project network partners. Regular network telephone conferences (TCs) with all partners were also held for 
additional discussions and assessments, in addition to other ad-hoc TCs according to the specific needs of part-
ners. If needed, site visits were conducted by members of the project coordination team to support partners and 
monitor implementation fidelity of the application of the survey protocols. Together, these actions were planned 
and delivered to minimise the potential for any deviations from the correct implementation of the survey. In 
addition to these control checks, regular monitoring reports (or ‘memorandums’) which included periodical 
updates on the status of the data collection were submitted to and approved by the WHO-ERC within the overall 
oversight provided by the ERC. 
Ethical issues in dissemination of the project results
Considerable care was taken in the preparation of all project documentation and dissemination materials to 
minimise the potential for misuse or misinterpretation of survey findings. As discussed in earlier Chapters, gay 
communities across the participating countries were involved in the project from the outset and were also an 
active part of the dissemination process. In order to ensure the involvement of gay communities in dissemina-
tion as well as the whole survey process, two specific meetings were organised. The Sialon II meeting in Berlin 
(February, 2013) was planned in order to cross-validate all the data collection procedures and tools both in TLS 
and RDS. Representatives from gay NGOs in the different partner countries were able to not only contribute 
directly to the Sialon II procedural debates (e.g. regarding process and implementation of the survey helping to 
ensure both feasibility and acceptability by gay communities), but also to participate actively in the fine-tuning 
of the project materials and manuals for the impending data collection. 
The Sialon II Antwerp meeting (September, 2014) was organised with the specific purpose of disseminating 
and discussing preliminary Sialon II survey results as a basis for strengthening HIV prevention efforts among 
heterogeneous MSM communities in Europe. Moreover, the meeting aimed to provide a space to reflect on how 
gay communities may disseminate and use the scientific results in future prevention practice (i.e. valorisation of 
the Sialon II findings). Interactive workshop sessions were conducted to discuss with scientific experts and NGO 
representatives the community needs for communication of Sialon II evidence. Experiences of dissemination were 
shared, as well as discussions of ways in which dissemination channels could be used to bring the Sialon II data to 
a broader audience whilst in the process, reducing the risk of any misuse or misinterpretations of survey findings. 
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Summary
The methodology adopted for the Sialon II project, from data collection to data analysis, incorporated the 
most advanced approaches in implementing bio-behavioural surveys. A key limitation however relates to the 
sampling methods adopted (TLS and RDS) both of which incorporate potential biases in enrolling members of 
the target population. Consequently, results cannot necessarily be compared easily across the different study 
sites, and the generalisation of the estimates to the overall MSM population might be problematic. However, in 
some of the Sections that follow (e.g. those focusing on sexual behaviours), TLS and RDS datasets were com-
bined to present aggregated data in circumstances where actual numbers were particularly low.
Introduction
This Chapter presents the main findings from the Sialon II survey (from both the TLS and RDS arms) and is 
therefore considerably longer than other Chapters in this report. Findings are therefore divided into a series of 
detailed sub-sections including:
•	 Section	5.1	-	Sample	description	
•	 Section	5.2	-	Prevention	programmes
•	 Section	5.3 / 5.4 Partner numbers, anal intercourse, and condom use with steady and non-steady partners 
in the last six months
•	 Section	5.5	-	Sexual	behaviour	in	the	last	six	months	with	a	female	partner
•	 Section	5.6	-	Sexual	behaviour	during	last	episode
•	 Section	5.7	-	Commercial	sex	
•	 Section	5.8	-	High	risk	behaviour	(fisting)
•	 Section	5.9	-	HIV	and	other	STIs
•	 Section	5.10	-	Treatment	and	viral	load
5. Survey results
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•	 Section	5.11	-	Sexual	health
•	 Section	5.12	-	Substance	use
There are some necessary variations in terms of how the above Sections are presented; for example due to 
the need to ensure that results are reported in line with UNAIDS guidance on GARPR reporting (e.g. Section 
5.2 and 5.9). In other cases, to contextualise the results appropriately, additional background information is 
provided to give an overview of the key issue(s) under scrutiny (e.g. Sections 5.4, 5.5, 5.8). In other cases (e.g. 
Section 5.9), additional information is provided on the sources of data used (variables) as well as on how second-
ary variables were calculated, and on how inconsistent or missing data were dealt with. In all Sections, where 
necessary, further contextual comments are provided as endnotes. 
Finally, in order to facilitate the reader, TLS cities/data and RDS cities/data are presented with a different back-
ground colours in the tables, so that it is clearer that different sampling methods were used in the different cities.
Limitations 
The Sialon II project’s methodology incorporated the most advanced approaches in implementing bio-be-
havioural surveys, in line with the indications in the scientific literature and international guidelines from ECDC, 
UNAIDS and WHO (UNAIDS/WHO, 2002; UNAIDS/WHO, 2000; Johnston, 2013; Kendall, 2008; Sabin, 2014; Zhao, 
2014; WHO, 2010; WHO, 2011). However, some limitations regarding the methodology, tools adopted or the char-
acteristics of the data were nevertheless evident and are described in the relevant parts of the report. Readers 
are advised to refer to Chapter 3 on Methodology where a clear description of the main limitations is provided.
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Summary
The samples enrolled in the different cities present remarkable differences in terms of the age composition 
and educational levels, which do not necessarily reflect the real difference in the cities’ MSM populations and 
could potentially be attributed to the differences in the social segments of the MSM population reached by the 
Sialon II study. Also the migration patterns present marked differences which, together with the tourism pat-
terns, should be taken into account in interpreting the estimates across the cities. In some cities the migrant 
population represents a significant percentage (>20%) of the enrolled MSM compared to others where it ap-
pears to be almost absent. In line with other survey results, some cities manifest an important attraction factor 
for the MSM population probably due to the vast variety of gay venues on offer. These aspects have important 
implications for prevention policy and programmes that should be tailored to reach all the segments of the MSM 
population
This Section includes a description of the project sample recruited through TLS and RDS methods, and a so-
cio-demographic description of the study population by city in terms of age, education, employment, migration 
status, city of residence and ‘outness’. It also reports on social attitudes including homonegativity, and reported 
attendance at gay venues and other gay locations. 
Sample description
In total 4,901 individuals participated in the Sialon II bio-behavioural survey. A total of 3,596 individuals were 
recruited through the TLS method. The TLS sample was distributed as follows among participating cities: 402 
in Barcelona, 411 in Brighton, 391 in Brussels, 407 in Hamburg, 408 in Lisbon, 394 in Ljubljana, 411 in Sofia, 
366 in Stockholm, and 406 in Warsaw. For RDS, a total of 1,305 individuals were recruited. The RDS sample was 
distributed as follows among participating cities: 400 in Bratislava, 183 in Bucharest, 400 in Verona, and 322 in 
Vilnius. 
Table 5.1.1 shows the number of questionnaires collected, the number that were valid, and the percentage 
that were invalid, as well as the number of valid biological samples collected for each city. For TLS cities, the in-
valid rate of questionnaires was below 5% with the only exception being Ljubljana at 5.3%. Given the complexity 
of the survey and the diverse social and cultural contexts within which the TLS arm was implemented, this rate 
is considered very low. For RDS cities, the invalid rate was zero which is likely to be due to the ‘ideal’ conditions 
in which the questionnaire was administered. (e.g. a specific room being available in all sites with a member of 
the research team available to offer clarifications if required). 
In TLS cities, HIV testing was carried out on oral fluid (OF) samples. According to the study protocol, the va-
lidity of the samples was assed using a Total IgG test. The total number of valid OF samples collected were: 400 
in Barcelona; 402 in Brighton; 379 in Brussels; 390 in Hamburg; 371 in Lisbon; 347 in Ljubljana; 361 in Sofia; 356 
in Stockholm, and; 405 in Warsaw (see Table 5.1.1). In RDS cities, HIV testing (as well as HBV, HCV, and syphilis) 
was carried out on serum samples. The total number of valid serum samples corresponds to the number of 
participants recruited (400 in Bratislava; 183 in Bucharest; 400 in Verona, and; 322 in Vilnius; Table 5.1.1).
The recruitment of TLS participants by venue type and age is shown in Figure 5.1.1. Discos, bars, and saunas 
were the venues with the highest number of participants recruited (1,202, 904 and 428, respectively). The high-
est number of MSM younger than 30 years old were recruited in discos, bars and cruising venues. 
5.1 Sample description
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Figure 5.1.1 Participants recruited by venue type and age group
Table 5.1.1 Number of valid and invalid questionnaires, and valid samples collected in TLS and RDS cities
TLS methodology
Barcelona Brighton Brussels Hamburg Lisbon Ljubljana Sofia Stockholm Warsaw
Questionnaires 
collected
408 418 406 408 409 416 411 377 408
Valid questionnaires 402 411 391 407 408 394 411 366 406
% invalid 
questionnaires
1,5 1,7 3,7 0,2 0,2 5,3 0,0 2,9 0,5
Valid samples 
collected
400 402 379 390 371 347 361 356 405
RDS methodology
Bratislava Bucharest Verona Vilnius
Questionnaires 
collected
400 183 400 322
Valid questionnaires 400 183 400 322
% invalid 
questionnaires
0,0 0,0 0,0 0,0
Valid samples 
collected
400 183 400 322
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Age
Respondents were aged between 18 and 81 years old. The age distribution of the MSM population in the 
study is presented in Figure 5.1.2. The most common age group overall was 25–35 years. Respondents in Ham-
burg, Barcelona and Lisbon had a similar age distribution and were the oldest (median age 36, 35.5, and 36 
respectively). The MSM population in Bratislava, Ljubljana, Sofia, Stockholm, Verona, Vilnius, and Warsaw were 
the youngest (median age less than 30 years; see Table 5.1.2).
Table 5.1.2 Mean, median, maximum and minimum of age by study city
City Mean SD Median Minimun Maximun
BARCELONA 37.2 1.88 35.5 19 79
BRATISLAVA 30.3 8.18 29 18 62
BRIGHTON 35.1 2.50 32 18 74
BRUSSELS 34.9 1.07 33 18 68
BUCHAREST 30.8 7.33 31 19 58
HAMBURG 38.0 1.18 36 18 79
LISBON 37.9 1.19 36 19 76
LJUBLJANA 30.5 0.87 29 18 73
SOFIA 29.6 0.30 29.5 18 58
STOCKHOLM 31.7 1.17 28 18 81
VERONA 31.9 10,37 29 18 70
VILNIUS 30.7 9.03 28 19 59
WARSAW 28.8 0.93 28 18 71
SD: Standard Deviation
Figure 5.1.2 Age group distribution by city
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Table 5.1.3 Percentage of MSM younger than 25 years old
City
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Denominator
BARCELONA 14.3 5.8 31.2 8.01 402
BRATISLAVA 29.6 24.3 35.1 1.98 400
BRIGHTON 18.6 11.8 28.2 3.42 411
BRUSSELS 15.9 8.9 26.8 9.37 391
BUCHAREST 18.0 10.5 25.2 1.76 181
HAMBURG 10.6 5.9 18.3 4.43 407
LISBON 10.0 5.3 18.1 6.60 408
LJUBLJANA 22.5 16.8 29.4 1.92 394
SOFIA 24.9 20.8 29.4 0.20 411
STOCKHOLM 28.1 20.5 37.3 5.29 366
VERONA 29.7 21.6 38.0 3.62 397
VILNIUS 26.1 19.5 32.7 2.27 322
WARSAW 30.0 18.5 44.8 8.26 406
Figure 5.1.3 Employment status by study city (only for RDS)
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According to the UNAIDS GARPR Guidelines, the disaggregation by age of the indicator estimates should 
be based on respondents younger than 25 years and equal/older than 25 years. In this report many estimates 
are reported based on this age disaggregation. The highest percentage of participants < 25 years were from 
Warsaw (30%), Bratislava (29.6%), Verona (29.7%), and Stockholm (28.1%; Table 5.1.3). The lowest percentage 
was reported in Lisbon (10%), Hamburg (10.6%), and Barcelona (14.3%). Due to the small sample size when 
disaggregated, the estimates of these cities are less precise with relatively wide confidence intervals. 
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Employment and education 
Participants in the RDS study were asked about their current occupation (see Figure 5.1.3). Most of the re-
spondents reported having some form of employment (full-time, part-time or self-employed) with 77.7% in Vil-
nius, 67.9% in Bratislava, 57.2% in Verona, and 51.6% in Bucharest. Respondents in Bucharest had the highest 
rate of unemployment (25.3%), whereas participants from Bratislava and Verona had the largest percentage of 
students (21.4% and 20.3%, respectively).
Participants were also asked about their highest educational qualification which was then grouped into low 
(elementary and secondary school), medium (high or post-high school education) or high (university education 
below degree, and university degree [Bachelor, Masters, PhD]) education.
The percentage of men reporting a high level of education ranged from 29.3% in Verona to 79.1% in Lisbon. 
Other cities where high levels of education were reported included Vilnius (70.1%), Warsaw (69.9%), Brussels 
(66.3%), and Brighton (65.1%). Verona, Barcelona, and Bucharest had the highest percentages of men with low 
levels of education (17.1%, 16.5%, and 12.3% respectively; see Table 5.1.4). 
Table 5.1.4 Educational qualifications by study city
City
Education 
Level
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Design 
Effect
BARCELONA
N=395
Low 16.5 10.2 25.6 2.73
Medium 31.7 27.4 36.4 0.60
High 51.8 43.6 59.9 1.74
BRATISLAVA
N=395
Low 4.6 2.0 7.2 2.12
Medium 42.1 36.2 47,5 1.79
High 53.3 47.7 59.2 1.87
BRIGHTON
N=402
Low 6.2 2.9 13.0 2.87
Medium 28.7 24.8 32.8 0.59
High 65.1 58.5 71.1 1.33
BRUSSELS
N=372
Low 2.2 1.00 5.0 2.31
Medium 31.5 25.0 38.7 3.34
High 66.3 58.9 73.0 3.45
BUCHAREST
N=176
Low 12.3 3.1 21.5 3.68
Medium 50.9 40.2 61.5 2.11
High 36.8 23.7 49.9 3.44
HAMBURG N=404
Low 5.3 2.0 13.1 5.66
Medium 45.3 37.1 53.7 3.23
High 49.4 40.0 58.9 4.18
LISBON N=402
Low 2.2 0.6 7.5 5.38
Medium 18.7 13.6 25.0 3.25
High 79.1 74.8 82.9 1.48
LJUBLJANA N=388
Low 2.6 1.3 5.1 1.03
Medium 43.1 39.3 47.0 0.51
High 54.3 50.7 57.9 0.44
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City
Education 
Level
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Design 
Effect
SOFIA N=402
Low 6.6 3.6 11.6 0.48
Medium 36.7 30.5 43.4 0.36
High 56.7 51.5 61.8 0.22
STOCKHOLM N=361
Low 5.2 1.9 13.3 7.78
Medium 47.5 39.8 55.3 3.66
High 47.3 39.0 55.6 4.22
VERONA N=386
Low 17.1 10.7 23.8 3.28
Medium 53,6 46,2 61,2 2,46
High 29,3 22.0 36.1 2.60
VILNIUS N=316
Low 0
Medium 29.9 22.8 37.7 2.6
High 70.1 62.3 77.2 2.6
WARSAW N=396
Low 1.5 0.3 7.4 3.85
Medium 29.7 21.7 39.1 3.50
High 68.9 60.3 76.3 2.89
Low: ≤Secondary education; Medium: high or post high school education; High: ≥university education
Figure 5.1.4 Inner-European and intercontinental migration by city
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Migration 
In Sialon II ‘migrants’ were considered as those men who were born in a different country from the one 
in which they currently reside. The cities with the highest percentage of migrants were Brussels (31.6%) and 
Barcelona (25.2%). In contrast, cities with the lowest percentages of migrants (less than 10%) were Bratislava, 
Bucharest, Hamburg, Ljubljana, Sofia, Vilnius, and Warsaw (Table 5.1.5).
Almost all migrants in Sialon II came from Europe, except in Barcelona and Lisbon where most migrants 
reported country of origin as being outside the European continent (see Figure 5.1.4). 
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Table 5.1.5 Percentage of migrants by city
City
Point 
Estimate
95% 
Lower Bound
95% Upper Bound
Estimated 
Design Effect
Denominator
BARCELONA 25.2 18.3 33.6 2.02 400
BRATISLAVA 3.2 1.6 5.0 1.32 400
BRIGHTON 14.2 11.6 17.2 0.51 408
BRUSSELS 31.6 22.4 42.6 7.75 391
BUCHAREST 3.0 0 6.3 1.82 183
HAMBURG 4.4 2.6 7.4 1.46 404
LISBON 11.7 6.9 19.3 5.59 408
LJUBLJANA 9.3 5.8 14.6 1.86 389
SOFIA 0.1 0 0.7 0.07 411
STOCKHOLM 18.0 15.3 21.1 0.86 366
VERONA 15.2 8.3 21.9 4.48 400
VILNIUS 5.2 2.1 8.5 2.06 322
WARSAW 2.4 0.8 7.4 3.08 405
Figure 5.1.5 Regions of origin among migrants by city 
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Based on EMIS and WHO countries classification, “Others” included: South East Asia and Western Pacific regions; “West Europe” 
included: West Europe, North West Europe, Central West Europe, South West Europe and “East Europe” included: North East Europe, 
Central East Europe, South East Europe and East Europe.
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It is worth noting that in Bucharest, Stockholm and Brighton both percentages (European and intercontinen-
tal migrants) were similar. 
In order to describe migration patterns better, an additional graph is provided showing the main regions of 
origin according to the WHO and EMIS country classifications (see Figure 5.1.5). Taking into account migrants 
from outside of Europe, the highest percentages of men from Latin American and Caribbean were seen in Bar-
celona (69.6%), in Lisbon (51%) and Stockholm (25.6%) whilst 51.5% of all migrants in Bucharest where from 
the Eastern Mediterranean Lisbon also received a significant percentage of migrants from Sub-Saharan Africa 
(45.3%), as well In as migrants from Latin America and the Caribbean.
City of residence
Participants were asked about their place of residence with the question ‘Where do you live?’ and in doing 
so, were offered the following options: ‘In the study city’; ‘Within 100 km from the study city’; ‘Tourist or visitor 
from the same country’; ‘Tourist or visitor from another country’. 
Almost all the participants from Bucharest and Sofia were men living in the study city (94.5% and 91.6%, re-
spectively). More than 80% of men in Barcelona, Bratislava, Brighton, Ljubljana, Stockholm, Verona and Vilnius 
reported living in the study city or within 100 km the study city. Brussels and Lisbon were the cities with the 
highest percentages of visitors from another country or tourists (21.5% and 32.3%, respectively; see Figure 5.1.6).
According to migrant and visitor status, the percentage of foreign-born participants by city ranged from 2.3% 
in Sofia, 3.0% in Bucharest or 3.5% in Bratislava to 41.3% in Barcelona, 48.9% in Lisbon and 54.1% in Brus-
sels. In the middle range were Hamburg (7.7%), Vilnius (9.0%), Warsaw (9.7%), Ljubljana (14.5%), Verona (16%), 
Brighton (17.3%) and Stockholm (29.0%). 
Figure 5.1.6 City of residence of participants by study city
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Table 5.1.6 Percentage of MSM out to no-one or only a few by study city
City
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Denominator
BARCELONA 19.3 15.5 23.8 0.72 390
BRATISLAVA 45.1 39.6 52.6 2.34 393
BRIGHTON 16.2 11.5 22.4 1.66 397
BRUSSELS 22.8 13.6 35.5 10.75 380
BUCHAREST 58.1 47.1 69.2 2.33 174
HAMBURG 13.2 8.2 20.7 3.65 396
LISBON 25.5 19.3 32.9 3.75 399
LJUBLJANA 26.3 21.4 32.0 1.18 380
SOFIA 36.5 31.1 42.2 0.28 409
STOCKHOLM 19.8 13.5 28.1 4.47 311
VERONA 38.9 31.8 46.7 2.58 393
VILNIUS 51.0 44.8 58.2 1.87 320
WARSAW 38.1 29.7 47.4 3.22 400
‘Outness’ 
In this study, ‘outness’ was defined as the degree to which people are open about their sexual attraction with 
others. The related question stated ‘Thinking about all the people who know you (including family, friends and 
work or study colleagues), what percentage know that you are attracted to men?’ Five possible responses were 
offered: ‘All or almost all’; ‘More than half’; ‘Less than half’; ‘Few’, and ‘None’.
The percentage of men who were out to ‘all or almost all’ of the people they knew ranged from 6.3% in So-
fia to 63.3% in Barcelona. More than half of the men in Brighton, Brussels, Hamburg and Stockholm reported 
being out to ‘all or almost all’ the people they knew (see Figure 5.1.7). The highest percentage of men out to 
Figure 5.1.7 Level of ‘outness’ by study city
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Table 5.1.7 Percentage of men reporting negative or very negative attitude towards gays or bisexuals at work/
school by study city
City
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Denominator
BARCELONA 25.4 16.9 36.3 3.21 384
BRATISLAVA 31.2 26.2 37.0 1.89 397
BRIGHTON 18.3 12.9 25.3 1.92 386
BRUSSELS 15.8 9.9 24.4 5.90 376
BUCHAREST 57.9 48.8 67.0 1.57 174
HAMBURG 14.0 9.0 21.1 3.25 400
LISBON 31.9 23.4 41.8 6.04 400
LJUBLJANA 21.9 16.3 28.7 1.83 387
SOFIA 57.0 51.1 62.7 0.28 409
STOCKHOLM 13.1 9.2 18.3 2.42 310
VERONA 35.0 27.4 42.5 2.73 388
VILNIUS 31.6 25.1 37.8 1.88 321
WARSAW 17.0 11.2 24.7 3.01 395
‘no-one or only a few were from the RDS study cities: 38.9% in Verona; 45.1% in Bratislava, 58.1% in Bucharest, 
and 51.0%, in Vilnius (Table 5.1.6).
Social attitude
Both TLS and RDS respondents were asked about other people’s attitude towards gays or bisexuals at work/
school, among their parents, and friends/acquaintances. Five answers were offered: ‘Very negative’; ‘Negative’; 
‘Neither negative nor positive’; ‘Positive’ and ‘Very positive’. Negative and very negative attitudes are called 
’perceived homonegativity’ and are analysed in detail as follows.
Figure 5.1.8 Attitude towards gays or bisexuals at work/school by study city
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Figure 5.1.9 Parents attitude towards gays or bisexuals by study city
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The highest percentage of perceived homonegativity towards gay or bisexual men at work/school was ob-
served in Bucharest and Sofia (more than half of the respondents). There were no men reporting ‘very positive’ 
attitudes in Sofia. The lowest percentage of men reporting perceived homonegativity at work/school was in 
Stockholm and Hamburg (13.30% and 14%, respectively; see Table 5.1.7 and Figure 5.1.8).
Perceived parent’s homonegativity level was reported to be highest in Bucharest followed by Vilnius (51.6% 
and 46.9%, respectively). 
The lowest percentage of men reporting perceived parent’s homonegativity was in Hamburg and Stockholm 
(13.8% and 16.6%, respectively) (see Table 5.1.8 and Figure 5.1.9).
The lowest reported levels of “homonegativity” were found in relation to the friend’s circles in all the cities. 
The highest percentage of men reporting ‘negative’ or ‘very negative’ attitudes of friends/acquaintances to-
Table 5.1.8 Percentage of men reporting negative or very negative parents’ attitude towards gays or bisexuals 
by study city
City
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Denominator
BARCELONA 29.9 21.1 40.5 2.65 367
BRATISLAVA 31.3 26.6 36.7 1.64 397
BRIGHTON 17.9 14.4 23.7 1.04 370
BRUSSELS 20.4 15.35 36.4 2.79 370
BUCHAREST 51.6 40.4 62.8 2.09 157
HAMBURG 13.8 8.9 20.9 3.23 391
LISBON 32.0 24.0 41.2 5.02 391
LJUBLJANA 29.5 24.4 35.1 1.11 378
SOFIA 41.7 36.1 47.6 0.29 411
STOCKHOLM 16.6 12.6 21.5 1.90 300
VERONA 33.1 25.7 40.6 2.68 382
VILNIUS 46.9 40.1 53.6 1.65 312
WARSAW 23.8 20.2 27.9 0.75 374
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wards gay or bisexuals was also in Bucharest (31.8%), whereas the lowest levels were observed in Brussels and 
Brighton (1.70% in each city) (see Table 5.1.9 and Figure 5.1.10).
Venue attendance
In the TLS cities, participants were asked about the number of times they had visited specific gay venues 
during the previous three months. These venues included: gay clubs; gay cafés; gay bars; saunas; sex clubs; sex 
shops; video clubs; cruising locations, and other special events (e.g. gay pride, carnival, etc.). Question regard-
ing venue attendance were slightly different between RDS and TLS arms as RDS participants were asked about 
Table 5.1.9 Percentage of men reported negative or very negative friends’/acquaintances’ attitude towards gays 
or bisexuals by study city
City
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Denominator
BARCELONA 4.3 1.8 10.4 2.23 377
BRATISLAVA 7.7 4.7 10.7 1.72 397
BRIGHTON 1.7 0.8 3.9 0.88 386
BRUSSELS 1.7 0.6 4.3 2.49 376
BUCHAREST 31.8 21.0 42.5 2.25 160
HAMBURG 3.4 1.7 6.7 1.83 394
LISBON 5.8 2.6 12.5 5.65 393
LJUBLJANA 5.5 2.9 10.0 1.78 383
SOFIA 11.9 8.4 16.6 0.33 411
STOCKHOLM 4.0 1.9 8.2 3.01 305
VERONA 12.8 7.3 18.5 3.02 384
VILNIUS 16.3 11.4 21.9 2.01 319
WARSAW 3.8 2.2 6.3 0.97 380
Figure 5.1.10 Friends’/acquaintances’ attitude towards gays or bisexuals by study city
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Table 5.1.10 Percentage of men attending gay clubs during the last three months by city (TLS only)
City
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Denominator
BARCELONA 56.4 39.3 72.0 6.94 354
BRIGHTON 65.9 55.9 74.8 2.68 328
BRUSSELS 83.5 73.4 90.3 7.34 332
HAMBURG 43.9 28.7 60.3 12.36 406
LISBON 54.8 49.1 60.3 1.68 347
LJUBLJANA 76.8 65.0 85.5 4.68 365
SOFIA 97.3 90.8 99.3 0.92 402
STOCKHOLM 72.1 60.4 81.4 6.16 245
WARSAW 77.0 68.4 83.8 3.11 397
Figure 5.1.11 Mean number of times visiting saunas, sex clubs, and gay clubs by city (among the attendees only) 
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how many times they had visited venues were sex is or is not possible on site respectively, saunas or cruisings 
during the last 3 months.
Sofia was the city where the largest percentage of men reported attendance at a gay club in the previous 
three months (97.3%) which is double that of the city where the lowest percentage was reported (see Table 
5.1.10). The largest mean number of times this type of venue was visited was by participants from Sofia (Figure 
5.1.11).
Of those participants who reported visiting gay cafés in the last three months, almost all were from Sofia 
(99.8%) (See Table 5.1.11). The largest mean number of times this type of venue was visited was by participants 
from Sofia (Figure 5.1.12).
Brighton was the city with the highest reported percentage of men who had visited a gay bar during the last 
three months (96.0%). The lowest percentage of attendance was observed in Ljubljana (29.5%; see Table 5.1.12). 
The largest mean number of times this type of venue was visited was by participants from Brighton (Figure 
5.1.12).
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Table 5.1.11 Percentage of men attending gay cafés during the last three months by city (TLS only)
City
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Denominator
BARCELONA 46.8 36.0 57.8 2.80 344
BRIGHTON 0
BRUSSELS 79.7 67.1 88.2 8.84 316
HAMBURG 42.9 37.1 48.8 1.55 405
LISBON 19.3 9.5 35.2 10.21 255
LJUBLJANA 21.4 13.2 32.9 3.62 285
SOFIA 99.8 99.2 100.0 0.09 407
STOCKHOLM 68.5 62.1 74.3 1.91 259
WARSAW 0
Figure 5.1.12 Mean number of times visiting cruising, gay bars, and cafes by city (among the attendees only) 
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Table 5.1.12 Percentage of men attending gay bars during the last three months by city (TLS only)
City
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Denominator
BARCELONA 48.7 35.8 61.8 4.33 349
BRIGHTON 96.0 88.3 98.7 3.67 366
BRUSSELS 81.6 70.7 89.0 7.09 319
HAMBURG 43.9 28.7 60.3 12.63 406
LISBON 37.7 25.2 52.1 10.70 348
LJUBLJANA 29.5 18.1 44.3 5.68 289
SOFIA 86.8 83.9 89.3 0.13 384
STOCKHOLM 35.3 26.6 45.0 3.81 218
WARSAW 45.5 33.6 57.9 5.92 397
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Sofia was the city where the largest percentage of men reported attendance at a gay sauna in the last three 
months, whilst the lowest was in Lisbon (69.8% and 4.9%, respectively) (Table 5.1.13). The largest mean num-
ber of times this type of venue was visited in the last three months was by participants from Barcelona (Figure 
5.1.11).
The proportion of men attending a sex club in the last three months was the highest in Brussels (35.5%) and 
the lowest in Ljubljana (See Table 5.1.14). The largest mean number of times this type of venue was visited was 
by participants in Brighton (Figure 5.1.11).
The percentage of men who reported attendance at a sex shop in the last three months ranged from 21,5% 
in Sofia to 39.3% in Brussels (see Table 5.1.15). The largest mean number of times this type of venue was visited 
was by participants in in Sofia (Figure 5.1.13).
Table 5.1.13 Percentage of men attending saunas during the last three months by city
City
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Denominator
BARCELONA 36.4 25.3 49.1 4.02 352
BRATISLAVA 27.5 0.6 33.2 1.82 380
BRIGHTON 29.8 16.5 47.6 8.13 314
BRUSSELS 50.7 42.5 58.8 3.55 312
BUCHAREST 12.0 3.9 20.2 2.27 137
HAMBURG 11.0 7.4 16.2 2.34 406
LISBON 4.9 2.3 9.8 3.39 314
LJUBLJANA 24.7 10.3 48.4 14.57 297
SOFIA 69.8 63.0 75.7 0.41 378
STOCKHOLM 0
VERONA 7.4 19.1 35.7 3.47 358
VILNIUS 13.5 8.5 18.3 2.01 312
WARSAW 19.8 11.7 31.4 6.13 397
Table 5.1.14 Percentage of men attending sex clubs during the last three months by city (TLS only)
City
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Denominator
BARCELONA 0
BRIGHTON 18.7 11.8 28.4 2.98 290
BRUSSELS 35.5 19.2 56.2 19.51 263
HAMBURG 23.9 15.1 35.7 7.43 406
LISBON 0
LJUBLJANA 10.2 5.9 17.2 2.29 261
SOFIA 18.2 14.8 22.1 0.20 364
STOCKHOLM 0
WARSAW 17.6 9.6 30.1 7.51 397
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The percentage of participants attending a video club in the last three months was the highest in Stockholm 
(20.5%). The largest mean number of times this type of venue was visited was by participants from Sophia (see 
Table 5.1.16 and Figure 5.1.13).
Attendance at special events in the previous three months were the most popular among respondents from 
Hamburg (42.5%). The largest mean number of times this type of location was visited was by participants from 
Barcelona (see Table 5.1.17 and Figure 5.1.13).
Cruising locations were visited in the last three months mostly by participants from Sofia (71.3%) with the 
lowest from Vilnius (8.6%). The largest mean number of times this type of location was visited was by partici-
pants from Bratislava (See Table 5.1.18 and Figure 5.1.12).
For RDS cities with regards to gay locations where sex was not possible on site (e.g. social venues, bars, 
discos etc.), the largest proportion of men reporting attendance were from Bucharest (80.5%). The largest mean 
number of times these types of locations were visited was by participants from Verona (See Table 5.1.19, and 
Figure 5.1.14).
For RDS cities with regards to gay locations where sex was possible on site (e.g. clubs, porn cinemas, bars 
Figure 5.1.13 Mean number of times visiting sex shops, video clubs, and special events by city (among the at-
tendees only) 
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Table 5.1.15 Percentage of men attending sex shops during the last three months by city (TLS only)
City
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Denominator
BARCELONA 26.0 18.8 34.7 2.58 352
BRIGHTON 0
BRUSSELS 39.3 27.8 52.1 8.80 271
HAMBURG 0
LISBON 0
LJUBLJANA 20.2 13.0 29.9 3.53 266
SOFIA 21.5 16.4 27.8 0.49 360
STOCKHOLM 0
WARSAW 0
69The Sialon II Project. Report on a Bio-behavioural Survey among MSM in 13 European cities
Table 5.1.17 Percentage of men attending special events during the last three months by city (TLS only)
City
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Denominator
BARCELONA 9.3 1.3 44.2 27.79 369
BRIGHTON 0
BRUSSELS 0
HAMBURG 42.5 23.3 64.2 31.21 405
LISBON 0
LJUBLJANA 15.4 9.4 24.2 3.62 262
SOFIA 8.3 3.5 18.2 1.68 351
STOCKHOLM 0
WARSAW 0
Table 5.1.16 Percentage of men attending video clubs during the last three months by city (TLS only)
City
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Denominator
BARCELONA 0
BRIGHTON 0
BRUSSELS 0
HAMBURG 0
LISBON 0
LJUBLJANA 1.1 0.4 3.3 0.96 252
SOFIA 4.9 4.4 5.6 0.02 350
STOCKHOLM 20.5 14.1 28.8 3.482 221
WARSAW 0
Figure 5.1.14 Mean number of times visiting venues where sex is not possible on site and venues where sex is 
possible on site (RDS only) (among the attendees only) 
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Table 5.1.18 Percentage of men attending cruising locations during the last three months by city
City
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Denominator
BARCELONA 24.0 13.1 39.9 6.26 342
BRATISLAVA 17.6 12.9 21.7 1.701 367
BRIGHTON 0
BRUSSELS 0
BUCHAREST 58.3 1.0 61.7 2.70 144
HAMBURG 21.3 13.4 32.2 6.47 406
LISBON 9.8 6.4 14.7 2.46 328
LJUBLJANA 14.3 8.2 23.8 3.23 280
SOFIA 71.3 63.5 78.0 0.56 403
STOCKHOLM 16.2 8.2 29.6 8.31 211
VERONA 21.7 15.0 8.0 2.76 352
VILNIUS 8.6 4.6 12.3 1.78 308
WARSAW 0
Table 5.1.19 Percentage of men attending gay social venues, NGOs, bars, discos where sex is NOT possible on 
site during the last three months by city (RDS only)
City
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Denominator
BRATISLAVA 58.6 51.3 63.4 2.02 388
BUCHAREST 71.1 59.0 83.2 2.90 154
VERONA 80.5 73.9 86.8 2.71 366
VILNIUS 42.8 37.9 52.1 2.02 320
Table 5.1.20 Percentage of men attending clubs, porn cinema, bars with dark room or where sex IS possible on 
site during the last three months by city (RDS only)
City
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Denominator
BRATISLAVA 11.3 7.5 13.9 1.30 377
BUCHAREST 24.6 15.2 33.9 1.83 147
VERONA 49.0 41.2 56.3 2.34 367
VILNIUS 27.6 20.7 32.0 1.55 310
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with dark rooms etc.), the largest proportion of men reporting attendance were from Verona (49%). The larg-
est mean number of times these types of location were visited was by participants from Bucharest (See Table 
5.1.20, and Figure 5.1.14).
Summary and conclusions
Differences in the age composition and educational level of the samples may not reflect real differences in 
the cities’ MSM population. This might be related to the differences in the social segments of the MSM popula-
tion reached by the Sialon II study. 
Migrants represent a significant percentage (>20%) of the MSM population visiting gay venues in Brussels 
and Barcelona. 
Lisbon, Brussels and Barcelona receive the highest number of tourists. 
Similarities found with previous surveys like EMIS seem to confirm that migrant MSM are attracted to coun-
tries in the Western European sub-region. 
The level of ‘outness’ differed substantially between the study areas. In Eastern European cities where homo-
sexuality has become legal only recently, men were less likely to be out regarding their sexual attraction to men.
Use of the RDS method reached more hidden MSM populations in terms of being less likely to be ‘out’ about 
their sexual attraction to men. 
Perceived homonegativity was most common in South-Eastern Europe, whilst Western levels were lower. 
Gay clubs, gay cafes and gay bars were the most popular among TLS respondents; RDS respondents seems 
to have visited more often gay venues where sex was not possible on site.
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Summary
There are important differences between cities when comparing the number of men reached by prevention 
programmes (GARPR indicator 1.11). Even if most of the men in the TLS and RDS surveys knew where to go to 
get an HIV test, the percentage of men that had been given condoms during the last 12 months varied between 
the cities from less than half to almost all men. This is, therefore, an area where there seems to be room for 
improvement.
Older participants (≥25 years) tested more recently and more frequently than younger participants (<25 
years). This might indicate that a larger group of young MSM are potentially not aware of their HIV status. The 
majority of the participants reported having tested within the last two years (2012 -2014); this was particularly 
evident in younger participants (<25 years).
There are marked differences between the cities regarding the extent of outreach activities and routines for 
providing condoms in health care settings and the type of venues sampled in the study. 
In this Section, data from two core GARPR indicators are presented including GARPR 1.11 (percentage of 
men who have sex with men reached with HIV prevention programmes) and GARPR 1.13 (percentage of MSM 
who received an HIV test in the past 12 months and know their results). To be consistent with UNAIDS guidance 
on GARP reporting1, findings relating to the GARPR indicators are presented differently from other sections (e.g. 
compared to Section 5.1 on sample description). In this present section data are disaggregated and presented by 
age categories <25/≥25. Data on other sexually transmitted infections (STIs) are then presented including syphilis, 
gonorrhoea, chlamydia, anogential warts, genital herpes, lymphogranuloma venereum (LGV), urethral outflow/
itching, and hepatitis B and C. The Section finishes with data from the RDS cities only on whether participating 
MSM would like to access HIV/STI testing in gay venues. 
GARPR 1.11 - Percentage of men who have sex with men reached with HIV prevention 
programmes
To measure the extent to which HIV prevention programmes are reaching MSM, there are specific core indi-
cators developed for international reporting to the WHO and UNAIDS as part of the GARP reporting. 
The GARPR 1.11 indicator consists of the results from two questions included in the Sialon II survey: Do you 
know where you can go if you wish to receive an HIV test?, and; In the last 12 months, have you been given con-
doms (e.g. through an outreach service, drop in centre or sexual health clinic) excluding this Sialon II project? 
For both items, possible responses were ‘yes’, ‘no’, or ‘I prefer not to answer’.
The percentage of men who answered yes to both these questions is shown in Table 5.2.1. In the TLS-cities 
more than half of respondents answered yes to both questions in all cities with the exception of Warsaw with 
less than one third of the participants answering yes. Conversely, less than half of the men in the RDS-cities 
answered yes to both questions, with the exception of men aged ≥25 years in Bucharest and men aged <25 years 
in Vilnius. The highest percentages were seen in Sofia and Hamburg with more than 80% reached with HIV pre-
vention programmes. The lowest levels answering yes to both questions were seen in Bratislava and Warsaw 
with less than 30% or less reached through HIV prevention programmes. 
1 UNAIDS (2015) Global AIDS Response Progress Reporting 2015. Construction of Core Indicators for monitoring the 2011 United Nations 
Political Declaration on HIV and AIDS. Geneva: WHO and UNAIDS.
5.2 Prevention programmes
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Table 5.2.1 Prevention Programmes Weighted Prevalence Among MSM, By City And Age Group (GARPR 1.11)
Numerator: Number of MSM who replied ‘yes’ to both questions 9 and 10.
Denominator: Total number of MSM surveyed.
Answers ‘I prefer not to answer’ in questions 9 and 10 were set to missing and thus ignored. 
Note: MSM with previously known HIV-positive diagnosis are included in the results.
City Age
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Sample 
Size
BARCELONA
<25 59.0 39.2 78.8 1.7 40
25+ 74.9 70.7 79.2 0.9 352
Total 72.7 68.4 77.0 0.9 392
BRATISLAVA
<25 19.2 10.0 27.5 2.0 115
25+ 24.0 17.0 29.5 2.1 276
Total 22.6 17.0 26.8 1.9 391
BRIGHTON
<25 64.0 43.8 84.1 2.8 63
25+ 54.5 39.8 69.2 7.5 328
Total 56.3 45.3 67.2 4.9 391
BRUSSELS
<25 49.1 18.0 80.2 4.6 47
25+ 64.4 55.1 73.7 3.2 324
Total 62.1 51.9 72.3 4.2 371
BUCHAREST
<25 27.4 12.6 42.4 1.4 46
25+ 50.7 38.4 62.9 2.0 122
Total 45.9 36.1 55.7 1.7 170
HAMBURG
<25 84.3 69.8 98.7 1.5 37
25+ 81.0 76.6 85.4 1.2 357
Total 81.4 77.6 85.1 1.0 394
LISBON
<25 79.9 63.9 95.9 1.4 35
25+ 64.4 51.2 77.6 7.2 364
Total 66.0 52.7 79.3 8.2 399
LJUBLJANA
<25 48.6 38.8 58.3 1.2 119
25+ 50.9 44.4 57.4 1.1 265
Total 50.4 44.4 56.4 1.4 384
SOFIA
<25 84.7 79.7 89.7 0.6 112
25+ 89.7 81.9 97.6 5.1 291
Total 88.4 82.9 94.1 3.2 403
STOCKHOLM
<25 72.7 51.6 93.7 3.5 61
25+ 78.0 70.1 85.9 2.3 245
Total 76.6 66.8 86.3 4.2 306
In all cities (except Brighton, Hamburg, and Lisbon), older participants (≥25 years) were reached to a higher 
extent compared with younger participants (<25 years), despite differences between these age categories being 
small in most cities. 
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Do you know where you can go if you wish to receive an HIV test? 
At least 80% of participants in each city knew where to go to get an HIV test. There were slight differences 
between participant age groups indicating that men younger than 25 years were less aware of where to get an 
HIV test. In the younger age group, 80–90% of the men reported knowing where to go, and in two cities (Brighton 
and Ljubljana), the percentages of knowing where to go were higher in the younger age group (>92%). In older 
participants (≥25 years), 90% or more in all cities reported knowing where to get an HIV test.
In the last 12 months, have you been given condoms? 
At least 50% of participants in each city reported having been given free condoms as part of HIV prevention 
activities during the last 12 months; except in Bratislava, Warsaw and Verona where less than half of partici-
pants (regardless of age group) reported having been given condoms (Table 5.2.2). In the other cities variations 
were observed from 51% in Ljubljana to 95% in Sofia for men aged ≥25 years. 
Among younger participants (<25 years), the highest percentages who reported having been given condoms 
were from Sofia and Hamburg (86% and 94% respectively). The lowest percentages were from Bratislava and 
Verona (23% and 29% respectively).
City Age
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Sample 
Size
VERONA
<25 27.7 15.5 39.5 2.2 99
25+ 39.1 30.6 47.7 2.7 275
Total 35.9 28.9 43.0 2.5 375
VILNIUS
<25 58.3 43.4 72.3 2.2 82
25+ 30.1 22.0 35.6 1.6 236
Total 37.5 30.1 42.8 1.7 318
WARSAW
<25 25.5 13.0 38.0 1.9 91
25+ 30.2 22.5 37.9 2.3 311
Total 28.8 23.3 34.3 1.5 402
Table 5.2.2. Percentage of MSM who reported having been given condoms in the last 12 months.
City Age
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Sample 
Size
BARCELONA
<25 64.5 49.3 79.7 1.0 41
25+ 76.8 72.7 80.9 0.9 356
BRATISLAVA
<25 22.5 17.0 22.4 1.4 117
25+ 24.4 17.4 29.0 2.1 276
BRIGHTON
<25 64.6 45.4 83.8 2.7 66
25+ 54.6 40.6 68.6 6.9 338
BRUSSELS
<25 53.6 21.7 85.4 5.1 49
25+ 65.0 57.8 72.2 2.0 338
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If you have been given condoms in the last 12 months, where did you get them from 
(excluding this Sialon II project)? [1]
When comparing the types of venues participants reported being given free condoms in, there were some 
differences between cities. For instance, in Sofia, Barcelona, Brussels, Lisbon, and Vilnius, it was common for 
participants to have been given condoms in saunas or night clubs/discos. However, in Hamburg, Bucharest, 
Verona and Warsaw, outreach services and gay organisations were the most commonly reported means of con-
dom distribution. Compared to other cities, in Lisbon, Sofia, Brighton, and Stockholm it was more common for 
participants to be given condoms at drop-in-centres, sexual health clinics, and health care facilities or in other 
kind of venues (not specified). 
Differences in where condoms were received were also evident between cities when compared by HIV status 
(oral fluid [OF] or blood testing results). For example, no HIV-positive men in Hamburg, Ljubljana, and Verona 
had been given condoms at drop-in-centres or other health care facilities; this was also relatively uncommon 
in Bratislava, Vilnius, Barcelona, and Warsaw. However, in contrast more than 70% of the HIV-positive men in 
Sofia, Brighton, and Stockholm had received condoms in such settings. Only 5% of the HIV-positive men in 
Stockholm had been given condoms by an outreach service whilst more than 80% of the HIV-positive men in 
Warsaw, Ljubljana, Sofia, Brighton, and Verona had received condoms that way. 
City Age
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Sample 
Size
BUCHAREST
<25 56.1 41.6 70.6 1.1 47
25+ 60.6 51.4 69.7 1.2 129
HAMBURG
<25 93.9 87.1 100 0.8 38
25+ 81.3 76.9 85.7 1.2 365
LISBON
<25 80.2 64.3 96.0 1.4 35
25+ 65.3 53.8 76.7 5.6 372
LJUBLJANA
<25 50.5 41.4 59.6 1.0 119
25+ 50.7 44.1 57.4 1.2 269
SOFIA
<25 86.2 80.7 91.7 0.8 114
25+ 95.3 89.2 100 6.4 294
STOCKHOLM
<25 75.5 60.5 90.5 2.0 65
25+ 78.9 71.1 86.7 2.5 266
VERONA
<25 29.1 16.5 40.8 2.4 99
25+ 41.1 32.0 50.5 2.8 280
VILNIUS
<25 67.4 54.4 74.4 2.2 83
25+ 32.9 24.2 38.7 1.8 237
WARSAW
<25 34.9 20.3 49.4 2.2 92
25+ 30.7 23.1 38.3 2.2 312
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GARPR 1.13: Percentage of MSM who received an HIV test in the past 12 months 
and know their results
The GARPR 1.13 indicator refers to the percentage of MSM who received an HIV test in the past 12 months 
and knew their results, and consists of the results from two questions included in the Sialon II survey: Have you 
been tested for HIV in the last 12 months?, and; If you had an HIV test in the last 12 months, did you receive the 
result of that test? Possible responses to both questions included ‘yes’, no’, or ‘I prefer not to answer’. 
In Barcelona, Hamburg, Sofia, Stockholm, and Verona, approximately 50% or more of participants (all 
ages) reported having received an HIV test within the last 12 months and knew the result of that test. In Brigh-
ton, Brussels, and Warsaw more than 50% of older participants (≥25 years) reported a known HIV test within 
the last 12 months whilst among younger participants (<25 years), it was less than 50%. In Lisbon only 21% 
of younger men reported a known HIV test in the last year which represented the lowest levels in the study 
(see Table 5.2.3). 
In several cities there were large differences between age groups (<25/≥25) with regard to receiving an HIV 
test within the last 12 months and knowing the results. Participants from Brighton, Brussels, Lisbon, and War-
saw all reported differences of greater than 20% for the two age groups (<25/≥25). Only in Hamburg did younger 
men report a clearly higher level of known HIV result from a test within the last 12 months. However, the pre-
cision of the estimate for the younger age group is questionable in many cities because the sample sizes are 
relatively small (<50) and sampling biases are possible. 
Table 5.2.3. HIV testing weighted prevalence among MSM by city and age group (GARPR 1.13)
Numerator: Number of men who have sex with men who have been tested for HIV during the last 12 months and who know their results 
(answered yes to q15).
Denominator: Number of men who have sex with men included in the sample
Answers ‘No’ in question 14 were set to ‘No’ in the indicator, whilst answers ‘I prefer not to answer’ were set to missing. Answers ‘I prefer 
not to answer’ in question 15 were set to ‘No’ in the indicator. All persons who stated that they were HIV-positive were excluded from the 
denominator.
City Age
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Sample 
Size
BARCELONA
<25 62.5 53.2 71.8 0.4 41
25+ 63.6 53.1 74.0 3.9 345
Total 63.0 52.6 73.4 4.7 386
BRATISLAVA
<25 29.0 19.1 39.0 1.9 112
25+ 41.0 31.8 48.8 2.2 228
Total 37.2 30.4 43.0 1.9 340
BRIGHTON
<25 36.1 22.7 49.6 1.2 63
25+ 54.6 43.9 65.3 3.3 313
Total 47.3 43.3 51.3 0.6 376
BRUSSELS
<25 42.5 18.6 66.4 2.9 50
25+ 72.1 59.8 84.4 5.7 317
Total 68.1 56.4 79.8 6.0 367
BUCHAREST
<25 39.0 21.8 56.2 1.6 47
25+ 44.8 32.5 57.1 2.0 122
Total 43.3 33.1 53.5 1.9 171
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HIV test details
In which year did you have your last HIV test (in order to detect your HIV-status)? 
Table 5.2.4 presents the results of all participants who reported which year they had had their last HIV test. 
Overall, the majority of participants reported having been tested within the last two years (2012 and 2013) al-
though this was particularly evident in younger participants (<25 years). In most cities, percentages of those 
who had never been tested were low. Only in younger participants in Bratislava, Bucharest, and Warsaw, were 
percentages of having never been tested over 45%. 
The highest percentage of younger participants (<25years) who reported testing in 2012-2013 were from 
Brussels (73%). The lowest percentages of younger participants were from Lisbon and Bratislava (both 41%).
The highest percentage of older participants (≥25 years) who reported testing in 2012-2013 were from Lis-
bon (77%). The lowest percentages of older participants were from Bratislava (43%). N.B. Data from Sofia were 
missing for this question due to incorrect translation of the question.
City Age
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Sample 
Size
HAMBURG
<25 69.5 53.0 86.0 1.1 37
25+ 53.3 41.1 65.6 5.1 350
Total 53.6 43.4 63.7 4.2 387
LISBON
<25 21.1 12.5 29.8 0.4 34
25+ 63.3 56.0 70.6 2.0 360
Total 60.9 53.4 68.4 2.4 394
LJUBLJANA
<25 40.1 23.5 56.6 3.4 117
25+ 47.4 41.9 53.0 0.8 256
Total 46.4 40.5 52.3 1.4 373
SOFIA
<25 75.2 68.1 82.2 0.8 115
25+ 74.0 65.4 82.6 2.9 295
Total 74.3 67.0 81.6 3.0 410
STOCKHOLM
<25 52.1 39.0 65.2 1.1 62
25+ 57.9 47.1 68.6 2.6 229
Total 56.3 45.6 66.9 3.5 291
VERONA
<25 50.2 36.3 64.0 2.3 99
25+ 47.3 36.1 57.1 3.1 233
Total 47.7 38.6 56.1 3.2 335
VILNIUS
<25 38.3 24.8 50.5 1.8 81
25+ 39.1 29.0 47.6 2.1 192
Total 38.8 31.2 45.0 1.7 273
WARSAW
<25 37.6 27.2 48.1 1.0 91
25+ 60.6 48.6 72.6 4.5 301
Total 54.0 45.7 62.2 2.8 392
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Table 5.2.4 Percentage of study participants reporting year of last HIV test
City Age Levels
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Sample 
Size
BARCELONA <25
<2012 24.6 10.0 39.2 1.2
40≥2012 67.1 56.9 77.3 0.5
Never tested 8.2 0 20.7 2.1
BARCELONA 25+
<2012 24.8 15.1 34.5 4.4
337≥2012 69.1 57.5 80.6 5.5
Never tested 6.0 2.8 9.2 1.6
BRATISLAVA
<25
<2012 8.0 1.8 14.3 2.2
118≥2012 41.2 30.0 51.0 1.9
Never tested 50.6 40.0 62.6 2.1
25+
<2012 24.7 17.7 30.6 2.2
282≥2012 43.2 35.5 50.4 2.2
Never tested 32.0 25.8 39.7 2.2
BRIGHTON
<25
<2012 15 3.1 26.8 1.8
62≥2012 50.7 19.0 82.3 6.4
Never tested 34.3 13 55.5 3.2
25+
<2012 34 28.6 39.3 1.0
311≥2012 57.6 48.3 66.9 2.9
Never tested 8.3 2.8 13.9 3.3
BRUSSELS
<25
<2012 0.1 0 0.5 0.1
42≥2012 73.0 57.6 88.5 1.3
Never tested 26.7 11.4 42.0 1.3
25+
<2012 20.1 7.01 33.2 8.7
313≥2012 72.4 58.9 86.0 7.5
Never tested 7.4 2.3 12.4 3.0
BUCHAREST
<25
<2012 3.6 0.0 8.5 0.9
47≥2012 50.7 31.0 70.2 1.9
Never tested 45.6 26.1 65.4 1.9
25+
<2012 14.0 6.7 31.3 1.6
134≥2012 55.2 43.1 67.4 2.1
Never tested 30.6 19.3 41.9 2.1
HAMBURG
<25
<2012 1.5 0 3.9 0.3
36≥2012 69.8 51.8 87.8 1.4
Never tested 28.5 10.5 46.6 1.5
25+
<2012 31.8 20.4 43.2 5.4
346≥2012 57.6 49.9 65.3 2.2
Never tested 10.5 2.9 18.2 5.6
LISBON <25
<2012 19.7 0 49.5 4.7
33≥2012 41.3 19.3 63.4 1.7
Never tested 38.9 15.3 62.5 2.0
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City Age Levels
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Sample 
Size
LISBON 25+
<2012 16.5 9.7 23.2 3.1
356≥2012 76.8 69.5 84.2 2.8
Never tested 6.6 2.7 10.4 2.2
LJUBLJANA
<25
<2012 12.6 0 26.0 4.8
113≥2012 52.0 34.5 69.5 3.6
Never tested 35.3 20.7 49.9 2.7
25+
<2012 30.0 21.5 38.5 2.3
255≥2012 58.0 50.5 65.5 1.5
Never tested 11.8 6.0 17.6 2.1
SOFIA*
<25
<2012 - - - -
111≥2012 - - - -
Never tested - - - -
25+
<2012 - - - -
275≥2012 - - - -
Never tested - - - -
STOCKHOLM
<25
<2012 3.3 0 6.9 0.5
53≥2012 67.0 47.8 86.3 2.3
Never tested 29.5 11.1 47.9 2.2
25+
<2012 21.6 14.6 28.6 1.8
234≥2012 66.3 60.6 72.1 0.9
Never tested 12.0 6.7 17.2 1.6
VERONA
<25
<2012 4.9 0.1 9.4 1.4
104≥2012 53.0 39.3 66.9 2.5
Never tested 41.9 27.8 56.2 2.7
25+
<2012 27.6 20.8 34.8 2.3
293≥2012 49.0 40.5 56.9 2.5
Never tested 23.2 15.9 30.8 2.9
VILNIUS
<25
<2012 10.4 1.7 19.8 2.3
83≥2012 43.9 30.1 56.5 1.8
Never tested 45.5 32.1 59.4 1.9
25+
<2012 27.8 20.5 35.5 2.1
239≥2012 44.6 35.2 52.9 2.4
Never tested 27.5 20.9 34.8 1.8
WARSAW
<25
<2012 2.6 0 6.0 0.9
82≥2012 47.7 37.7 57.7 0.8
Never tested 49.6 38.8 60.3 1.0
25+
<2012 18 7.4 28.5 5.8
293≥2012 72.4 61.6 83.2 4.4
Never tested 9.5 3.9 15.1 2.8
* Results for Sofia are missing due to incorrect translation.
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What was the result of your last HIV test? 
In TLS and RDS cities, the percentage of participants reporting a positive HIV result from their last test was 
highest in older participants (≥25). Few younger participants (<25 years) reported a positive result from their 
last test (0-1.7%). Over 10% of older men (≥25 years) from Brighton and Brussels, reported having received a 
positive HIV test, whilst all other cities reported under 10% (Sofia as low as 0.2%).
In RDS cities, the percentage of participants reporting a positive HIV result from their last test was highest 
in Bucharest, both among younger (7%) and older (13%) participants.
In TLS cities, of those participants with a positive OF test, a large percentage of participants reported having 
a negative result at their last test. Only in Brighton, Brussels, and Hamburg did the majority of HIV-positive 
participants (as determined by their OF test) report that the result of their last HIV test had been positive. In 
Ljubljana, the percentage of participants who reported receiving a positive test result and the percentage re-
ceiving a negative test result from last testing was about the same, independent of HIV status by OF test (40%). 
In the other cities (Lisbon, Sofia, Stockholm, and Warsaw) the majority of men with a positive HIV OF test 
reported that their last test was negative, suggesting that they did not know about their HIV infection (see also 
Section 5.9). 
Other sexually transmitted infections
In the last 12 months, have you been tested for sexually transmitted infections other than HIV? 
Among younger respondents (<25 years), the percentage of those who reported having been tested for 
STIs during the past 12 months varied between 27-68% (see Table 5.2.5). The highest percentages relating 
to younger men were reported in Hamburg (68%) and Stockholm (63%) respectively. The lowest percentages 
among younger participants were reported in Vilnius (23%), Bratislava (24%), and Lisbon (31%).
In all TLS cities older participants (≥25 years) reported slightly higher prevalence of STI testing (range 41-72%) 
compared with younger MSM. The highest percentage in this older age group was reported in Brussels (72%) and 
Table 5.2.5. Percentage of study participants who reported having been tested for STIs (other than HIV) in the 
last 12 months
City Age
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Sample 
Size
BARCELONA
<25 58.32 49.6 67.0 0.3 42
25+ 61.01 51.0 70.9 3.8 354
BRATISLAVA
<25 23.62 19.9 25.7 1.8 118
25+ 30.16 23.6 35.4 1.9 281
BRIGHTON
<25 49.6 39.2 59.9 0.7 66
25+ 60.39 49.7 71.0 4.2 340
BRUSSELS
<25 38.7 23.4 53.9 1.2 50
25+ 72.23 63.3 81.0 3.4 338
BUCHAREST
<25 42.88 19.0 66.7 2.9 47
25+ 37.89 29.7 46.0 0.9 134
HAMBURG
<25 68.55 48.3 88.7 1.8 37
25+ 52.19 35.7 68.6 10.3 364
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the lowest in Sofia (41%). In RDS cities, older participants reported lower prevalence of STI testing compared with 
younger MSM, with the lowest percentage reported in Vilnius (27%) and the highest in Bucharest (38%).
In the last 12 months, have you been diagnosed with the following?  [2]
Syphilis
In general, prevalence of self-reported syphilis during the past 12 months was low in all cities (0-6%) with some 
exceptions. In Sofia for example, younger participants (<25 years) reported the highest syphilis prevalence (19.1%; 
5 syphilis cases out of 41 respondents). Notably, no cases of syphilis were reported by younger participants in 
Barcelona, Brighton, Brussels, Hamburg, Lisbon, Bucharest, or Verona. Prevalence of self-reported syphilis was 
reported to be somewhat higher among HIV-positive study participants, but in general numbers were low with 
the highest percentage observed in Hamburg where 45% of HIV-positive individuals reported having had syphilis. 
Gonorrhoea
Although prevalence of self-reported gonorrhoea was relatively low in both age categories (<25/≥25; range 
0-11%), prevalence was generally higher in older participants (≥25 years) compared to younger participants 
(<25 years). The exceptions however, were in Vilnius, Ljubljana and Hamburg where prevalence was as high as 
22.2% (4 cases out of 21 respondents), 14% (4 cases out of 50 respondents), and 2 cases out of 20 respondents 
respectively among younger participants (<25 years). 
Chlamydia infection
Prevalence of self-reported chlamydia was low in both age categories (<25/≥25; below 11%) in all cities. The 
exceptions were in Brighton and Ljubljana where prevalence among younger participants (<25) was as high as 
27.2% (7 cases out 46 respondents) and 14.9% (4 cases out of 49 respondents) respectively. Chlamydia preva-
lence was quite low in all RDS cities (3-5%) irrespective of age group with Bucharest reporting no cases at all.
Anogenital warts
In general, prevalence of self-reported anogenital warts was very low (< 8%) in both age categories and in all 
City Age
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Sample 
Size
LISBON
<25 31.04 8.4 53.6 2.1 35
25+ 53.9 45.7 62.0 2.6 372
LJUBLJANA
<25 37.24 20.6 53.8 3.7 120
25+ 43.72 37.9 49.5 1.0 270
SOFIA
<25 36.66 21.8 51.4 2.8 115
25+ 40.73 32.4 49.0 2.2 296
STOCKHOLM
<25 63.41 51.8 74.9 1.0 65
25+ 60.71 51.3 70.0 2.5 266
VERONA
<25 40.85 27.0 54.6 2.8 103
25+ 36.78 28.0 45.1 2.6 286
VILNIUS
<25 22.68 12.1 29.3 2.0 83
25+ 27.23 19.7 33.8 1.9 239
WARSAW
<25 42.18 33.2 51.1 0.8 90
25+ 55.29 43.6 66.8 4.4 312
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TLS and RDS cities. However, Sofia and Hamburg were notable exceptions with prevalence of 21.4% (18 cases 
among 118 respondents) among older participants (≥25), and 50.5% (4 cases among 20 respondents) among 
younger participants (<25 years) respectively. 
Genital herpes
Prevalence of self-reported genital herpes was very low (< 9%) in both age categories and in all TLS and RDS 
cities. However, Sofia was a notable exception with a prevalence of 10.3% (3 cases out of 39 respondents) among 
younger participants (<25 years).
Lymphogranuloma venereum (LGV)
In general prevalence of self-reported LGV was extremely low (0-0.3%) in both age categories and all TLS 
cities with only three cases of LGV reported. No cases of LGV were reported in RDS cities.
Urethral outflow/itching
Self-reported prevalence of urethral outflow/itching was generally very low range with the exception of some 
TLS cities. The highest observed percentages were in Sofia (22.2%; 6 cases out of 38 respondents) and in Bu-
charest (8%; 3 cases out of 19) both among younger participants (<25 years). 
Hepatitis B
Self-reported prevalence of hepatitis B was low ranging between 0-8% in the majority of the TLS and RDS 
cities. Exceptions were seen in older participants (≥25 years) from Ljubljana (11.6%; 8 cases reported out of 108 
respondents) as well as in younger participants (<25 years) from Lisbon (15%; 1 case out of 13 respondents).
Hepatitis C
Self-reported prevalence of hepatitis C varied by TLS and RDS cities and age category (<25/≥25 years) with 
a total 18 cases reported in TLS cities, and 26 cases reported in RDS cities. The highest prevalence of hepatitis 
C was reported among young participants (<25 years) in Lisbon (14.7%; 1 reported case out of 13 respondents) 
and among participants over 25 years in Bucharest (31%; 15 cases out of 43). All remaining cities reported 
prevalence below 9%. 
Request of community based HIV testing
Would you like access to HIV/STI testing at gay venues?
In RDS cities only, MSM were asked whether they would like to access HIV/STI testing in gay venues. High 
percentages of participants from all RDS cities reported that would like to access testing at gay venues. The 
highest frequency was reported in Verona with 58% of younger and 58% of older participants expressing this 
view, followed by 59% of older participants in Vilnius. A relatively lower number of older respondents (≥25 years) 
in Bratislava reported that they would be interested in such an activity (47%). A small percentage of participants 
reported that they were not interested in accessing testing in gay venues (11-19%). The highest percentage was 
reported by older participants (≥25 years) from Bucharest.
Summary and conclusions
•	 There are differences between the cities when comparing whether men had been reached by prevention 
programmes (GARPR indicator 1.11). Although most of the men in the survey (both TLS and RDS) report 
knowing where to go to get an HIV test, the percentage of men that had been given condoms during the last 
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12 months varied between the cities from less than half to almost all men. Thus there seems to be room 
for improvement in some cities when it comes to condom distribution.
•	 Differences between the cities in terms of the types of venues and settings where free condoms are dis-
tributed were evident. For instance, the extent of outreach activities and routines for providing condoms in 
health care settings and the type of venues sampled in the study varied considerably. Thus comparing the 
cities is challenging and means that strategies for condom distribution should be developed taking into 
consideration the local context.
•	 Older participants (≥25 years) tested more recently and to a higher extent than younger participants (<25 
years). This might indicate that a larger group of young MSM are potentially not aware of their HIV status.
•	 The percentage of participants receiving their result after being HIV tested was high in all TLS and RDS 
cities.
•	 The majority of the participants reported having tested within the last two years (2012 and 2013) and this 
was particularly evident in younger participants (<25 years).
•	 Few younger men (<25 years) reported having received a positive HIV result from their last test.
•	 Prevalence of self-reported STIs in general was low in TLS and RDS cities. Chlamydia and gonorrhoea were 
the most commonly reported STIs during the past 12 months. 
•	 Most participants from the RDS cities were open to being offered HIV/STI testing at gay venues.
Endnotes
[1] When interpreting these responses, it is of course possible that differences in health care systems between the participating coun-
tries could explain where and how free condoms are distributed. Also, the type of setting may affect how participants perceive who actually 
distributes the free condoms e.g. in a nightclub or sauna (an outreach service/gay organisation or the club owner) and this could, at least 
partly, explain differences in how participants responded to these questions.
[2] The question asked in which year the participants had their last HIV test, disregarding HIV status. In all cities self-reported negative 
men reported having had their last test in 2012-2013 rather than before. Also the majority of the self-reported HIV-positive men were tested 
2012-2013 in all cities except for Brighton and Warsaw. It remains unclear whether men aware of being HIV-positive referred to HIV antibody 
tests or HIV viral load tests when answering this question.
[3] Due to possible confusion between testing and diagnosis of STIs by participants in responding to this question on diagnosed STIs, it 
was decided to set answers to missing if respondents had indicated having been diagnosed with all three serologically diagnosed infections 
(HBV, HCV, Syphilis) or all three swab-diagnosed infections (Chlamydia, Gonorrhoea, LGV) in the previous 12 months. Consequently, 52 
answers were set to missing in the TLS arm and 3 in the RDS arm, and are therefore excluded from both the nominator and the denomina-
tor. The denominator for this question includes only those respondents who had indicated having been tested for the respective STI. Small 
sample sizes, particularly when looking at the lower age strata, should be kept in mind when interpreting reported prevalence.
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Summary
Anal intercourse without a condom in the previous six months was reported by approximately half of the 
study participants, slightly more often by men living in the Central European study cities. In addition unpro-
tected anal intercourse was reported more frequently with steady partners compared to non-steady partners.
The association between age, condom use and partner type was not consistent across the study cities. In 
most cities, condom use with a steady partner was lower for younger men than for men 25 years and older, but 
sample sizes for younger men living in steady relationships were small for several cities. 
The effect of knowledge of HIV status on condom use differed by partner type: reported condom use was lowest 
among HIV negative respondents having anal sex with a steady partner and highest among HIV negative respon-
dents having anal sex with a non-steady partner. Among respondents aware of being infected with HIV, condom 
use with steady partners was higher than among HIV negative men, however, condom use with non-steady part-
ners was lower. Men unaware of being infected with HIV reported the lowest condom use with non-steady partners. 
The percentage of study participants reporting more than one UAI partner in the previous six months varied 
across cities with high frequency reported in almost all Eastern European cities. High numbers of partners 
with whom condomless AI was practiced were reported most frequently by study participants infected with HIV, 
regardless of whether they knew to be HIV infected or not. However, almost half of the individuals unaware of 
being infected with HIV reported only one or no UAI partner in the previous six months.  
Reporting a STI diagnosis in the previous 12 months was also associated with a higher number of sex part-
ners in the previous six months: more than one third of all STIs reported were diagnosed in men reporting more 
than 10 partners, while among men without STIs less than one MSM in five reported more than 10 partners.
Introduction
This section provides a description of the findings on sexual behaviour in the last six months with male 
steady and non-steady partners. 
The number of sexual partners appears to be important for MSM with regards to sexual satisfaction and 
risk for STIs including HIV (associations with HIV status). As reported from the European MSM Internet Survey 
(EMIS), respondents’ satisfaction with their sex life was high for many men currently living in a steady rela-
tionship with a male partner; otherwise satisfaction increased with the number of non-steady sexual partners 
(Bourne et al., 2013; EMIS, 2013).
The risk for STIs increases with the number of different partners. Due to more restricted modes of trans-
mission for HIV (sexually transmitted among MSM primarily through unprotected anal intercourse [UAI]), the 
risk for HIV depends on the number of partners, but also on sexual practices, condom use for anal intercourse 
[AI], knowledge of own and partner’s HIV serostatus, and other factors which may influence the probability of 
HIV acquisition and transmission. HIV risk management among MSM has diversified over time and in addition 
to condom use, now includes tactics and strategies such as: negotiated safety (e.g. partnership agreements to 
reduce the risk of HIV acquisition from non-steady partners [NSP] and allowing condomless sex with a steady 
partner [SP]); HIV serosorting (deciding about condom use for AI with a SP or NSP based on assumed HIV 
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serostatus concordance); strategic positioning (choice of sexual role during AI based on the HIV transmission 
risks involved); viral sorting (taking viral load under effective antiretroviral treatment into account), and others 
(Matser et al., 2014; Snowden et al., 2014; Cassels et al., 2013; van den Boom et al., 2014; Mitchell et al., 2013; 
Vallabhaneni et al., 2012; McDaid et al., 2012; Prestage et al., 2013; Dubois-Arber et al., 2012; McFarland et 
al., 2012; McFarland et al., 2011; Lattimore et al., 2011; McDaid et al., 2010; Anglemyer et al., 2013). Accurate 
knowledge of own or own and partners’ HIV status is a critical factor for the efficacy of most of these risk man-
agement tactics and strategies, except condom use.
In these two sections (5.3 and 5.4), data on partner numbers, AI, and condom use with SP and NSP in the 
last six months is presented. 
Results
Partner numbers in the last six months by age (unweighted) [1]
In the survey (both the TLS and RDS arms), participants were asked to report (or estimate) the number of SP 
and NSP they had had in the previous six months. Response options included: the number of partners (or zero if 
none) and ‘I prefer not to answer’. The proportion of respondents reporting more than ten partners in the previ-
ous six months increased with age (Figure 5.3.1). Lower partner numbers were more frequently reported by men 
younger than 30 years. Although the effects of possible misinterpretation of some questions by participants were 
minimised by setting inconsistent answers to missing, misunderstanding of the time period (last six months) 
and reporting lifetime partner numbers instead, might have continued to have an effect. The increase of partner 
numbers with age may partly reflect the report of lifetime partner numbers which of course increase with age. An 
alternative explanation would be that participants older than 44 years were more frequently recruited in venues 
with higher partner numbers (e.g. saunas) which could explain the higher partner numbers. Thus the association 
between partner number and age could be confounded by misinterpretations and sampling effects.
Figure 5.3.1 Partner numbers in categories in the last six months and age group (n=4,637)
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Anal intercourse and unprotected anal intercourse
Participants were also asked to report (or estimate) the number of partners (SP and/or NSP) with whom they 
had had AI, and then the number of partners with whom this intercourse had been unprotected i.e. condomless 
AI or UAI. For both questions response options included: the number of partners (or zero if none) and ‘I prefer 
not to answer’. 
Approximately half of all participants reported condomless AI (Figure 5.3.2), with Sofia (75.5%) and Bratislava 
(71.2%) reporting the highest, and Stockholm (47.2%) and Hamburg (45.6%) reporting the lowest proportions 
(median 54.5%). Any type of AI was reported by approximately 80% from all study sites, again with Sofia leading 
with 99.6% of all participants engaging in any AI, and Bucharest (72.6%), Hamburg (72.6%), and Stockholm 
(64,9%) lagging (see Figure 5.3.2). 
Figure 5.3.2 Type of sexual practice by city (weighted)
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Anal intercourse with a steady partner with and without condoms
Between 30.3% and 55.6% of respondents from TLS and RDS cities reported UAI with a SP in the previous 
six months, and an additional 7.2% to 20.8% reported AI with condoms. Across all cities, approximately one in 
three to one in four of participants reported exclusively condom-protected AI with their SP. Only in Sofia was the 
proportion significantly lower. Most of the respondents not reporting AI with a SP did so because they had not 
had a SP in the previous six months (Figure 5.3.3).
Anal intercourse with a non-steady partner with and without condoms
About one third of the respondents from all cities reported UAI with a NSP in the previous six months (me-
dian 33.5%). In Sofia and Bratislava respectively, this proportion reached 54.0% and 55.8%. An additional 14.2% 
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Figure 5.3.3 Condom use and anal intercourse with steady and non-steady partners by city (weighted)
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to 38.3% reported condom-protected AI (median 24.5%) in the different cities. Thus, in the Western European 
cities close to 50% of the participants reporting AI with NSPs reported exclusively condom-protected AI; in the 
Central European cities and in Stockholm this proportion was lower. 
Overall, proportions of respondents reporting any AI with a NSP were highest in Sofia (87.1%) and lowest 
in Brighton (48.4%), Ljubljana (52.0%), Stockholm (53.1%) and Hamburg (53.6%). Those not reporting AI with 
a NSP in the previous six months either had no anal sex with their NSP or had sex only with their SP (Figure 
5.3.3).
Anal intercourse and unprotected anal intercourse, by steady and non-steady partners
Among participants reporting anal sex with their partners, UAI was reported to be much more frequent with 
SPs (ranging from 70.0% in Hamburg to 95.3% in Sofia) than with NSPs (ranging from 21.4% Ljubljana to 66.3% 
in Bratislava). The proportion of participants using condoms consistently for AI with their SP was particularly 
low in the Southern European cities of Barcelona and Lisbon, as well as in Sofia (Figure 5.3.4). 
Consistent condom use for AI with NSPs was highest in Ljubljana, Brussels and Lisbon and lowest in Bra-
tislava, Vilnius, Sofia, and Bucharest (Figure 5.3.4).Thus, the proportion of respondents reporting UAI with SPs 
was higher than the proportion reporting UAI with NSP. This strongly suggests that knowing the partner better 
is associated with less condom use for AI. This may be due partly to a better HIV serostatus knowledge of the 
SP, and/or partly due to feeling less at risk for HIV infection when the partner is a SP.
Condom use with SP and NSPs varied considerably between age groups and between cities. In Brighton, 
Brussels, Hamburg, Ljubljana, and Sofia the proportion of respondents reporting UAI with NSPs increased with 
age. In Barcelona, Bratislava, Bucharest, and Warsaw the proportion decreased, and in Lisbon, Stockholm, Vil-
nius, and Verona there was not much difference. Since the proportion of participants less than 25 years of age 
recruited in the different cities varied considerably, these different trends may be confounded partly by sampling 
biases.
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Partner types in the last six months [1]
There were some differences between cities as well as between age groups regarding the different partner 
types reported for the previous six months. Overall the most frequently reported partner type category was a 
combination of SPs and NSPs, ranging from between 36.2% in Hamburg up to 64.7% in Bratislava (median 
47.1%). The second most frequent category of partner type were NSPs only, ranging from 15.4% in Ljubljana up 
to 47.7% in Sofia (median 29.6%). Exclusively steady partners were reported in a range from 10.6% in Brussels 
up to 29.5% in Brighton (median 16.2%; Figure 5.3.5). 
The exclusive SP category was higher for younger MSM (<25 years) in Brussels, Warsaw, Lisbon, and Brigh-
ton, and lower for younger men in Sofia, Hamburg, Barcelona, and Stockholm. In Ljubljana there was no real 
difference by age group. Having no partners was particularly common among young MSM in Brussels (14.2%), 
Brighton (21.7%), and Ljubljana (14.7%), but was not reported in Sofia and Barcelona (both 0%). These differ-
ences, particularly in the younger age group, are likely due to differences in the composition of the samples. The 
segments of young MSM reached by the study appear to be quite different in the different cities.
Condom use with SP, NSP, and female partners by known HIV status (unweighted) [2]
The impact of knowledge of HIV status (never tested/ previously tested negative; unaware of positive HIV 
status; aware of HIV-positive status) on condom use with the steady partner was small. Among respondents 
who were aware of being HIV positive, 75% (unweighted) reported UAI with their steady partner. Among re-
spondents not suspecting an HIV infection and testing negative for HIV, the proportion using no condoms for 
AI with their SP was 79.1% (unweighted). Not reflected in this type of analysis are additional risk management 
tactics or strategies such as HIV serosorting (opting for UAI with partners who are presumed to have the same 
HIV serostatus), and decisions not to use condoms when the viral load becomes undetectable due to effective 
antiretroviral treatment. It would thus be misleading to assume that all respondents not reporting condom use 
with their SP are at risk for HIV infection or transmission because most of them are probably not at risk.
Figure 5.3.4 Unprotected anal intercourse with steady and non-steady partners (weighted)
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Figure 5.3.5 Partner types by city (weighted)
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Figure 5.3.6 Condomless anal/vaginal intercourse with steady, non-steady and female partners by HIV status 
(unweighted)
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Knowledge of HIV status also had very little impact on condom use for anal sex with NSPs. Independent of 
knowledge about HIV status, any anal sex without condoms with NSPs was reported by about two thirds of the re-
spondents. Again, these relatively minor differences regarding proportions reporting UAI cannot be interpreted as 
knowledge about HIV status not having an impact on risk or risk behaviour. As with SPs, for NSPs risks associated 
with UAI may be modified by HIV serosorting and reduced infectivity by effective antiretroviral treatment.
When comparing reported UAI with SP and NSPs by awareness of HIV status, the difference was statistically 
significant only for HIV negative respondents. However, not considered in this comparison is the number of 
partners with whom UAI was practiced. 
In contrast, when looking at sex without condoms with female partners, a different association with HIV 
serostatus knowledge can be observed. 38.5% of respondents aware of being infected with HIV reported con-
domless sex with women, while 57.2% of HIV negative and unsuspecting respondents did so. However, due to 
the low numbers of HIV-positive MSM (either diagnosed in Sialon II or diagnosed previously) reporting sex with 
female partners, the confidence intervals are broad and the differences between male steady and non-steady 
partners are not statistically significant.
Partner numbers by city [1]
There was some variation in the numbers of sexual partners reported overall reported by participants be-
tween cities. 59.5% of respondents from Sofia reported six or more partners in the previous six months, while 
12.9% in Ljubljana did so. In most cities the proportion was about one third (median 30.6%). The proportion of 
men reporting one or no sex partner in the previous six months was lowest in Sofia with 12.9% and highest in 
Brighton with 41.1% (median 32.4%; Figure 5.3.7).
Figure 5.3.7 Partner numbers in categories in the last six months by city (weighted)
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UAI partner numbers by city
Between 22.7% (Bratislava) and 48.3% (Hamburg) of respondents reported no UAI with sex partners in the 
previous six months; the lowest partner numbers were reported from Bratislava and Sofia with less than 25%. 
Overall, UAI with not more than one partner was reported by 47.7% of the respondents from Bratislava; 49.2% 
from Sofia; up to 75.7% from Barcelona and 77% from Hamburg. UAI with five or more partners in the previous 
six months were reported by 2.6% in both Ljubljana and Stockholm of the respondents up to 15.9% in Sofia 
(median 5.5%; Figure 5.3.8).
UAI partner numbers and knowledge of HIV status (unweighted) [2]
Awareness of being HIV positive was associated with higher numbers of partners with whom no condoms 
were used during AI. Among respondents aware of being HIV-positive, 23.5% reported more than five UAI part-
ners in the previous six months compared with just 7.0% among HIV negative respondents. Compared with 
HIV negative respondents, respondents unaware of their HIV positive status reported more UAI partners in the 
previous six months. Having had UAI with more than one partner was reported by 45.3% of as yet undiagnosed 
participants compared to 33.9% among those testing HIV negative (Figure 5.3.9).
On the other hand, it is notable that one third of the men with as yet unknown HIV infection reported no UAI 
partner in the previous six months. Whilst this relatively high proportion may be biased by underreporting of 
UAI, it does still suggest that a high proportion of the as yet undiagnosed HIV infections will be found in men 
with relatively low partner numbers. Low partner numbers may also be the reason why these men do not feel at 
risk for HIV and do not test for HIV more frequently. This represents a considerable challenge for avoiding late 
HIV diagnosis in this group. 
Figure 5.3.8 Number of UAI partners during the last 6 months in categories by city (weighted)
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Figure 5.3.9 HIV status knowledge and number of UAI partners (unweighted)
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Figure 5.3.10 Number of UAI partners in the last 6 months and newly diagnosed HIV (unweighted)
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Number of UAI partners in the last 6 months and recency of as yet undiagnosed HIV [2]
Looking at the association between reported UAI partner numbers and as yet undiagnosed HIV infection, 
undiagnosed HIV infection is less prevalent among respondents reporting fewer than two UAI partners in the 
previous six months; it is more prevalent among respondents reporting more than one UAI partner in the pre-
vious six months (Figure 5.3.10). If the association is not biased by unreported risks in the group reporting low 
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numbers of UAI partners, this observation suggests that a large proportion (56.7% of incident HIV infections and 
50% of as yet undiagnosed infections with unknown duration) of undiagnosed HIV infections could be found in 
men with relatively low levels of risky sexual behaviour (≤1 UAI partner in the previous six months); which may 
contribute to low testing rates in this group. On the other extreme, about 19% of incident (as yet undiagnosed 
infections in men who reported a preceding negative HIV test result within the previous 12 months) and 28% of 
other as yet undiagnosed HIV infections were found in a subgroup of men who report four or more UAI partners 
in the previous six months. Such an UAI frequency would make any effective HIV status knowledge-based risk 
management challenging even with extremely frequent testing. 
If almost 20% of incident HIV infections are detected among men reporting four or more UAI partners in the 
previous six months, this suggests that the risk of acute phase forward transmission to other sex partners is 
high in this subgroup of participants. 
As yet undiagnosed and incident HIV and partner types in the previous six months [2]
Looking at the association between reported partner types (SP/NSP) and undiagnosed HIV infection, the 
prevalence of incident and as yet undiagnosed HIV was highest among men reporting SP as well as NSPs in 
the previous six months (4%). The proportions were only slightly lower (3.7%) among men reporting only NSPs, 
and was still 3.4% among men reporting only SPs in the previous six months. Prevalence was 2.8% among men 
reporting no partners in the previous six months.
Table 5.3.11 Partner types and undiagnosed HIV infection (unweighted)
Steady partner(s) 
(n=652)
Non-steady partner(s) 
(n=1,294)
Steady and non-steady partner(s) 
(n=1,994)
No partner 
(n=216)
HIV negative 96.6% 96.3% 96.0% 97.2%
As yet undiagnosed 1.7% 1.2% 1.1% 0.5%
Incident 1.7% 2.5% 2.9% 2.3%
Figure 5.3.12 STI diagnosis and partner numbers (unweighted)
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 The prevalence of newly acquired as yet undiagnosed HIV infection (incident HIV) was 1.7% among respon-
dents reporting only SPs, 2.5% among respondents reporting only NSPs, and 2.9% among those reporting SPs 
as well as NSPs in the previous six months. The prevalence of undiagnosed HIV infection in men without a neg-
ative pre-test in the previous 12 months (newly diagnosed but not incident HIV) was between 1.1% and 1.7% in 
all groups except those reporting no partner in the previous six months.
This suggests a less than optimal testing frequency in men with NSPs, and a relatively high risk of HIV 
transmission in steady partnerships in which condom use is stopped without previously ascertaining HIV status 
concordance. 
STI diagnosis and partner numbers
Reporting an STI diagnosis in the previous 12 months was associated with a higher number of partners in 
the previous six months. 37.2% of all STIs reported were diagnosed in men reporting more than 10 partners 
in the previous six months, whilst among men without STIs, only 17.1% reported more than 10 partners in the 
previous six months.
Summary and conclusions
UAI in the previous six months was reported by approximately half of the study participants, slightly more 
often from men living in the Central European study cities. UAI was reported more frequently with steady com-
pared to non-steady partners.
The association between age, condom use, and partner type was not consistent across the study cities. In 
most cities, condom use with a steady partner was lower for younger men than for men 25 years and older, but 
sample sizes for younger men living in steady relationships were small for several cities. Consequently, firm 
conclusions about the association between age and condom use with different types of partners are not pos-
sible, because associations particularly for the younger age group (<25 years) may be confounded by sampling 
biases. The most frequent partner type category was the combination of steady and non-steady partners, fol-
lowed by non-steady partners only and steady partners only.
The effect of knowledge of HIV status on condom use differed by partner type: reported condom use was 
lowest among HIV negative respondents having AI with a SP and highest among HIV negative respondents 
having AI with a NSP. Among respondents aware of being infected with HIV, condom use with SPs was higher 
than among HIV negative men, however, condom use with NSPs was lower. Due to the lower number of men, 
the differences for respondents aware of being infected with HIV were statistically not significant. Men unaware 
of being infected with HIV reported the lowest condom use with NSPs. Knowledge of HIV status had a greater 
impact on unprotected vaginal or AI with female partners. Among men with a negative HIV test result 57.2% of 
those reporting female sex partners in the previous six months had unprotected intercourse with their female 
partners, whilst among men aware of being infected with HIV 38.5% had unprotected intercourse. With large 
confidence intervals due to small numbers, these findings must be interpreted cautiously (see also Section 5.5).
The proportion of participants reporting more than one UAI partner in the previous six months varied be-
tween 24.2% and 36.2% in most cities (median 30.9%). Higher proportions were reported from Bratislava, Sofia 
and Bucharest. High numbers of partners with whom UAI was practiced were reported most frequently by 
participants infected with HIV, regardless of whether they knew to be HIV infected. However, almost 55% of 
participants unaware of being infected with HIV reported only one or no UAI partner in the previous six months. 
Reporting an STI diagnosis in the previous 12 months was associated with a higher number of sex partners 
in the previous six months: 37.2% of all STIs reported were diagnosed in men reporting more than 10 partners, 
while among men without STIs only 17.1% reported more than 10 partners.
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Endnotes
[1] The section on partner numbers in the Sialon II survey had the highest proportion of inconsistent answers. According to the se-
quence of questions, the number of partners reported in subsequent questions would be expected to stay equal or decline. An answer was 
therefore regarded as being inconsistent if an increasing number was given. If a number was reported following missing numbers in the 
respective sequence, this was not regarded as inconsistent. Similarly, due to possible confusion regarding partner categories, replies to 
non-steady partner questions were set to missing if the number of steady partners ranged from 4 to 6 and equal or less numbers of non
-steady partners were given. Implausibly high numbers of reported SP/NSP were also regarded as inconsistent. We defined as ‘implausible’ 
a number of more than six SPs and more than 200 NSPs in the previous six months. Implausibly high numbers of SP/NSP in the previous 
six months were set to missing in the analyses.
[2] HIV status knowledge:
•	 HIV	negative: negative saliva test result for anti-HIV antibodies (TLS) or negative serological test result for anti-HIV antibodies (RDS), 
no previous HIV test or negative previous HIV test reported;
•	 HIV	newly	diagnosed: positive saliva test result for anti-HIV antibodies (TLS) or positive serological test result for anti-HIV antibodies, 
no previous HIV test or negative previous HIV test reported (HIV=1, Q32=2/3);
•	 HIV	indeterminate: positive HIV saliva test result (TLS), no clear information given on previous testing or test result, (HIV=1, Q32=4 did 
not get result/9 prefer not to answer/missing/Q31 not answered); reported previous HIV diagnosis (Q32=1/Q29o3=1) and no reactive test 
result; HIV = missing and Q32=1; HIV=2 or missing and Q29o3=1 and Q31>2011 (but not missing); 
•	 HIV-positive: positive saliva test result (TLS) or serological test result (Elisa, Western Blot; RDS), report of a previous HIV diagnosis 
(HIV=1, Q32=1/Q29o3=1);
•	 As	yet	undiagnosed	HIV	infection;
•	 HIV	negative: negative saliva test result for anti-HIV antibodies (TLS) or negative serological test result for anti-HIV antibodies (RDS), 
no previous HIV test or negative previous HIV test reported;
•	 HIV	incident: positive saliva test result for anti-HIV antibodies (TLS) or positive serological test result for anti-HIV antibodies, negative 
HIV test within the previous 12 months reported;
•	 HIV	as	yet	undiagnosed: positive saliva test result for anti-HIV antibodies (TLS) or positive serological test result for anti-HIV antibodies, 
no previous positive HIV test result and no negative HIV test result within the previous 12 months reported;
•	 Known HIV-positive or indeterminate HIV status.
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Summary
Most MSM reported only having sex with male partners in the past six months. However, a minority of partic-
ipants also reported sex with female partners (steady and non-steady) in the past six months. The percentage 
of behaviourally bi-sexual men varies considerably across cities but seems to be present in all study sites. This 
subgroup of MSM reported a high number of episodes of unprotected sex with women (almost half) leading to a 
possible bridging effect for the HIV transmission. The knowledge of HIV status had a greater impact on unpro-
tected vaginal or anal intercourse with female partners. 
Introduction
In Europe and elsewhere, it is widely accepted that a percentage of MSM also have sex with female partners 
irrespective of their sexual identity or orientation (e.g. ECDC, 2013; EMIS, 2010; Montgomery et al., 2003; Seku-
ler et al., 2014; Godbole et al., 2014). Indeed, findings from the EMIS Network (2010) study showed that whilst 
most respondents only had had sex with men (82%), 11% of MSM reported sex with both men and women. In 
Estonia for example, half of respondents to the survey reported that they had previously or were currently also 
having sex with women. Similarly, among heterosexually active Norwegian MSM, more than 80% stated that 
they had had unprotected vaginal or anal sex with a woman in the past year. Given that men who have sex with 
men and women have been reported to be less likely to disclose their behavioural bisexuality to partners of both 
sexes (e.g. Montgomery et al., 2003; see also Godbole et al., 2014), understanding such interactions is important 
in order to be able to develop specific interventions for this particularly hard to reach and often isolated (from 
other MSM) sub-population of MSM. 
In this Section, data are presented on the percentages of participants who reported having had sexual inter-
course with a female partner (steady and non-steady) in the last six months stratified by city. Sex with a female 
partner is then explored by ‘outness’ and sexual satisfaction. Finally, for those who reported having had sexual 
intercourse with a female partner, average numbers of female partners are presented along with the percent-
ages of participants whose intercourse with a female partner was unprotected. 
Variables 
To explore sexual behaviour with a female partner in the last six months, for TLS cities, participants were 
asked two questions: 1) “In the last 6 months, how many female partners (steady and non-steady) have you had 
sex with?”, and; 2) “In the last 6 months, did you have any unprotected (without condom) anal or vaginal inter-
course with a woman?” Participants could respond by stating the number of female partners (or zero if applica-
ble), or state ‘I prefer not to answer’. For RDS cities separate questions were asked for steady and non-steady 
female partners using the same item and response structure as above. 
5.5 Sexual behaviour in the last six months  
with a female partner
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Results
Sex with female partners 
The percentage of MSM reporting sexual intercourse with a female partner (steady and non-steady) in the 
last six months varied considerably between the study sites (Figure 5.5.1). The highest percentage was reported 
by MSM in Bucharest (43.2) and the lowest in Brussels (2.3). 
Figure 5.5.1 Percentage of MSM having had sexual intercourse with a female partner (steady and non-steady) 
in the last six months
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Table 5.5.1 Percentage of MSM having had sexual intercourse with a female partner (steady and non-steady) in 
the last six months
City
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Denominator
BARCELONA 10.6 5.2 16.0 1.7 391
BRATISLAVA 26.1 21.0 31.2 1.9 393
BRIGHTON 11.6 6.4 16.8 1.5 411
BRUSSELS 2.3 0.2 4.5 1.4 407
BUCHAREST 43.2 31.6 54.8 2.6 177
HAMBURG 10.1 5.8 14.4 1.4 402
LISBON 10.1 3.5 16.8 2.2 406
LJUBLJANA 11.8 7.7 15.9 1.3 408
SOFIA 9.0 1.4 16.7 2.4 366
STOCKHOLM 16.8 12.2 21.4 1.2 394
VERONA 27.4 19.3 35.5 3.7 360
VILNIUS 15.1 10.1 20.1 1.9 321
WARSAW 8.0 4.3 11.7 1.3 411
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As can be seen with reference to Table 5.5.1, because the number of participants declaring sex with female 
partners is relatively low compared to other study variables, age categorisation is not used as a stratification 
variable in the present section. In addition to Bucharest, high percentages were reported in Bratislava (26.1%) 
and Verona (27.4%). On the contrary, low percentages were reported in Sofia (9.0%) Warsaw (8.0%) and – as 
mentioned – Brussels (2.3%). A significant variability was present in the design effects of each city, with design 
effect ranging from 1.2 to 3.7. 
Sex with female partners by ‘outness’
In Sialon II, ‘outness’ was defined as the degree to which people are open about their sexual attraction with 
others and asked: “Thinking about all the people who know you (including family, friends and work or study 
colleagues), what percentage know that you are attracted to men?” Five answers were possible including: ‘All 
or almost all’; ‘more than half’; ‘less than half’; ‘few’ and ‘none’. Reporting sex with female partners in the 
previous six months (steady and non-steady) was associated with a lower level of ‘outness’ regarding sexual 
attraction to men towards family, friends and co-workers compared with sex with only male partners. As can 
be seen from Figure 5.5.2, 70% of participants who reported having sex with both male and female partners in 
the last six months were ‘out’ to less than half of all the people who knew them; compared to just over 30% for 
participants with male partners only. 
Figure 5.5.2 Sex with women by ‘outness’ 
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Sex with female partners by sexual satisfaction
With reference to Figure 5.5.3, participants in both TLS and RDS cities were asked about their level of satis-
faction with their sex lives (see also Section 5.11) in response to being asked: “How satisfied are you with your 
sex life?” (options provided were: ‘very satisfied’; ‘somewhat satisfied’; ‘somewhat unsatisfied’; ‘very unsatis-
fied’, and; ‘I prefer not to answer’). When stratifying sex with female partners by sexual satisfaction, there were 
no significant differences in reported sexual satisfaction between respondents reporting male sex partners only 
versus those men reporting male and female sex partners in the previous six months (Figure 5.5.3).
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Average number of female partners
In terms of the average number of female partners (steady and non-steady) in the last six months as de-
clared by MSM respondents, the highest averages were in Bratislava (11.4), Bucharest (7.3) and Hamburg and 
Verona (both 6.9). The lowest average number of female partners was declared by participants from Brussels 
(1.8). However, with the exception of Bratislava, Bucharest, and Verona, median values suggest a more similar 
distribution between the cities with values of <3.5 for the majority of the cities (Table 5.5.2). Nevertheless, in 
some cases confidence intervals are relatively wide and with small sample sizes for some cities, variable esti-
mates must be interpreted cautiously. 
Unprotected sex with female partners 
Of those participants who reported having had sexual intercourse with a female partner (steady and non
-steady) in the last six months, there was some variation in those who also reported that this sex had been 
unprotected (Table 5.5.3). The highest percentages of unprotected anal or vaginal intercourse were reported 
by participants from Brighton (76.9%), Verona (73.1%), and Vilnius (63.0%), and the lowest in Ljubljana (25.1%). 
However, once again the estimates must be interpreted cautiously given that sample sizes are small and in 
many cases, confidence intervals wide. 
Unprotected sex with female partners by HIV status
Given the above, of particular interest is to explore the percentage of participants reporting unprotected in-
tercourse (anal or vaginal) with a steady and/or non-steady female partner in the last six months who are also 
HIV-positive as indicated by laboratory analysis (OF for TLS cities and serum for RDS cities). However, as the 
sample size calculation and the study design were done in order to estimate the HIV prevalence, considering 
the low subsample size due when stratifying by HIV serostatus among those declaring sex with women, analysis 
revealed that the point estimates were not meaningful and thus are not presented here. 
Figure 5.5.3 Sex with male and female partners and sexual satisfaction 
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Table 5.5.2 Average number of female partners (steady and non-steady) in the last six months
City Mean Median
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Denominator
BARCELONA 4.7 1 0.7 8.7 1.8 31
BRATISLAVA 11.4 10 6.7 16.2 1.5 35
BRIGHTON 2.7 2 1.8 3.6 1.0 55
BRUSSELS 1.8 1 1.0 2.5 1.2 18
BUCHAREST 7.3 5 4.9 9.7 1.2 51
HAMBURG 6.9 2 0.0 16.7 1.5 46
LISBON 2.0 2 1.2 2.8 1.1 54
LJUBLJANA 5.7 1 4.0 7.4 1.3 41
SOFIA 3.7 1 1.2 6.2 2.0 32
STOCKHOLM 2.1 2 1.3 2.9 1.6 58
VERONA 6.9 4 4.4 9.4 1.2 42
VILNIUS 5.9 3.5 2.5 9.4 1.3 20
WARSAW 2.6 1 1.6 3.6 1.3 28
Table 5.5.3 Percentage of MSM having had an unprotected intercourse with a female partner (steady and non
-steady) in the last six months
City
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Denominator
BARCELONA 37.7 2.4 73.0 2.0 35
BRATISLAVA 51.2 37.8 64.6 1.3 67
BRIGHTON 76.9 61.5 92.3 1.2 56
BRUSSELS 36.6 9.9 63.4 1.1 21
BUCHAREST 55.8 40.6 71.0 1.7 70
HAMBURG 52.7 25.9 79.5 1.2 48
LISBON 35.7 18.9 52.5 1.3 62
LJUBLJANA 25.1 4.7 45.6 1.4 40
SOFIA 57.3 9.2 105.5 2.7 38
STOCKHOLM 49.4 33.5 65.3 1.2 66
VERONA 73.1 56.5 89.7 2.5 67
VILNIUS 63.0 60.0 66.1 0.0 36
WARSAW 41.1 20.8 61.4 1.0 29
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Summary and conclusions
•	 Most MSM who participated in this study reported having sex with only male partners in the past six months. 
However, a minority of participants also reported sex with female partners (steady and non-steady) in the 
past six months. It is possible that these behaviourally bisexual MSM who also have sex with women may 
constitute a subgroup that differs from the study’s larger group of participants who report male-only part-
ners; for example, in terms of percentages by country, age distribution, ‘outness’, sexual behaviours, and 
other variables. However, as an in-depth analysis of this subgroup and these differences was not a main 
focus of the Sialon II survey, only a very basic analysis was conducted to estimate sex with women stratified 
by few variables. 
•	 Relatively high percentages of participants reporting sex with women reported that this sex was unpro-
tected; biological data (not reported here) suggest a possible risk of HIV transmission to female partners 
(e.g. due to undiagnosed HIV infection). 
•	 Overall, the findings suggest that there are important HIV prevention opportunities for tailored programmes 
in order to capture MSM who have sex with both men and women, particularly in those cases where MSM 
do not disclose their behavioural bisexuality to both their male or female partner. 
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Summary
The last episode of anal sex is an important indicator suggested to estimate the sexual behaviour and its 
associated risk. This was reported almost equally as often with a steady and a non-steady partner. Sexual roles 
during this last anal intercourse were found to be distributed equally between insertive, receptive, and both, 
with only minor variations between cities. The HIV serostatus concordance with the last steady anal sex partner 
was almost always assumed and also the HIV seroconcordance with non-steady anal sex partners was rarely 
established. Not knowing one’s own HIV status or the steady partner’s HIV status was most frequent in Central 
European cities. Condomless AI was considerably more frequent when the last anal sex partner was a steady 
partner compared to a non-steady partner. 
Introduction
In order to understand more about condom use and HIV serostatus communication (two of the most fre-
quently employed risk management tactics/strategies), participants in the survey were asked to report details 
regarding their last episode of anal sex. 
Assuming that, on a population level, sexual behaviours and practices with the last anal sex partner represent 
behaviour patterns, an analysis of serostatus communication and sexual risks with the last anal sex partner in 
the context of HIV test results (from biological samples) may provide information on current risk management 
tactics/strategies and may provide evidence for improving and better targeting prevention messages.
This section therefore presents findings from a series of questions around the last time participants had 
anal sex including the partner type, which role was assumed (insertive, receptive, versatile), condom use, and 
communication regarding HIV serostatus. 
Results 
Last anal intercourse by partner type and city
Participants were asked: “The last time you had anal intercourse with a male partner, who did you have 
it with?” Possible responses were: ‘one steady partner’, ‘one non-steady partner’, ‘more partners at once’, ‘I 
never had anal intercourse’, and’ I prefer not to answer’ [1]. Approximately half of the last anal intercourse (AI) 
episodes were reported to be with a steady partner (SP) ranging from 37.4% in Sofia to 65.4% in Ljubljana. Half 
were reported to be with a non-steady partner (NSP) ranging from 33.0% in Ljubljana to 61.0% in Sofia. A low 
proportion of participants ranging from 1.4% in Lisbon to 14.7% in Warsaw were with more than one partner 
(Figure.5.6.1).
5.6 Sexual behaviour during last episode
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Sexual roles (insertive, receptive, versatile) by city [3]
Participants were asked whether they assumed the insertive or receptive role or both, and whether condoms 
were used by themselves or their partners. The item stated: “Last time you had anal intercourse, were you…” 
and respondents could answer ‘yes’ or ‘no’ (or ‘I prefer not to answer’) to four items: ‘penetrated (fucked) with a 
condom?’, ‘penetrating (fucking) with a condom?’, ‘penetrated (fucked) without a condom?’, ‘penetrating (fuck-
ing) without a condom?’
Figure 5.6.1 Last anal intercourse by partner type and city (weighted)
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Figure 5.6.2 Sexual role during last anal intercourse by city (weighted)
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Sexual roles were almost equally distributed between insertive, receptive or versatile. The proportion of men 
engaging only in receptive AI was particularly high in Sofia (46.9%) and Stockholm (46.1%). The proportion of 
men engaging only in insertive AI was particularly high in Bucharest (51.4%), followed by Brighton and Lisbon 
(both 43.7%); while Brussels had the highest proportion of versatile respondents (40.2%; Figure 5.6.2). 
Knowledge of HIV serostatus concordance with last steady anal sex partner by city [2] [3]
If the last AI was with a SP, reported knowledge of partners’ HIV serostatus was generally very high. In Bar-
celona and Brighton 95.5% of the respondents with a SP reported knowing their partners’ HIV serostatus. The 
lowest knowledge was reported from respondents from Central European cities (Bratislava 35.0% not knowing, 
Bucharest 31.0%, Vilnius 26.7%, Bucharest 23.7%, Warsaw 20.9%, and Sofia 19.3%). This suggests lower overall 
testing rates. 
Reported HIV discordance with the steady partner was higher in the Western European cities (7.7% to 14.1%, 
minimum value in Verona with 4.1%) than in the Central European cities (1.8% to 5.9%, maximum value in Bu-
charest with 8.4%), (see Figure 5.6.3).
HIV serostatus concordance with last non-steady anal sex partner by study site [2] [3]
In contrast, the HIV serostatus of the last non-steady anal sex partner was usually unknown (range 72.2% in 
Brighton to 94.5% in Lisbon). Known HIV serodiscordance with a NSP was very rarely reported (see Figure 5.6.4). 
This suggests that HIV serostatus communication with non-steady partners is infrequent.
Of note is that the large difference in serostatus knowledge and concordance between SP and NSPs is due 
partly to a less restrictive definition of concordance with the SP (also including ‘assumed’ seroconcordance). 
The rationale for using this less restrictive definition is that serostatus communication was queried only for the 
last AI. However, in most cases the relationship with the SP will have existed for a longer time period than the 
survey encompasses. Thus, serostatus knowledge may exist although it was not specifically communicated 
during the last AI event. 
Figure 5.6.3 Concordance with steady partner during last anal intercourse by city
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HIV seroconcordance with last anal sex partner and as yet undiagnosed HIV [3]
Looking at reported HIV concordance with the last anal sex partner and the prevalence of undiagnosed HIV 
infection, assumed serostatus concordance and non-concordance were associated with a prevalence of 3.1% 
and 3.6% undiagnosed HIV infections. Known discordance of partners’ HIV status was associated with a preva-
lence of 1.1% undiagnosed infections (see Figure 5.6.5). 
The lower prevalence of undiagnosed HIV in men reporting a discordant last anal intercourse partner may 
be explained by higher frequency of condom use with known HIV status discordance, low infectiousness of 
HIV-positive men disclosing their HIV status due to effective antiretroviral treatment, and by more frequent HIV 
Figure 5.6.4 Concordance with last non-steady partner during last anal intercourse by city (weighted)
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Figure 5.6.5 Assumed concordance during last anal intercourse and undiagnosed HIV infection (unweighted)
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testing of HIV negative men aware of having had anal sex with a discordant partner. It should be noted anyway 
that the numbers in the “discordant” group are small, therefore data should be interpreted with caution. 
Prevalence of recently acquired and as yet undiagnosed HIV infection (incident HIV) was highest (2.6%) 
among respondents reporting no knowledge or no discussion about HIV serostatus (non-concordance). This 
was not statistically different from the 1.8% prevalence when the partners’ HIV serostatus was assumed to be 
concordant with the serostatus of the respondent. 
Undiagnosed HIV infections of unknown duration (as yet undiagnosed but not incident HIV) were most prev-
alent among men reporting serostatus concordance with their last anal sex partner, slightly less prevalent 
among men reporting no knowledge or discussion about HIV serostatus with their last anal sex partner, and 
absent among men reporting assumed HIV-serostatus discordance with their last anal sex partner. 
 Sexual roles (insertive, receptive, versatile) by knowledge of HIV status [3] 
Reported sexual roles during the last AI varied due to HIV serostatus knowledge (see previous sub-section 
on sexual roles for the item wording and response options). Whilst the proportion of respondents reporting to 
have been ‘insertive’ was largest among men assuming to be HIV negative, men who were aware of being in-
fected with HIV most often reported having been receptive or versatile during the last AI (Figure 5.6.6). This dif-
ference may be at least partly due to intentional decisions associated with different perceived HIV transmission 
probabilities during insertive and receptive AI and has been described as ‘strategic positioning’.
Condom use during last anal sex partner by city (GARPR 1.12) [3]
Condom use during last AI (consistent, inconsistent, none) with a male sex partner is one of the indicators 
collected for the Global AIDS response progress monitoring (GARPR 1.12). Condom use in the Sialon II cities 
ranged between 68.7% in Barcelona and 45.2% in Bratislava. In most cities higher proportions of condom use 
were reported from younger participants (<25 years). Exceptions were Bratislava, Bucharest, Lisbon, Verona, 
and Warsaw. Variability was also larger in younger participants; condom use was reported by 84.6% of young 
MSM in Barcelona and 34.6% in Bucharest. In the older age group (≥25 years) proportions varied between 72.0% 
Figure 5.6.6 Sexual role by HIV status (unweighted)
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Table 5.6.1 Condom use during last anal intercourse with a male partner (GARPR 1.12)
City Age
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Sample 
Size
BARCELONA
< 25 84.6 70.5 92.7 1.05 36
≥ 25 65.7 56.5 73.9 2.26 267
total 68.7 59.1 77.0 2.95 303
BRATISLAVA
< 25 41.7 27.2 53.1 1.96 88
≥ 25 46.7 38.5 54.8 1.74 202
total 45.2 38.1 51.4 1.67 290
BRIGHTON
< 25 56.8 34.9 76.3 1.88 46
≥ 25 51.7 40.9 62.4 2.81 222
total 52.4 41.3 63.4 3.48 268
BRUSSELS
< 25 83.7 67.3 92.8 0.95 39
≥ 25 57.6 44.5 69.8 4.51 253
total 60.7 47.7 72.3 4.97 292
BUCHAREST
< 25 34.6 11.8 56.9 1.84 31
≥ 25 62.3 47.8 76.8 2.00 85
total 56.6 43.7 69.5 2.06 116
HAMBURG
< 25 74.9 44.0 91.9 2.90 29
≥ 25 49.1 38.8 59.6 2.80 252
total 52.5 42.6 62.1 2.84 281
LISBON
< 25 53.1 28.5 76.3 2.65 30
≥ 25 72.0 65.2 77.9 1.45 294
total 69.6 64.5 74.3 0.95 324
LJUBLJANA
< 25 57.6 35.8 76.8 3.35 91
≥ 25 47.1 37.7 56.6 2.13 204
total 49.5 42.6 56.5 1.50 295
SOFIA
< 25 80.0 71.7 86.2 0.85 114
≥ 25 59.3 54.5 64.0 0.72 278
total 64.7 60.6 68.5 0.70 392
STOCKHOLM
< 25 62.6 44.2 78.0 1.71 38
≥ 25 56.9 43.9 69.0 2.47 160
total 58.4 47.0 69.0 2.61 198
VERONA
< 25 55.7 39.5 71.1 2.62 87
≥ 25 63.9 55.2 73.9 2.70 235
total 61.6 53.9 70.1 2.70 324
VILNIUS
< 25 59.6 45.2 74.3 1.77 67
≥ 25 55.3 46.0 65.5 2.02 177
total 56.6 48.9 65.0 1.91 244
WARSAW
< 25 51.4 37.3 65.3 1.70 67
≥ 25 57.0 47.9 65.7 1.70 215
total 55.4 48.2 62.4 1.50 282
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in Lisbon and 46.7% in Bratislava (Table.5.6.1). However, the small sample sizes for the younger age group in 
many of the study cities should be considered when interpreting these findings. 
Differences between cities can be explained partly by different proportions of men having their last AI with a 
SP. As shown in Figures 5.6.7 and 5.6.8, condom use was much lower when the last anal sex partner was a SP 
compared to a NSP. Condom use during the last anal sex when the partner was the SP and the respondent was 
younger than 25 years, was high in Brussels (60.0%), Sofia (63.0%) and Barcelona (69.0%), and low in Hamburg 
(26.0%) and Ljubljana (25.0%). Among older respondents (≥25 years) with SPs, condom use increased among 
men from Warsaw, Lisbon, Ljubljana, and Stockholm. Condom use declined in older men from Brussels, Sofia, 
Hamburg, Barcelona, and Brighton.
When the last anal sex partner was a NSP, condom use during the last anal sex episode was generally high. 
Condom use with NSPs was usually higher among younger participants (< 25 years) compared to older partic-
ipants (≥25 years).
Figure 5.6.8 No condom use during last anal intercourse with non-steady partner by age group and city (weighted)
Figure 5.6.7 No condom use during last anal intercourse with steady partner by age group and city (weighted)
0%
20%
30%
10%
40%
50%
60%
70%
80%
90%
100%
< 25 ≥ 25
Barcelona
< 25 ≥ 25
Brighton
< 25 ≥ 25
Brussels
< 25 ≥ 25
Hamburg
< 25 ≥ 25
Lisbon
< 25 ≥ 25
Ljubljana
< 25 ≥ 25
Sofia
< 25 ≥ 25
Stochkolm
< 25 ≥ 25
Warsaw
< 25 ≥ 25
Bratislava
< 25 ≥ 25
Bucharest
< 25 ≥ 25
Verona
< 25 ≥ 25
Vilnius
Pr
op
or
tio
n 
no
t u
si
ng
 c
on
do
m
s
0%
20%
30%
10%
40%
50%
60%
70%
80%
90%
100%
< 25 ≥ 25
Barcelona
< 25 ≥ 25
Brighton
< 25 ≥ 25
Brussels
< 25 ≥ 25
Hamburg
< 25 ≥ 25
Lisbon
< 25 ≥ 25
Ljubljana
< 25 ≥ 25
Sofia
< 25 ≥ 25
Stochkolm
< 25 ≥ 25
Warsaw
< 25 ≥ 25
Bratislava
< 25 ≥ 25
Bucharest
< 25 ≥ 25
Verona
< 25 ≥ 25
Vilnius
Pr
op
or
tio
n 
no
t u
si
ng
 c
on
do
m
s
 116 The Sialon II Project. Report on a Bio-behavioural Survey among MSM in 13 European cities
Condom use with last non-steady anal sex partner by knowledge of HIV status (unweighted) [3]
If the last anal sex partner was a SP, the percentage of UAI was slightly lower when the respondent was 
aware of being infected with HIV compared to men assuming to be HIV negative. Compared with HIV negative 
respondents, reported proportion of UAI with the last non-steady anal sex partner was higher among respon-
dents aware of being HIV-positive (see Figure 5.6.9). This is likely partly due to reported or assumed HIV-positive 
seroconcordance with the partner, partly due to a perception of reduced infectiousness under effective antiret-
roviral treatment, and partly due to a reduced sense of personal responsibility in specific settings such as sex 
clubs (O’Leary et al., 2013).
Figure 5.6.9 No condom use with steady and non-steady partner during last anal intercourse by HIV status 
knowledge (nSP=1,617; nNSP=1,596)
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Figure 5.6.10 Concordance with last steady partner (unweighted) (n=1,641)
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 HIV serostatus knowledge of last steady anal sex partner by HIV status (unweighted) [3]
Knowledge (or assumed knowledge) of the HIV serostatus of the last steady anal sex partner was high. 
Awareness of last steady anal sex partners’ HIV status was highest among men diagnosed with HIV. Assumed 
negative concordance with the last steady anal sex partner was highest among men unaware of being infected 
with HIV, pointing to the high risk associated with incorrect assumptions about the steady partners’ HIV se-
rostatus (Figure 5.6.10). 
Communication of HIV serostatus with last non-steady anal sex partner by HIV status (unweighted) [2] [3]
When the last anal sex partner was a NSP, usually the respondents had no reliable information on the HIV 
serostatus of their partners. The men unaware of being infected with HIV was the group with the lowest level of 
serostatus communication with the last non-steady anal sex partner (Figure 5.6.11). This suggests that trans-
mission risks with NSPs are mostly associated with lack of condom use combined with absence of serostatus 
disclosure or knowledge. 
Summary and conclusions
•	 The last episode of anal sex was reported almost equally as often with a steady and a non-steady partner. 
Sexual roles during this last AI were distributed equally between insertive, receptive, and versatile, with 
only minor variations between cities.
•	 Assumed HIV serostatus concordance was very high with the last steady anal sex partner.
•	 Not knowing the own or the steady partner’s HIV status was most frequent in Central European cities. 
•	 HIV seroconcordance with non-steady anal sex partners was rarely established.
•	 UAI was considerably more frequent when the last anal sex partner was a SP compared to a NSP. 
•	 The proportion of UAI was relevant among known HIV-positive participants with both steady and non-steady 
partners.
Figure 5.6.11 Concordance with last non-steady partner (n=1,690)
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•	 The proportion of as yet undiagnosed HIV infections was approximately 3-3.5%, independent of assumed 
HIV seroconcordance with the last anal sex partner. 
•	 If the last anal sex partner was a SP, those with as yet undiagnosed HIV infection reported the highest level 
of (wrongly) assumed HIV seroconcordance with their partner.
•	 If the last anal sex partner was a NSP, those with as yet undiagnosed HIV infection reported the lowest level 
of HIV status knowledge of their sex partner.
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Endnotes
[1] For participants who answered ‘I never had anal sex’, all subsequent answers to questions Q27-Q29 were set to missing. Since one 
possible answer to Q26 was ‘multiple partners’, participants were instructed to tick all options which applied in Q27-Q29. However, many 
participants who indicated only one steady or non-steady partner in Q26 indicated more than one response options in Q28 and Q29. Closer 
analysis revealed that almost all of these multiple responses could not be regarded as inconsistent. E.g., several participants indicated: ‘I 
thought my partner was HIV negative’, ‘I knew my partner was HIV negative’, ‘I was not interested in his HIV status’. Thus, only the answers 
of six participants, who had checked all available response options, were set to missing.
[2] To examine participants’ knowledge of their partners’ HIV serostatus at last AI, respondents were asked: “Last time you had anal 
intercourse, what did you think about your partner/s HIV status before having sex?” Possible responses included: ‘I thought he was HIV 
negative’, ‘I knew he was HIV negative’, ‘I thought he was HIV-positive’, ‘I knew he was HIV-positive’, ‘I knew he was unsure about his HIV 
status’, ‘I didn’t have any thoughts about his HIV status’, ‘I do not remember’, and ‘I prefer not to answer’. Similarly, participants were also 
asked about what they had disclosed about their HIV status to their partner at last AI: “Last time you had anal intercourse, what did you tell 
your partners/s about your HIV status before having sex?” Possible responses included: ‘I told him I didn’t know my HIV status’; ‘I told him 
I was HIV negative’, ‘I told him I was HIV-positive’, ‘I said nothing about my HIV status’, ‘I told him I was unsure about my HIV status’, ‘I do 
not remember’, and ‘I prefer not to answer’.
[3] Secondary variables computed included: 
•	 Sexual role during last anal intercourse (insertive [top]; receptive [bottom]; versatile);
•	 Condom use during last anal intercourse (consistent; inconsistent/ none);
•	 Serostatus concordance with steady partner (concordance defined as respondent reporting the same HIV serostatus as the reported or 
assumed serostatus of the steady partner); 
•	 Serostatus concordance with non-steady partner (concordance defined as respondent reporting the same HIV serostatus as the re-
ported – but not the assumed – serostatus of the non-steady partner); 
•	 Not knowing the own HIV serostatus or the serostatus of the last anal sex partner or not communicating about HIV status was defined 
as non-concordant.
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Summary
The majority of study participants in the RDS samples reported low levels of involvement in commercial sex 
with the exception of Bucharest. Among those who had been paid for sex, a high percentage reported that they 
had used a condom during anal sex the last time they were paid. Finally, the commercial sex with female part-
ners was infrequent among RDS study participants. 
Introduction
Commercial sex is thought to be associated with an increased vulnerability to HIV. Current research indi-
cates that men who engage in commercial sex may have differential HIV risk compared to MSM who do not 
engage in commercial sex. However, there is conflicting evidence as to whether engagement in commercial sex 
is associated with increased risk-taking behaviour or a higher HIV prevalence. 
A systematic review showed that worldwide regions in which the HIV epidemic is largely driven by sexual 
transmission and concentrated among MSM had also the largest disparities in the burden of HIV among men 
who engage in commercial sex. In Latin America, North America, and Europe, regions in which the HIV epi-
demic is concentrated among MSM, both absolute and relative measures of HIV burden among men engaging 
in commercial sex were high (Oldenburg, Perez-Brumer, Reisner, Mattie, Bärnighausen et al. 2014). Another 
systematic review confirms that HIV prevalence is elevated among MSM who engage in commercial sex as 
compared to MSM who do not. This supports existing literature that suggests that this subpopulation of MSM 
has different and increased risks associated with HIV vulnerability, and that there are geographic differences in 
these associations globally (Oldenburg, Perez-Brumer, Reisner, Mimiaga, 2015).
Finally, MSM who engage in commercial sex are a highly heterogeneous group, and a large percentage may 
identify as heterosexual or bisexual or may be married to women or have female primary and/or casual sexual 
partners (Landers, Closson, Oldenburg, Holcomb, Spurlock, Mimiaga 2014; Wong, Huang, He, Smith, Ding, et 
al. 2008; Prado Cortez, Boer, Baltieri 2011). This may not only act as an HIV transmission ‘bridge’ to the general 
population but means that MSM who engage in commercial sex may not be responsive to HIV prevention ser-
vices that are designed specifically for gay-identified MSM.
In this current Section data are presented from the RDS cities only[1]. Specifically, findings on the percent-
ages of men who have paid or been paid for sex in the last six months are reported. In addition, findings on the 
percentages of men who have paid or been paid for sex in the last six months with a woman are also reported. 
Findings 
Commercial sex
Commercial sex can be interpreted broadly as the exchange of sex for money, goods, drugs, or other items of 
value (including protection, housing, or food). In Sialon II, items in the RDS questionnaire  were operationalised 
simply as either ‘having paid’ or ‘having been paid’ for sex. Moreover, in order to collect relevant data indepen-
dently by self-identification as a ‘sex worker’, no distinction was made between individuals who self-identify as 
sex workers and engage in commercial sex regularly, and those who engage in commercial sex occasionally 
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and may not identify as such. Overall, the findings from the four RDS cities show that the vast majority of par-
ticipants did not report commercial sex with the exception of Bucharest. Stratification by age for this variable 
was not possible due to the low numbers of participants who declared engaging in commercial sex activities. 
Instead, findings are presented aggregating all those who reported they either paid or were paid for sex at least 
once in the last six months.
MSM having paid for sex 
Looking at the percentages of men who reported having paid for sex in the last six months, there was a 
variation between the cities which increased when the question was about having been paid. Participants were 
asked: “In the last 6 months have you ever paid to have sex with men?”, and; “In the last 6 months have you 
ever been paid to have sex with men?” Respondents could answer with the number of times this happened or 
write a zero if applicable. The percentages of men who reported having paid to have sex with a man in the last 
six months were higher in Bucharest (6.7%) and Bratislava (3.0%) and lower in Verona and Vilnius with similar 
figures (0.9%; see Table 5.7.1). 
Table 5.7.1 Percentage of MSM having paid to have sex with a man in the last six months 
City
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Sample 
Size
BRATISLAVA 3.0 1.4 4.1 0.9 16
BUCHAREST 6.7 3.3 10.1 0.9 12
VERONA 0.9 0.0 1.8 1.0 5
VILNIUS 0.9 0.1 1.7 0.7 5
MSM having been paid for sex 
When participants were asked about having been paid for sex in the last six months, percentages were 
generally higher than for those who had paid for sex. For instance, the highest percentage was again found in 
Bucharest with 27.5% of participants reporting that they had been paid for sex; this is almost ten times lower 
than the percentage found in Vilnius (2.8%; Table 5.7.2). In general, the percentages of people reporting that 
they had been paid were much higher compared to those participants reporting that they had paid; with the only 
exception of Bratislava where the two figures were very similar.
Table 5.7.2 Percentage of MSM having been paid to have sex with a man in the last six months 
City
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Sample 
Size
BRATISLAVA 3.0 1.3 4.6 1.3 13
BUCHAREST 27.5 19.0 36.0 1.7 48
VERONA 6.1 2.9 9.5 2.0 21
VILNIUS 2.8 0.7 4.9 1.6 9
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Condom use by MSM having been paid to have sex 
With regard to  the use of a condom the last time participants reported having been paid to have anal inter-
course, estimates varied from country to country (Table 5.7.3). Participants were asked: “Last time you were 
paid to have anal intercourse, were you…” and respondents could answer ‘yes’ or ‘no’ (or ‘I prefer not to an-
swer’) to four items[2]: ‘penetrated (fucked) with a condom?’, ‘penetrating (fucking) with a condom?’, ‘penetrated 
(fucked) without a condom?’, ‘penetrating (fucking) without a condom?’[3]. In Bratislava, Bucharest, and Vilnius 
the majority of participants reported having used a condom during paid anal intercourse (64.3%, 58.0% and 
78.4% respectively); whilst in Verona the large majority of participants reported unprotected anal intercourse 
the last time they had been paid for anal intercourse (69.5%). 
Table 5.7.3 Use of a condom among MSM having been paid to have sex with a man the last time they were paid 
to have anal intercourse in the last six months 
City
Use 
of condom
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Sample 
Size
BRATISLAVA
With 64.3 27.2 100 1.2 4
Without 35.7 0 72.8 1.2 3
BUCHAREST
With 58.0 37.2 78.7 1.8 23
Without 42.0 21.3 62.8 1.8 16
VERONA
With 30.5 29.7 29.7 0 10
Without 69.5 70.3 70.3 0 8
VILNIUS
With 78.4 60.8 98.9 0.4 4
Without 21.7 1.1 39.2 0.4 3
MSM having paid or been paid to have sex with a woman 
In order to be able to explore the percentage of commercial sex with both men and women, and its signifi-
cance in terms of a ‘bridging’ factor for possible HIV transmission to female partners , participants were asked: 
“In the last 6 months have you ever paid or been paid to have sex with a woman?” Respondents could state the 
number of times this happened respectively if they paid (“I have paid roughly ….”) or if they were paid (“I have 
been paid roughly…”) or write zero if applicable. Commercial sex with women in the last six months (either pay-
ing or having been paid) was much less frequent than for commercial sex with men (Table 5.7.4). The highest 
percentage was found in Bucharest with 3.4% of respondents reporting commercial sex with women. In Vilnius 
nobody reported this behaviour.
Table 5.7.4 Percentage of MSM having paid or been paid to have sex with a woman in the last six months 
City
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Sample 
Size
BRATISLAVA 1.3 -0.5 3.4 4.0 2
BUCHAREST 3.4 0.7 6.2 0.9 5
VERONA 1.9 -0.2 4.0 2.3 5
VILNIUS - - - - -
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Summary and conclusions
ìThe Sialon II RDS survey assessed a limited number of commercial sex related indicators. However, some 
indicators collected (such as the number of times respondents paid or were paid for sex) were collected, but 
were difficult to interpret particularly by city level due to the limited numbers of those reporting commercial sex. 
Nevertheless it was still possible to draw some key conclusions from our analysis of the data:
•	 The large majority of study participants reported low levels of involvement in commercial sex with the ex-
ception of Bucharest where 27.5% of respondents reported they had been paid in the last six months and 
6.7% reported that they had paid for sex;
•	 The majority of those who had been paid for sex reported that they had used a condom during anal sex the 
last time they were paid; with the only exception of respondents in Verona where almost 70% reported not 
using a condom;
•	 Commercial sex with female partners was infrequent. The highest percentage was found in Bucharest 
(3.4%) in line with the highest percentages found for commercial sex with male partners.
This high number of MSM having been paid for sex in Bucharest, also much higher than the percentage of 
buying sex, could be due to lack of convergence of the recruitment chains for the drug use variable. In effect 
the samples contained a high proportion of people who use drugs, higher that could be expected in the source 
population. 
Although there may be large differences in the definition of commercial sex which may influence how it af-
fects HIV risk, this Section has only presented a first basic and descriptive analysis of the HIV risk measured as 
condom use in anal intercourse related to commercial sex. Future analysis should analyse whether: there are 
differences between MSM who engage in commercial sex compared with the broader general MSM population; 
whether reported commercial sex is a stable or occasional activity using ‘number of times’ as a proxy indica-
tor, and; for behaviourally bisexual MSM who engage in commercial sex activities, whether there is a potential 
‘bridging’ factor for possible HIV transmission to female partners. 
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Endnotes
[1] Due to the practical constraints of data collection at the TLS venues which required a short as possible questionnaire, questions 
about commercial sex and condom use were only included for RDS sites. 
[2] The use of an explicit description of the behaviour via a slang expression (e.g. fucked) was meant to clarify the question and to avoid 
potential misunderstandings. A preliminary qualitative piloting of the item (including translation to local languages) was carried out in order 
to ensure a correct understanding of the items related to commercial sex. 
[3] Insertive or receptive anal intercourse was aggregated into a general ‘anal intercourse’ variable.
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Summary
Despite some variations between the RDS cities, fisting was a relatively common practice among partici-
pants, at least once in their lifetime. Higher percentages of older participants (>40 years) reported ever having 
engaged in fisting behaviours compared to younger participants. 
Introduction
Brachioproctic insertion or ‘fisting’ is a sexual practice involving the insertion of a hand, fist, or arm into a 
partner’s rectum. Some research suggests that the practice can be a high risk behaviour for lesions and some 
STIs (Donovan, 1986; Fernández-Dávila, 2014; Fletcher, 2003). Although fisting or fingering the rectum carries a 
negligible risk of HIV transmission for the insertive or active partner (unless there is an open cut, sore or other 
wound or skin lesion on the hand), it can present a high risk for rectal tissue trauma for the receptive/passive 
partner (Cohen, 2004; De Bakker, 2012); increasing the probability of contracting blood borne diseases (Browne, 
2004; Haar, 2013) and STIs such as Hepatitis B and C (Macdonald, 2014; McFaul, 2014; Rönn, 2011; Turner et al., 
2006). For instance, whilst there have been few reported cases of HIV as a consequence of fisting, since 2000 there 
has been growing evidence of the Hepatitis C virus (HCV) infection spread among HIV-positive MSM associated 
with this practice (Urbanus, 2010; Va De Laar, 2010). Reported increases in HCV seroconversion among HIV-pos-
itive MSM in association with high risk sexual behaviours (including unprotected anal sex, fisting, and rimming) 
suggest an interaction between HIV and sexual practice. Fisting has consequently been identified as a possible 
risk factor for HCV acquisition for both the insertive and receptive partner (Van Kamseke, 2009; Ward, 2014). 
In this Section, behavioural and biological data from the RDS cities  on fisting and HIV (serum testing) are pre-
sented (in TLS cities, as HBV/HCV testing was not planned along with the need for questionnaires to be as short 
as possible given they were administered in gay venues, items on fisting were not included). For RDS cities, point 
estimates on fisting behaviours are provided (with Confidence Intervals and Estimated Design Effect) from two 
questionnaire items which differentiated between active fisting, passive fisting, and ever having engaged in fisting 
behaviour (i.e. lifetime; active, and/or passive). Findings are also stratified by age and by HIV status. 
Unfortunately despite the relevance, comparison of fisting behaviour with biological data on HBV and HCV 
infections (from serum testing) are not presented due to very small sample sizes for those indicators (i.e. small 
numbers of positive cases). This is because sample sizes for the RDS cities were calculated on the basis of esti-
mated HIV prevalence levels (from the former Sialon I project and other available data) rather than on estimated 
Hepatitis prevalence. However, full details of HBV and HCV prevalence can be found in Section 5.9.
Results 
Fisting lifetime (active and/or passive) [1]
In general, engaging in fisting behaviour at least once in their lifetime (active and/or, passive) was fairly 
common among MSM in all RDS cities although there were some variations between cities (see Table 5.8.1). 
Percentages of participants who reported having ever engaged in fisting behaviours ranged from 10.5% in Vil-
nius to the highest of 34.1% in Verona.  In Bratislava, the percentage of participants who reported fisting was 
5.8 High risk sex behaviour (fisting)
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15.4%, whilst in Bucharest over one quarter of participants (27.5%) reported having practiced active or passive 
fisting at some point in their lifetimes.  
Table 5.8.1 Percentage of MSM who reported having practiced fisting – lifetime (active and/or passive)
City
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Denominator
BRATISLAVA 15.4 10.9 19.6 1.88 377
BUCHAREST 27.5 21.2 33.8 0.887 171
VERONA 34.1 26.5 41.7 2.6 385
VILNIUS 10.5 6.1 14.4 1.73 314
Active fisting
The numbers of participants who reported active fisting (lifetime) were relatively low. Table 5.8.2 presents 
point estimates of active fisting behaviour, that is, the percentage of participants who replied ‘yes’ (in the last 
six months and/or lifetime) to the item “did you insert your hand into a man’s rectum (fist-fucked him)?”[2]. The 
highest percentages of active lifetime fisting were reported by participants from Verona (29.5%) and Bucharest 
(23.7%). Lower percentages were reported by Vilnius (10.2%) and in Bratislava (13.3%) respectively. 
    
Table 5.8.2 Percentage of MSM who reported having practiced active fisting – lifetime 
City
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Denominator
BRATISLAVA 13.3 9.3 17.0 1.66 375
BUCHAREST 23.7 17.8 29.6 0.84 168
VERONA 29.5 22.3 36.7 2.50 379
VILNIUS 10.2 6.0 14.0 1.62 313
Passive fisting
The numbers of participants who reported passive fisting (lifetime) were relatively low although variations 
were observed between RDS cities. Table 5.8.3 presents point estimates of passive fisting behaviour, that is, the 
percentage of participants who replied ‘yes’ (in the last six months and/or lifetime) to the item “have you had a 
man’s hand inserted into your rectum (got fist-fucked)?” The highest percentages of engaging in passive life-
time fisting were reported by participants from Verona (19.1%) and Bucharest (18.5%). Relatively lower percent-
ages were reported by participants from Bratislava (11.4%), and even lower by participants from Vilnius (4.0%). 
Fisting by city and age (active and/or passive) – lifetime
Some variations in lifetime fisting behaviour (active and/or passive) were evident when stratified by age 
(<30 years, 30-39 years, >40 years; see Table 5.8.4) although findings must be interpreted cautiously given the 
very small sample sizes in some cases. In Bratislava and Vilnius, higher percentages of older participants 
(>40 years) reported ever having engaged in fisting behaviours compared to younger participants. For instance, 
in Bratislava, younger participants (<30 years) reported fisting in 13.1% of the cases, whilst the percentage 
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increased to 21.7% for older participants (>40 years). In Vilnius, the same pattern was observed; for younger 
participants (<30 years) only 8.2% of respondents reported ever having engaged in fisting behaviours whilst in 
older participants (>40), the percentage increased to 18.2%. 
There were small variations in fisting behaviour by age reported by participants from Verona with percent-
ages ranging from 31% (30-39 years, >40) to 36.3% (<30 years). 
Finally, in Bucharest in the middle age category (30-39), the highest percentage of participants reporting 
fisting was observed (34.9%).  
Fisting by city and HIV status
According to the literature, fisting behaviour may be associated with HIV status. However, the estimates 
presented here are limited by small numbers (both for HIV-positive participants and for those participants de-
claring fisting) so the results should be interpreted with caution. 
Nevertheless, some differences were evident when fisting was stratified by HIV status (based on serum). 
Higher percentages of HIV-positive participants from Bratislava and Verona, reported engaging in fisting be-
haviours compared to HIV-negative participants. In Bratislava for example, the percentage of HIV-positive par-
ticipants who reported fisting was 35.0% which dropped to 14.4% for HIV-negative participants. Similarly in 
Table 5.8.3 Percentage of MSM who reported having practiced passive fisting – lifetime
City
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Denominator
BRATISLAVA 11.4 7.4 15.6 2.20 377
BUCHAREST 18.5 13.2 23.8 0.81 168
VERONA 19.1 13.0 25.2 2.42 382
VILNIUS 4.0 1.3 6.7 1.73 310
Table 5.8.4 Percentage of MSM reported having practiced fisting (active or passive) lifetime by age
City Age
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Denominator
BRATISLAVA
<30 13.1 8.1 17.5 2.09 207
30-39 17.8 12.0 23.7 2.52 130
>=40 21.7 12.0 23.3 1.09 40
BUCHAREST
<30 23.3 14.0 32.6 1.12 89
30-39 34.9 23.2 46.7 0.907 57
>=40 27.0 5.9 48.2 1.39 23
VERONA
<30 36.3 27.1 45.9 2.19 191
30-39 31.5 19.6 44.3 2.68 108
>=40 31.0 18.9 41.9 1.86 84
VILNIUS
<30 8.2 3.1 13.1 2.05 176
30-39 14.4 5.8 20.8 2.28 98
>=40 18.2 6.2 18.3 1.15 40
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Verona, 53.6% of HIV-positive participants reported fisting compared to only 32.1% of HIV negative participants. 
However, in Bucharest no substantial differences were found between HIV negative (28.6%) and HIV-positive 
(23.2%) men in terms of fisting behaviour point estimates. Finally, in Vilnius (and in contrast to Bratislava and 
Verona), engaging in fisting was reported more often by HIV negative participants (10.6%) compared to just 
3.0% by HIV-positive participants (although this finding is probably due to the small number of HIV-positive 
respondents). These point estimates are not precise due to the limited sample size, as can be seen by the wide 
confidence intervals. However, the use of weighted estimates provides a clear indication of its limitations. 
Table 5.8.5 Percentage of MSM who reported having practiced fisting – lifetime (active and/or passive) by HIV 
status
City HIV status
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Denominator
BRATISLAVA
HIV – 14.4 9.7 18.9 2.12 357
HIV + 35.0 12.2 59.9 1.88 20
BUCHAREST
HIV – 28.6 20.9 36.3 1.04 137
HIV + 23.2 11.2 35.2 0.72 34
VERONA
HIV – 32.1 25.2 39.1 2.2 353
HIV + 53.6 27.7 79.5 2.4 32
VILNIUS
HIV – 10.6 5.8 15.2 1.88 306
HIV + 3.0 0.0 8.9 0.261 8
Summary and conclusions 
•	 Given the literature proposes links between high risk sexual behaviours including fisting and Hepatitis and 
HIV infection, in the RDS questionnaire (only) two behavioural items were included on active/passive, and 
lifetime fisting which could then in principle, be compared with participants’ biological data on HIV, Hepa-
titis B, and Hepatitis C, from serum testing. 
•	 CI and estimated DE demonstrate that the point estimates on fisting prevalence are robust. Despite some 
variations between the RDS cities, fisting was a relatively common practice among participants, at least 
once in their lifetime. The percentages of participants ever engaging in fisting (active and/or passive) ranged 
from 10.5% in Vilnius to 34.1% in Verona. In Bratislava, the percentage of participants who reported fisting 
was 15.4%, whilst in Bucharest over one quarter of participants declared to have practiced active or passive 
fisting in their life (27.5%).   
•	 A limitation of the findings in this section is that despite the established link in the literature between fisting 
practices and Hepatitis infection, it was unfortunately not possible to compare fisting and tested HBV/HBC 
status due to limited sample sizes. This is because sample sizes for the RDS cities  were calculated on the 
basis of estimated HIV prevalence levels rather than estimated Hepatitis prevalence. However, full details 
of HBV and HCV prevalence can be found in Section 5.9.
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Endnotes
[1] Fisting behaviour in RDS cities was assessed through two items focusing on the last six months representing active and passive 
behaviours respectively: In the last 6 months, did you insert your hand into a man’s rectum (fist-fucked him)?; In the last 6 months, have you 
had a man’s hand inserted into your rectum (got fist-fucked)? Respondents had the possibility to choose one of the following options: ‘Yes’; 
‘No, I did it more than 6 months ago’; ‘No, I have never done it’; and ‘I prefer not to answer’. The second and third options were included 
to differentiate between participants who had never practiced fisting vs. those participants who had practiced it at least once in their life.  
[2] The use of an explicit slang expression for fisting in the question items (fist-fucked) was deliberate to disambiguate the question and 
avoid potential misunderstanding (as for instance between fisting and fingering). Piloting of these items was carried out in order to ensure 
understanding of the questions. 
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Summary
In terms of HIV prevalence, data suggested that this varies between 2% and 20%, with higher rates among indi-
viduals older than 25 years of age. A relevant proportion (ranging between 12% and 88%) of participants were un-
aware of being HIV-positive. These findings are particularly alarming in terms of potential for new HIV outbreaks. 
Introduction 
HIV infection remains of major public health importance in Europe. The most recent surveillance data show 
that, despite significant efforts dedicated to the prevention and control of HIV, the rate of new HIV diagnoses 
has not declined in the EU/EEA and has increased substantially over the last decade in the European Region. 
HIV is mainly concentrated in key populations at higher risk of HIV infection. Specifically MSM show a persistent 
increase in new HIV diagnoses across Europe in the last decade (ECDC/WHO, 2014; ECDC, 2014), suggesting 
that current prevention and control efforts are not yet being delivered with sufficient effect and would need to 
be significantly strengthened.
Although populations most at risk vary across countries, it is recognised that in the countries of the Euro-
pean Union and the European Economic Area (EU/EEA) MSM are disproportionately affected by HIV and other 
sexually transmitted infections (STI). Despite numerous interventions targeting behaviour, knowledge and atti-
tudes of MSM, increases of STI and HIV have been recently observed. Outbreaks of syphilis, lymphogranuloma 
venereum (LGV), hepatitis C viral infection (HCV) and other STI have been reported in multiple European cities 
suggesting high-risk sexual behaviour and extensive sexual networking (ECDC, 2013.)
Variables
Variables used for the present analysis are the following: city, age, country of origin, HIV status, syphilis sta-
tus, hepatitis B serostatus, hepatitis C serostatus, HIV serostatus, and HIV serostatus knowledge. 
HIV serostatus knowledge was based on HIV serostatus and answers to the questionnaire in the following mode:
•		 Known	HIV-positive:	positive	anti-HIV	test	performed	in	Sialon	II	(on	blood	or	saliva)	and	previous	HIV	pos-
itive test self-reported in the questionnaire;
•		 Newly	diagnosed	HIV-positive:	positive	anti-HIV	test	performed	in	Sialon	II	(on	blood	or	saliva)	and	either	no	
previous HIV test result or negative previous HIV test self-reported in the questionnaire;
•		 Indeterminate	knowledge	HIV-positive:	positive	HIV	test	result	and	contradicting	or	missing	 information	
on HIV serostatus, such as: self-reported positive but saliva test negative, no information on previous test 
result but previous test reported, or missing information on HIV serostatus.
Laboratory case definition 
For the present analysis, we used laboratory results obtained from the laboratories working in 13 EU coun-
tries involved in Sialon II project, using the standard procedures reported in the “Handbook for HIV and STI 
testing in Sialon II study using RDS” and “Manual for HIV-testing from oral fluids in TLS study”.
5.9 HIV and other STIs
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HIV: 
•	 TLS	arm:	HIV	serostatus	was	based	on	saliva	sample.	Oral	fluid	(OF)	was	collected	with	Oral	Specimen	
Collection Devices ORACOLE at room temperature in gay venues. The quality of the OF samples found 
HIV-negative in HIV-testing was established by total IgG measurement using Human IgG ELISA kit (Immu-
nology Consultants Laboratory, Inc.). Linked anonymous testing of HIV-antibodies from OF (with informed 
consent) was provided according to testing strategy recommended by WHO (WHO, 2009) using the follow-
ing commercial ELISA diagnostic kits: Genscreen HIV ½ version 2 (BIO-RAD) and Vironostika HIV Ag/Ab 
(Biomerieux). An individual was defined HIV-positive when reactive to both ELISA tests.
•	 RDS	arm:	HIV	serostatus	was	based	on	serum	sample.	Anti-HIV	antibodies	were	assayed	using	a	CE	marked	
commercial fourth generation ELISA (detecting both Ag and Ab); an individual was defined HIV-positive 
when reactive to the ELISA Ag/Ab test and confirmed with Western Blot. 
Syphilis: Syphilis serostatus was investigated in the RDS arm only and based on blood testing using a battery 
of serological tests. Treponemal tests included Treponema pallidum Haemoagglutination (TPHA), Treponema 
Pallidum Particle Agglutination (TPPA), Chemiluminescent Microparticle Immunoassay (CMIA). Non-trepone-
mal test included Rapid Plasma Reagin (RPR). Overall seropositivity for syphilis was calculated including indi-
viduals reactive to a treponemal test having either a positive or a negative non-treponemal test. Seropositivity to 
both treponemal and at least one non-treponemal test suggested a probable active syphilis.
HBV: Hepatitis B serostatus was investigated in the RDS arm only and was based on the following serolog-
ical markers: HBsAg, HBsAb, and HBcAb tested form serum using commercial CE marked diagnostic kits and 
following usual testing guidelines for these infections. The combinations of these markers (see box below) were 
used to identify different phases of HBV infection. An individual reactive to HBcAb and to either HBsAg or HBsAb 
was defined as ‘exposed to HBV’.
HBV serological markers Results Interpretation of HBV serostatus 
HBsAg
HBsAb
HBcAb
negative
negative
negative
Susceptible
HBsAg
HBsAb
HBcAb
negative
positive
negative
Immune due to hepatitis B vaccination (a)
HBsAg
HBsAb
HBcAb
positive
negative
positive
Acute or chronic infection (b)
HBsAg
HBsAb
HBcAb
negative
positive
positive
Immune due to natural infection (c)
Source: “Interpretation of Hepatitis B Serologic Test Results”, Centers for Disease Control and Prevention (CDC), http://www.cdc.gov/
hepatitis/HBV.
HCV: Hepatitis C serostatus was investigated in the RDS arm only and was based on serological test results 
for anti-HCV antibodies in the blood using commercial CE marked diagnostic kit. An individual reactive to both 
anti-HCV ELISA and LIA assays was defined as positive for HCV.
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GARPR indicators
GARPR indicators are a set of core indicators to be used among different countries in order to monitor the 
HIV epidemic and the 2011 United Nations Political Declaration on HIV and AIDS (UNAIDS, 2014). In this para-
graph, data referring to GARPR 1.14 indicator are provided. 
The GARPR 1.14 refers to the HIV prevalence in MSM population. The prevalence was calculated from OF for 
TLS method (9 cities) and from serum samples for the RDS method (4 cities). As shown in Table 5.9.1, HIV prev-
alence estimates are different by city ranging from a minimum of 2.4% in Stockholm to a maximum of 18.0% in 
Bucharest.
Five cities had an HIV prevalence in the range 10-20% (Brussels, Barcelona, Lisbon, Brighton, Bucharest), 
four cities in the range 5-10% (Hamburg, Warsaw, Verona, Sofia), and four cities below 5% (Stockholm, Vilnius, 
Ljubljana, Bratislava). The highest prevalence was observed in Bucharest (18%); however, 37.7% of participants 
in this city reported having used injecting drugs. As mentioned in the introduction and methodology, this was 
due to the recruitment process occurred in Bucharest, where a sub-population of IDU-MSM was enrolled. 
Table 5.9.1 HIV weighted prevalence among MSM, 95% confidence intervals, design effect and number of par-
ticipants, by city (GARPR 1.14)
City
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Denominator
BARCELONA 14.2 10.1 19.5 1.2 400
BRATISLAVA 4.3 2.2 6.2 1.4 400
BRIGHTON 17.6 13.8 22.3 0.9 402
BRUSSELS 12.3 7.6 19.4 4.9 379
BUCHAREST 18.0 9.1 27.0 2.6 183
HAMBURG 7.5 3.9 13.8 3.6 390
LISBON 17.1 12.4 23.0 2.6 371
LJUBLJANA 4.4 2.1 8.9 1.8 347
SOFIA 3.0 0.9 9.1 0.8 361
STOCKHOLM 2.4 1.1 5.2 2.2 356
VERONA 9.6 4.5 14.9 3.5 400
VILNIUS 3.4 0.0 6.9 3.6 322
WARSAW 7.2 4.3 11.9 2.0 405
The prevalence according to age group is reported in Table 5.9.2. The sample size varied when stratified by 
age and city. Individuals younger than 25 years accounted for 10% to 30% of the participants included in the sur-
vey; the proportion of younger MSM was higher in Central/Eastern Europe than in Western Europe. The small 
number of HIV-positive participants younger than 25 years prevalence in Bratislava, Sofia and Verona hampered 
the calculation of confidence intervals for HIV prevalence. The highest prevalence among individuals younger 
than 25 years was observed in Bucharest: about 10% of individuals in this subgroup and 38% of HIV positive 
individuals reported injecting drugs. 
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In all cities, HIV prevalence was higher among individuals older than 25 years compared to those younger 
than 25 years, except in Bucharest where it was similar in both groups (18.5% vs. 11.6%, respectively).
Similar prevalence estimates were reported in Sialon I for four out of five cities that were included also 
in Sialon II i.e. Barcelona, Bratislava, Ljubljana, and Verona. In Barcelona and Ljubljana, the same sampling 
method was used and similar HIV prevalence estimates were observed when comparing Sialon II with Sialon I: 
14% vs. 17% in Barcelona, 4% vs. 5% in Ljubljana, respectively. In Bratislava and Verona the sampling method 
was different in Sialon II compared to Sialon I. Nevertheless, the HIV prevalence estimates were similar: in 
Bratislava 4% vs. 6%, in Verona 10% vs. 12%, respectively. Only in Bucharest, a higher prevalence was observed 
in Sialon II, which, as mentioned above, may be attributed to the high proportion of injecting drug user MSM 
Table 5.9.2 HIV weighted prevalence among MSM, 95% confidence intervals, design effect and number of par-
ticipants, by city and age group. (GARPR 1.14)
City Age
Point 
Estimate
95% 
Lower Bound
95% 
UpperBound
Estimated 
Design Effect
Denominator
BARCELONA
<25 0.8 0.1 6.6 0.5 42
25+ 16.4 12.4 21.5 1.2 358
BRATISLAVA
<25 2.1 0.0 4.7 1.5 118
25+ 5.3 1.8 8.4 2.2 282
BRIGHTON
<25 2.9 0.5 15.5 1.5 65
25+ 20.7 15.7 26.8 1.4 337
BRUSSELS
<25 0.5 0.1 4.3 0.3 49
25+ 14.4 8.6 23.0 3.1 330
BUCHAREST
<25 11.6 2.1 21.0 1.1 47
25+ 18.5 8.4 28.7 2.4 134
HAMBURG
<25 1.9 0.3 9.9 0.6 37
25+ 8.1 4.1 15.4 3.3 353
LISBON
<25 1.2 0.1 9.2 0.5 33
25+ 18.9 14.2 24.8 1.4 338
LJUBLJANA
<25 1.4 0.2 11.1 1.1 107
25+ 5.3 2.2 12.2 2.6 240
SOFIA
<25 0.1 0.0 16.1 0.1 99
25+ 3.9 1.0 14.0 4.1 262
STOCKHOLM
<25 0.0 0.0 0.0 - 73
25+ 3.4 1.5 7.4 1.3 283
VERONA
<25 3.8 0.0 9.6 3.0 104
25+ 12.2 3.8 20.8 5.6 293
VILNIUS
<25 0.0 0.0 0.0 - 83
25+ 4.6 0.4 9.2 3.3 239
WARSAW
<25 1.6 0.7 3.7 0.3 92
25+ 9.7 5.7 15.9 1.9 313
In most cities, HIV prevalence was higher among individuals older than 25 years compared to those youngerthan 25 years, except in Bu-
charest where it was similar in both groups. The highest prevalence among individuals younger than 25 years (excluding Bucharest) was 
observed in Sofia.
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included in the sample (Mirandola et al., 2009). Explosive spread of HIV among intravenous drug users has been 
reported repeatedly in various countries and has occurred in southeast Europe in the context of economic crisis 
since 2010.
Table 5.9.3 shows the distribution of HIV positive MSM by HIV status knowledge: known HIV-positive, newly 
diagnosed HIV-positive, indeterminate knowledge HIV-positive.
Among HIV-positive individuals, the highest percentage of MSM aware of their serostatus was observed in 
Hamburg (75%), whereas the highest percentage of newly diagnosed was observed in cities of previous social-
ist countries, such as Sofia, Vilnius, and Bratislava (88,4%, 59.2%, 51.8%, respectively). Bucharest showed the 
highest percentage of MSM with indeterminate knowledge of their HIV-positive.
Table 5.9.3 Distribution (weighted percentage) of HIV-positive MSM by HIV status knowledge and city
City
Known HIV positive
(%)
Newly diagnosed 
HIV positive
(%)
Indeterminate 
knowledge HIV positive
(%)
Denominator 
(N. of HIV positive 
individuals)
BARCELONA 50.9 28.9 20.2 62
BRATISLAVA 34.1 51.8 14.0 20
BRIGHTON 64.6 23.7 11.7 68
BRUSSELS 69.9 12.3 17.8 47
BUCHAREST 27.1 28.6 44.2 36
HAMBURG 74.5 18.3 7.3 50
LISBON 17.9 47.7 34.4 69
LJUBLJANA 31.6 35.9 32.5 16
SOFIA 4.0 88.4 7.6 17
STOCKHOLM 28.8 44.2 26.9 18
VERONA 57.8 33.1 9.1 32
VILNIUS 16.7 59.2 24.1 8
WARSAW 21.8 37.9 40.3 54
HIV prevalence among native-born and foreigner is shown in Table 5.9.4. Most cities showed a higher prev-
alence among native-born participants, being such difference quite relevant in a few cities such as Barcelona, 
Bratislava and Bucharest. In some cities (Brussels, Hamburg, Ljubljana, Sofia) the prevalence was similar in 
both groups, whereas in Lisbon and Vilnius a higher prevalence was found among foreign participants. The 
highest prevalence among foreigners was reported in Lisbon and among native-born in Barcelona.
Table 5.9.4 HIV weighted prevalence among MSM, 95% confidence intervals, design effect and number of par-
ticipants, by city and origin. (GARPR 1.14)
City Origin
Point 
Estimate
95% 
Lower Bound
95% 
UpperBound
Estimated 
Design Effect
Denominator
BARCELONA
Native-born 18.9 11.8 26.1 1.8 268
Foreigner 7.6 1.4 13.7 1.3 130
BRATISLAVA
Native-born 4.5 2.1 6.6 1.6 386
Foreigner 0.0 0.0 0.0 - 14
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City Origin
Point 
Estimate
95% 
Lower Bound
95% 
UpperBound
Estimated 
Design Effect
Denominator
BRIGHTON
Native-born 18.5 13.6 23.4 1.2 339
Foreigner 14.7 2.4 27.0 2.0 60
BRUSSELS
Native-born 12.6 3.4 21.9 3.2 229
Foreigner 12.1 4.1 20.0 2.9 150
BUCHAREST
Native-born 18.6 9.6 27.5 2.5 178
Foreigner 0.0 0.0 0.0 - 5
HAMBURG
Native-born 6.4 2.5 10.3 2.2 338
Foreigner 7.0 0.6 13.5 0.4 49
LISBON
Native-born 16.0 6.8 25.1 2.8 216
Foreigner 18.2 9.8 26.5 2.1 155
LJUBLJANA
Native-born 4.4 0.4 8.3 2.6 303
Foreigner 5.1 0.0 12.4 0.9 40
SOFIA
Native-born 3.0 0.0 6.8 3.7 351
Foreigner 2.0 0.0 7.6 0.3 10
STOCKHOLM
Native-born 2.5 0.2 4.8 1.3 242
Foreigner 2.4 0.0 5.6 1.0 114
VERONA
Native-born 10.1 1.1 19.4 9.7 334
Foreigner 6.4 0.0 14.9 2.3 66
VILNIUS
Native-born 3.3 0.0 8.3 7.1 301
Foreigner 4.8 0.0 13.5 1.0 21
Lab results for other Sexually Transmitted Infections (syphilis, HBV,HCV)
Serological tests for other STI were performed only in the four cities that used RDS (i.e. Bratislava, Bucha-
rest, Verona, and Vilnius) because only in the RDS study design were blood samples taken. 
Syphilis
Seropositivity for syphilis showing at least one positive treponemal test was similar to that reported for HIV 
in Bratislava and Bucharest, whereas in Verona and Vilnius was higher compared to HIV prevalence; the highest 
percentage was observed in Bucharest. Similarly to what observed for HIV prevalence, syphilis seropositivity 
showing at least one positive treponemal test was higher among individuals older than 25 years compared to 
those younger than 25 years, probably reflecting the increasing exposure to sexually transmitted agents with 
increasing age. This difference was lowest in Bucharest, where seropositivity among individuals younger than 
25 years was the highest compared to other cities.
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Table 5.9.5 Syphilis seropositivitya among MSM, 95% confidence intervals, design effect and number of partici-
pants, by city
City
Point 
Estimate
95%
Lower Bound
95% 
UpperBound
Estimated 
Design Effect
Denominator
BRATISLAVA 4.7 2.2 7.2 1.9 400
BUCHAREST 16.4 9.0 23.8 1.9 183
VERONA 12.7 7.1 18.2 3.5 400
VILNIUS 10.6 5.5 16.1 3.0 322
a positive for TPHA or TPPA or CMIA
Table 5.9.6 Syphilis seropositivitya among MSM, 95% confidence intervals, design effect and number of partici-
pants, by city and age
City Age
Point 
Estimate
95% 
Lower Bound
95% 
UpperBound
Estimated 
Design Effect
Denominator
BRATISLAVA
<25 2.4 0.0 5.4 1.8 118
25+ 5.6 2.5 9.0 1.9 282
BUCHAREST
<25 12.5 1.0 23.8 1.5 47
25+ 17.4 8.8 26.0 1.8 134
VERONA
<25 0.4 0.0 0.7 0.2 104
25+  17.9 11.0 25.0 3.1 293
VILNIUS
<25 4.6 0.0 10.3 2.0 83
25+ 12.8 6.7 19.3 2.7 239
a positive for TPHA or TPPA or CMIA 
Table 5.9.7 Syphilis seropositivity (probable active syphilisa) among MSM, 95% confidence intervals, design ef-
fect and number of participants, by city.
City
Point 
Estimate
95% Lower 
Bound
95% 
UpperBound
Estimated 
Design Effect
Denominator
BRATISLAVA 1.4 0.2  2.8  1.8 400
BUCHAREST 9.7 3.8 15.4  1.9  183
VERONA 5.1 2.0  8.3 2.5  400
VILNIUS 0.1 0.0   0.1  0.1 322
a positive for both TPHA or TPPA or CMIA and RPR 
 
Seropositivity suggesting a probable active syphilis (positivity of both a treponemal and non-treponemal 
tests) was highest in Bucharest and lowest in Vilnius.
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Table 5.9.8 Syphilis seropositivity among MSM, splitted by type of serological test and city
City
Seropositivity a (treponemal+ AND 
nontreponemal+ or nontreponemal-)
Splitted seropositivity Denominator
BRATISLAVA 4.7
treponemal+ and nontreponemal+ b 
(probable active syphilis) 
1.4
400
treponemal+ and nontreponemal- c 3.3
BUCHAREST 16.4
treponemal+ and nontreponemal+ b
(probable active syphilis) 
9.7
183
treponemal+ and nontreponemal- c 6.7
VERONA 12.7
treponemal+ and nontreponemal+ b 
(probable active syphilis) 
5.1
400
treponemal+ and nontreponemal- c 7.6
VILNIUS 10.6
treponemal+ and nontreponemal+ b
(probable active syphilis) 
0.1
322
treponemal+ and nontreponemal- c 10.5
a positive for treponemal test (TPHA or TPPA or CMIA) and either positive or negative for RPR 
b positive for treponemal test (TPHA or TPPA or CMIA) and positive for RPR 
c positive for treponemal test (TPHA or TPPA or CMIA) and negative for RPR 
Table 5.9.8 provides a summary of serological results for syphilis: overall, the highest proportion of MSM 
with positive serology for syphilis (i.e., reactive to a treponemal test and either a positive or a negative non-tre-
ponemal test) was observed in Bucharest (16.4%) and the lowest in Bratislava (4.7%) (confidence intervals and 
estimated design effect are not shown here because they are already presented in previous tables).
HBV vaccinated participants
Verona showed the highest proportion of participants immune to HBV probably due to HBV vaccination, as 
expected according to the age distribution of participants and the vaccination policy that started earlier in Italy 
compared to other European countries. This is also in line with the information available on the vaccination 
policies in the different countries. 
Table 5.9.9 Percentage of MSM Immune due to hepatitis B vaccinationa, 95% confidence intervals, design effect 
and number of participants, by city. 
City
Point 
Estimate
95% 
Lower Bound
95% 
UpperBound
Estimated 
Design Effect
Denominator
BRATISLAVA 26.0 20.8 30.6 1.7 400
BUCHAREST 23.7 13.9 33.4 2.6 183
VERONA 44.9 37.6 52.2 2.4 400
VILNIUS 22.4 16.6 28.1 1.9 322
a HBsAb positive, HBsAg negative, HBcAb negative
HBV infection
Among non-vaccinated individuals, Bucharest showed the highest and Bratislava the lowest HBV preva-
lence. The highest proportion of participants with an acute or chronic infection was observed in Bucharest. The 
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high prevalence of those exposed to HBV in Bucharest is probably associated with the high proportion of inject-
ing drug users among participants. 
Table 5.9.10 Positivity for hepatitis Ba (HBV exposure, Immune due to natural infection, and acute or chronic 
infection) among MSM, 95% confidence intervals, design effect and number of participants, by city
City Point Estimate
95% 
Lower Bound
95% 
UpperBound
Estimated 
Design Effect
Denominator
BRATISLAVA
HBV exposurea 8.2 4.2 11.9 1.8 289
Immune due to natural infectionb 5.9 2.7 8.9 1.6 289
Acute or chronic infectionc 2.2 0.0 4.7 2.5 289
BUCHAREST
HBV exposurea 49.7 36.9 62.5 2.4 141
Immune due to natural infectionb 42.9 29.5 56.3 2.7 141
Acute or chronic infectionc 6.8 0.2 13.4 2.5 141
VERONA
HBV exposurea 30.4 21.3 39.4 2.3 213
Immune due to natural infectionb 27.6 18.1 37.1 2.6 213
Acute or chronic infectionc 2.8 0.0 5.6 1.7 213
VILNIUS
HBV exposurea 9.2 8.7 9.5 1.2 250
Immune due to natural infectionb 5.7 2.9 8.1 1.0 250
Acute or chronic infectionc 3.6 0.7 6.5 1.8 250
a HBcAb positive and either HBsAg or HBsAb positive; point estimate calculated using the number of non-vaccinated individuals as denom-
inator;
b HBcAb positive, HBsAg negative, HBsAb positive
c HBcAb positive, HBsAg positive, HBsAb negative
In all cities, the prevalence of those exposed to HBV was higher among individuals older than 25 years com-
pared to those younger than 25 years.
Table 5.9.11 HBV exposurea among MSM, 95% confidence intervals, design effect and number of participants, 
by city and age
City Age
Point 
Estimate
95% 
Lower Bound
95% 
UpperBound
Estimated 
Design Effect
Denominator
BRATISLAVA
<25 2.6 0.0 4.4 0.5 78
25+ 10.2 4.5 16.0 2.5 211
BUCHAREST
<25 12.3 0.0 25.7 1.2 26
25+ 54.2 40.2 68.1 2.3 113
VERONA
<25 14.2 3.8 24.2 1.2 52
25+ 37.0 25.3 49.2 2.6 158
VILNIUS
<25 2.0 0.0 5.0 0.5 35
25+ 10.4 5.7 14.9 1.5 215
a HBcAb positive and either HBsAg or HBsAb positive; point estimate calculated using the number of non-vaccinated individuals as denom-
inator;
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HCV
The prevalence of anti-HCV antibodies which reflects lifetime exposure to HCV infection, was the highest in 
Bucharest and the lowest in Vilnius. The high anti-HCV prevalence found in Bucharest is probably associated 
with the high proportion of injecting drug users among participants enrolled in the RDS study for this site. 
Table 5.9.12 Positivity for antibodies against hepatitis Ca among MSM, 95% confidence intervals, design effect 
and number of participants, by city. 
City
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Denominator
BRATISLAVA 1.4 0.0 3.2 2.9 400
BUCHAREST 22.8 6.4 39.2 7.3 181
VERONA 5.3 0.0 11.7 9.1 400
VILNIUS 0.9 0.0 2.1 1.7 322
a anti-HCV positive
In Bratislava and Vilnius, no anti-HCV-positive participants were reported among individuals younger than 
25 years. In Bucharest and Verona, individuals older than 25 years showed a higher anti-HCV prevalence com-
pared to those younger than 25 years.
Table 5.9.12 Positivity for hepatitis Ca among MSM, 95% confidence intervals, design effect and number of par-
ticipants, by city and age. 
City Age
Point 
Estimate
95% 
Lower Bound
95% 
UpperBound
Estimated 
Design Effect
Denominator
BRATISLAVA
<25 0.0 0.0 0.0 0.0 118
25+ 2.1 0.0 4.3 2.4 282
BUCHAREST
<25 11.8 0.8 22.5 1.4 46
25+ 25.5 11.7 39.3 3.5 133
VERONA
<25 1.4 0.0 3.2 0.8 104
25+ 7.0 0.0 15.0 8.0 293
VILNIUS
<25 0.0 0.0 0.0 0.0 83
25+ 1.2 0.0 2.6 1.3 239
a anti-HCV positive
Co-infections
Co-infections of sexually transmitted infections are frequent due to the same transmission routes, which 
may facilitate the transmission of other STIs. Sexually transmitted co-infections are associated with atypical 
and generally more severe clinical features, more complications, resistency to treatment, unfavourable out-
come, and worse prognosis. STIs may increase the likelihood of acquiring and the transmission of HIV infection 
(ECDC, 2013). Although populations most at risk vary across countries, it is recognised that in the countries of 
the European Union and the European Economic Areas MSM are disproportionately affected by HIV and other 
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STIs. Despite numerous interventions which targeted behaviour, knowledge and attitudes of MSM, increases 
in STIs and HIV have been recently observed. Outbreaks of syphilis, lymphogranuloma venereum (LGV), HCV 
infection and other STIs have been reported in various European cities suggesting high-risk sexual behaviour 
and extensive sexual networking. In addition, overall deficit of outcome evaluation has been observed in HIV/STI 
prevention interventions targeted at MSM (ECDC, 2013).
Overall, 14 participants with HIV-syphilis co-infection, 44 participants with HIV-HBV co-infection, and 29 
participants with HIV-HCV co-infection were reported. However, the tests used to identify positivity for HCV are 
not markers of current infection but rather of exposure to the respective infectious agent. In syphilis it is also 
important to distinguish between primary or secondary and latent co-infection, and perhaps between current 
and past HIV infection and co-infections. 
The number of co-infected HIV-positive individuals was low in all cities except in Bucharest where a high 
prevalence of HIV-HBV and HIV-HCV co-infections was observed; however, this high prevalence was probably 
associated with the high proportion of injecting drug users among participants in this city. The prevalence of HIV 
and syphilis co-infection was similar in Bucharest and Verona whereas no such cases were reported in Vilnius.
Table 5.9.13 Number of co-infected individuals, number of tested and weighted prevalence of HIV-syphilisa, 
HIV-HBVb, and HIV-HCVc co-infection, by city
City HIV and syphilis HIV and HBV HIV and HCV
N. of co-infected /
N. tested for syphilis 
and HIV
Prevalence
(%)
N. of co-infected /
N. tested for HBV 
and HIV
Prevalence 
(%)
N. of co-infected /
N. tested for HCV 
and HIV
Prevalence 
(%)
BRATISLAVA 1/400 1.2 4/289 1.9 0/400 0.0
BUCHAREST 7/181 7.5 25/141 18.5 22/181 8.6
VERONA 6/400 5.9 13/213 7.1 7/400 2.7
VILNIUS 0/322 0.0 2/250 0.8 0/322 0.0
a HIV positive and TPHA or TPPA or CMIA positive
b HIV positive and HBcAb positive and either HBsAg or HBsAb positive
c HIV positive and anti-HCV positive
Summary and conclusions
HIV prevalence among MSM varies between 2% and 20%, with higher rates among individuals older than 25 
years of age. 
A relevant proportion (ranging between 12% and 88%) of participants was unaware of being HIV-positive.
Periodical serological testing for HIV, syphilis, HBV, and HCV should be actively offered to MSM. 
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Summary
In terms of viral load and treatment, consistent differences were reported across participating cities. In gen-
eral, unsatisfactory treatment coverage and treatment adherence were reported in the Eastern European cities. 
In terms of HIV-positive MSM who had been diagnosed with HIV prior to the Sialon II study (known positives or 
‘aware’) the percentage of participants on treatment was high with a median of 95.1%, whilst it should be noted 
that the continuum of care was quite different across cities. 
Introduction 
Viral load (VL) is the most important indicator of initial and sustained response to antiretroviral treatment 
(ART). As such, VL should be measured in all HIV-infected patients at initiation of therapy, and on a regular basis 
thereafter. Pre-treatment VL level is also an important factor in the selection of initial antiretroviral (ARV) regi-
mens because several currently approved ARV drugs or regimens have been associated with poorer responses 
in patients with a high baseline viral load (Panel on Antiretroviral Guidelines for Adults and Adolescents, 2014).
Clinical trials have found that a decrease in VL following initiation of ART is associated with reduced risk of 
disease progression or death (Marschner et al., 1998; Murray, Elashoff, Iacono-Connors, Cvetkovich, and Stru-
ble, 1999; Thiébaut et al., 2000). Thus, VL testing is established as an essential marker to monitor treatment 
response (“Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surro-
gate end points,” 2000). Optimal viral suppression is defined generally as a VL persistently below the level of 
detection (HIV RNA <50 copies/mL). Isolated and temporary VL fluctuations, typically with HIV RNA <400 copies/
mL, may occur in successfully treated patients and are not predictive of virological failure (Human immunodefi-
ciency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: a meta-analysis. 
HIV Surrogate Marker Collaborative Group, 2000). Furthermore, data on the association between persistent 
low but quantifiable viremia (HIV RNA <200 copies / mL) and virological failure should be taken into account 
(Laprise, de Pokomandy, Baril, Dufresne, and Trottier, 2013). 
In addition to the benefit of therapy for patients with HIV, ART can play an important role in preventing HIV 
transmission (Das et al., 2010; Montaner et al., 2010). Lower levels of plasma HIV RNA have been associated 
with decreases in the concentration of the virus in genital secretions (Baeten et al., 2011; Graham et al., 2007; 
Sheth et al., 2009; Vernazza et al., 2000). Observational studies have revealed an association between low se-
rum or genital HIV RNA and a decreased rate of HIV transmission among heterosexual serodiscordant couples 
(Baeten et al., 2011; Hughes et al., 2012; Quinn et al., 2000). A lack of virus transmission has also been con-
firmed for homosexual HIV serodiscordant couples, if the infected partner was on antiretroviral treatment and 
had a VL below the limit of detection (Baeten et al., 2011; Hughes et al., 2012; Quinn et al., 2000). 
Effectively the coverage of successful treatment in different settings depends on the availability and uptake 
of testing, linkage to care and then retention in care and adherence to treatment. Analysis of continuum of care 
data shows that in many countries the percentage of HIV-positive people who are appropriately treated is far 
from optimal. Furthermore, there are different break points in the cascade, where the greatest loss occurs in 
different countries (Marcus et al., 2015; Raymond, Hill, and Pozniak, 2014) and between population subgroups 
(Millett et al., 2012; Singh et al., 2014). 
In this Section, findings relating to treatment coverage and VL suppression are presented. Specifically, data 
are provided on the percentages of HIV-positive participants on ART (including those who are aware and not 
5.10 Treatment and viral load
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aware of their serostatus), percentages of diagnosed HIV-positive participants on ART (i.e. known positives), as 
well as data on HIV-positive MSM who have undetectable VL and those on ART who have undetectable VL. The 
Section goes on to present data on continuum of care indicators for HIV-positive participants by city. In the final 
part of the Section, data are first presented on the percentages of HIV-positive participants with undetectable 
VL, by age and sampling method (TLS/RDS), and then on the percentage of HIV-positive MSM who used a con-
dom at the last anal intercourse by VL status and sampling method. 
Results
Treatment coverage and viral load suppression
To explore the extent of ART coverage and levels of VL suppression among MSM in TLS and RDS cities, 
participants were asked two questions: 1) “In case you are living with HIV: are you currently taking drugs for 
treatment for HIV (known as antiretroviral, ART, HAART)?” Possible responses included: ‘yes’, ‘no’ and ‘I prefer 
Table 5.10.1 Percentage of HIV-positive MSM on ART [1]
City Residence*
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Sample 
Size
BARCELONA
Study city or <100km 49.6% 34.7% 64.5% 1.06 50
Total 47.3% 31.9% 62.7% 1.12 52
BRATISLAVA Total 20.1% 0.0% 50.0% 1.90 13
BRIGHTON
Study city or <100km 65.0% 30.9% 99.2% 2.60 54
Total 65.1% 33.5% 96.7% 2.51 56
BRUSSELS
Study city or <100km 82.9% 61.4% 100.0% 1.70 33
Total 84.7% 65.3% 100.0% 1.69 39
BUCHAREST Total 8.7% 0.0% 27.6% 2.49 21
HAMBURG
Study city or <100km 79.5% 51.0% 100.0% 1.99 36
Total 78.9% 54.3% 100.0% 1.95 41
LISBON
Study city or <100km 14.7% 1.5% 27.9% 0.76 36
Total 12.3% 4.0% 20.5% 0.95 55
LJUBLJANA
Study city or <100km 44.9% 0.0% 91.1% 1.40 10
Total 36.9% 0.0% 85.6% 1.71 12
SOFIA
Study city or <100km 4.4% 0.0% 13.8% 0.83 13
Total 4.3% 0.0% 13.5% 0.83 14
STOCKHOLM
Study city or <100km 21.8% 0.0% 50.6% 1.06 10
Total 37.1% 0.0% 77.4% 1.41 12
VERONA
Study city or <100km 55.1% 30.5% 79.7% 1.61 25
Total 51.5% 27.8% 75.2% 1.66 28
VILNIUS Total -    7
WARSAW
Study city or <100km 35.2% 10.8% 59.6% 1.32 34
Total 36.5% 14.9% 58.1% 1.41 39
* Only one estimate is provided if all respondents included in the table resided in the study city or within the 100 km (namely, participants 
from Bucharest, Bratislava, and Vilnius). 
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not to answer’; 2) To collect information on VL participants were asked: “In case you are living with HIV: what 
was your last viral load?” Possible responses included: ‘undetectable’, ‘detectable’, ‘I do not remember / I don’t 
know / I didn’t get the result of the test’ and, ‘I prefer not to answer’.
HIV-positive MSM (aware and not aware) on ART 
Given that testing and treatment coverage may vary in different geographical areas, in addition to the pro-
vision of an overall estimate of HIV-positive MSM on ART, estimates are also provided for those residing in the 
study city or within 100 km of their city (Table 5.10.1). The percentage of HIV-positive MSM (including those 
aware and not aware of their serostatus) who reported being on ART varied greatly across cities. The highest 
percentage was found in Brussels (84.7%) and Hamburg (78.9%) and the lowest in Sofia (4.3%) and Bucharest 
(8.7%) with a median of 37% across all cities (Table 5.10.1). However, the confidence intervals are wide and thus 
these estimates should be interpreted with caution.
ART coverage of MSM already diagnosed with HIV 
Among MSM who had been diagnosed with HIV prior to the Sialon II study (known positives or ‘aware’) 
the percentage of participants on treatment was high with a median of 95.1% (Table. 5.10.2). Slightly lower 
estimates (but still high) were noted in Barcelona (77.3%), Ljubljana (78.6%), and Verona (80.5%). The second 
lowest point estimate (45.8% in Lisbon) was associated with very wide confidence intervals and should thus 
be interpreted cautiously. When excluding tourists the estimate in Lisbon exceeded 90%. The lowest estimate 
(although again with wide confidence intervals) was noted in Bucharest (18.0%), and may be influenced by the 
specific characteristics of the recruited sample (a large percentage of drug users). Due to very small sample 
sizes, estimates are not provided for Bratislava, Vilnius, and Sofia.
Table 5.10.2 Percentage of MSM diagnosed with HIV who receive ART
City** Residence*
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Sample 
Size
BARCELONA Total 77.3% 59.0% 95.6% 1.22 31
BRIGHTON
Study city or <100km 90.7% 77.6% 100.0% 1.39 40
Total 91.4% 79.4% 100.0% 1.38 41
BRUSSELS
Study city or <100km 99.5% 98.5% 100.0% 0.42 26
Total 99.6% 98.7% 100.0% 0.42 32
BUCHAREST Total 18% 0.0% 57.2% 2.98 11
HAMBURG
Study city or <100km 98.4% 94.9% 100.0% 0.62 22
Total 98.8% 96.3% 100.0% 0.56 25
LISBON
Study city or <100km 91.1% 77.8% 100.0% 0.35 16
Total 45.8% 0.0% 96.2% 2.58 26
LJUBLJANA Total 78.6% 43.5% 100.0% 0.87 5
STOCKHOLM
Study city or <100km 100.0% - - - 7
Total 100.0% - - - 9
VERONA
Study country 79.3% 51.1% 100.0% 2.29 18
Total 80.5% 54.7% 100.0% 2.24 20
WARSAW
Study city or <100km 100.0% - - - 14
Total 100.0% - - - 17
* Only one estimate was provided if all respondents included in the table resided in the study city or within the 100 km (namely, Barcelona, 
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Bucharest, and Ljubljana).
** The table was reduced to exclude cities where the sample size was < 5: Bratislava (3), Sofia (2), and Vilnius (2).
MSM infected with HIV with undetectable viral load
The percentages of MSM infected with HIV with undetectable viral load (VL) were highly variable across TLS and 
RDS cities. In Bucharest, Sofia, and Vilnius, all HIV-infected participants, including those who had been diagnosed 
with HIV before the Sialon study already, and more than 90% of men infected with HIV in Bratislava and Lisbon, 
had detectable VLs (Table 5.10.3). This indicates problems regarding the quality of treatment in some of the study 
cities, an increased risk of rapid disease progression, and an increased probability of onward transmission.
Table 5.10.3 Percentage of MSM infected with HIV with undetectable VL
City Residence*
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Sample 
Size
BARCELONA
Study city or <100km 48.7% 33.7% 63.7% 1.07 50
Total 46.5% 31.0% 62.0% 1.13 52
BRATISLAVA Total 9.9% 0.0% 25.5% 1.31 12
BRIGHTON
Study city or <100km 68.0% 34.6% 100.0% 2.56 53
Total 67.8% 37.1% 98.5% 2.46 55
BRUSSELS
Study city or <100km 78.5% 59.2% 97.8% 1.42 34
Total 78.3% 58.1% 98.4% 1.56 40
BUCHAREST Total 0.0% - - - 20
HAMBURG
Study city or <100km 77.9% 47.6% 100.0% 2.08 37
Total 76.3% 49.8% 100.0% 2.06 43
LISBON
Study city or <100km 7.8% 0.0% 16.3% 0.79 37
Total 7.0% 0.6% 13.4% 0.95 56
LJUBLJANA
Study city or <100km 51.2% 6.2% 96.3% 1.36 10
Total 42.1% 0.0% 90.5% 1.66 12
SOFIA
Study city or <100km 0.0% - - - 12
Total 0.0% - - - 13
STOCKHOLM
Study city or <100km 22.7% 0.0 % 51.7% 1.10 11
Total 37.7% 0.0% 77.2% 1.44 13
VERONA
Study country 49.1% 3.3% 94.9% 5.07 23
Total 46.2% 0.0% 100.0% 8.76 26
VILNIUS Total 0.0% - - - 6
WARSAW
Study city or <100km 32.0% 10.6% 53.4% 1.20 35
Total 33.6% 14.1% 53.1% 1.31 40
* Only one estimate was provided if all respondents included in the table resided in the study city or within the 100 km (namely, Bratislava, 
Bucharest, and Vilnius).
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Viral load in MSM diagnosed with HIV and receiving ART
In all cities the percentage of participants diagnosed with HIV and already receiving ART with undetectable 
VL exceeded 90% (see Table 5.10.4), with the exception of Lisbon where a greater percentage of participants 
reported high VLs. Due to very small sample sizes, estimates are not provided for Vilnius, Bratislava, Bucharest, 
Sofia, and Ljubljana.
Table 5.10.4 Percentage of MSM diagnosed with HIV and receiving ART with undetectable VL.
City Residence
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Sample 
Size
BARCELONA Total 92.1% 81.7% 100.0% 0.93 23
BRIGHTON
Study city or <100km 99.6% 98.6% 100.0% 0.40 32
Total 99.6% 98.7% 100.0% 0.40 33
BRUSSELS
Study city or <100km 96.6% 91.0% 100.0% 0.80 24
Total 94.0% 87.3% 100.0% 0.78 30
HAMBURG
Study city or <100km 98.2% 94.2% 100.0% 0.64 20
Total 98.6% 95.8% 100.0% 0.57 23
LISBON
Study city or <100km 100.0% - - - 14
Total 71.9% 32.4% 100.0% 2.10 23
STOCKHOLM
Study city or <100km 100.0% - - - 7
Total 100.0% - - - 9
VERONA
Study country 98.0% 96.4% 99.6% 0.04 13
Total 98.2% 97.5% 98.9% 0.01 15
WARSAW
Study city or <100km 93.3% 84.3% 100.0% 0.51 14
Total 94.3% 85.5% 100.0% 0.77 17
* Only one estimate was provided if all respondents included in the table resided in the study city or within the 100 km.
** The table was reduced to exclude cities where the sample size was < 5: Vilnius (1), Bratislava (1), Bucharest (1), Sofia (1), Ljubljana (3).
Continuum of care
Continuum of care was assessed on a subgroup of HIV-positive participants who provided valid data for all 
relevant elements (i.e. whether they were: diagnosed prior to participating in the Sialon II survey; on ART; and 
whether their VL was suppressed). In TLS cities 21.2% of HIV-infected participants (or 85 of 401) and 33.3% (or 
32 of 96) of HIV-infected participants in RDS cities, were excluded due to missing values in one or more contin-
uum of care indicators. 
Due to small sample sizes when stratifying continuum of care by city, estimates are imprecise and should 
be interpreted cautiously. Keeping these limitations in mind, a fairly consistent feature across all the city-spe-
cific graphs is a substantial drop between the total of HIV-infected MSM and those diagnosed with HIV (Figure 
5.10.1). These drops exceed 60% in Bratislava, Lisbon, Sofia, Stockholm and Warsaw. Drops at the level of link-
age to care (between the diagnosed and those on treatment) are smaller with the exception of Bucharest. It can 
be concluded that a lack of diagnosis remains the main reason for which the percentages of MSM living with 
HIV, who have undetectable VL, are low. Linkage to care may represent an additional problem.
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Viral load, age, and condom use
Once again, due to limited sample sizes disaggregated estimations for VL by age and condom use were 
not feasible by city. For this subsection, data are therefore presented without city disaggregation and hence 
estimates are un-weighted. However, separate estimates are presented for data arising from TLS and RDS 
sampling methods. 
In terms of age, the percentage of HIV-infected participants with undetectable VL was higher among older 
MSM exceeding half among those aged 45 or more. In the younger age groups this percentage was much lower, 
especially in the RDS cities (Figure 5.10.2). In several RDS cities, estimates of treatment coverage were gener-
ally low.
Figure 5.10.1 Continuum of care for HIV-positive MSM, by city (excluding Vilnius)
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Figure 5.10.3 depicts the differences in condom use during last anal intercourse (GARPR 1.12) by awareness 
of HIV status and VL. In TLS cities those who did not know their HIV status were significantly more likely to use 
a condom although no significant differences were observed in RDS cities. In addition, no significant differences 
in condom use were found among HIV-positive MSM with self-reported detectable VL compared to individuals 
with self-reported undetectable VL.
Figure 5.10.2 Percentage of HIV-infected MSM with undetectable VL, by age, and sampling method (unweighted)
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
18-24 25-34 35-44 45-54 55+ 18-24 25-34 35-44 45-54
TLS RDS
Pe
rc
en
t u
nd
et
ec
ta
bl
e 
VL
Age (years)
Figure 5.10.3 Percentage of HIV-positive MSM who used a condom at last anal intercourse (GARPR 1.12), not 
aware of HIV status and aware of HIV status by VL, by sampling method (un-weighted)
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Summary and conclusions
•	 By using the VL as a marker for the coverage with and the quality and success of treatment, significant 
differences were found across different European cities. In general, unsatisfactory indicators were reported 
in most Central and Eastern European cities (Sofia, Bucharest and Vilnius), but also in Lisbon. 
•	 Much higher treatment coverage and, consequently, a higher percentage of HIV-positive MSM who had 
undetectable VL was attained in Western European cities (Brussels, Hamburg, Brighton and Verona).
•	 The break points in the continuum of care were different in different cities. However, the lack or delay in 
diagnosis is a crucial factor in all areas. 
•	 In several cities, the treatment coverage may be less than optimal even among the individuals who have been 
diagnosed with HIV, indicating potential challenges in linkage to care and retention in care. This subject mer-
its further research since due to limited sample sizes it was not possible to obtain precise estimates.
•	 Among HIV-diagnosed participants on ART the percentage of persons with undetectable VL was high, indi-
cating good adherence and appropriate quality of treatment across the participating cities. 
•	 Age of the participants was found to be related to effective suppression of viral replication, which is consistent 
with previous studies. More attention should be paid to ensuring the continuum of care for younger MSM.
•	 Finally, it should be noted that condom use is poorly reported even among persons with diagnosed HIV in-
fection who knew that their VL was high. However, these observations may be limited by the type of partner 
(steady/non-steady) in conjunction with the perception of the respondents whether the intercourse was 
serodiscordant or seroconcordant. Although small sample sizes limited the possibility of stratified analysis, 
it is nonetheless clear that counselling for HIV-positive MSM should be strengthened.
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Endnotes
[1] The first indicator is referring to the percentage of HIV-positive MSM (positive OF or blood test), who are on ART. Numerator: number 
of MSM living with HIV and taking ART drugs (answered ‘Yes’ to Question 33). Denominator: number of MSM, who were positive in their OF/
blood test and who either did not know earlier that they were positive (answered to Question 32 ‘HIV negative’, ‘Indeterminate’, ‘Did not get 
the results’ or answered ‘Never tested’ to Question 31) or knew that they were HIV-positive and reported their treatment status (answered 
‘Yes’ or ‘No’ to Question 33).
[2] The second indicator is the percentage of MSM already diagnosed with HIV who are on ART. Numerator: number of MSM living with HIV 
 156 The Sialon II Project. Report on a Bio-behavioural Survey among MSM in 13 European cities
and taking ART drugs (answered ‘Yes’ to Question 33), who were positive in their OF/blood test. Denominator: number of MSM living with HIV, 
who reported their treatment (answered ‘Yes’ or No’ to Question 33), who were positive in their OF test. Inconsistent answers were excluded.
[3] The third indicator is the percentage of HIV-positive MSM, who have suppressed VL
Numerator: number of MSM living with HIV and having undetectable VL (answered ‘Undetectable’ to Question 34), who were positive in 
their OF/blood test. Denominator: number of MSM, who were positive in their OF/blood test and who either did not know earlier that they 
were positive (answered to Question 32 ‘HIV negative’, ‘Indeterminate’. ‘Did not get the results’ or answered ‘Never tested to Question 31) 
or knew that they were HIV-positive and reported their VL (answered ‘Detectable’ or ‘Undetectable’ to Question 34).
[4] The forth indicator is the percentage of HIV-positive MSM on treatment, who have suppressed VL. Numerator: number of MSM living 
with HIV and having undetectable VL (answered “Undetectable” to Question 34), who were positive in their OF/blood test and reported being 
on treatment (answered ‘Yes to Question 33). Denominator: number of MSM, who were positive in their OF/blood test and reported being on 
treatment (answered ‘Yes’ to Question 33), and reported their VL (answered ‘Detectable’ or ‘Undetectable to Question 34).
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Summary
The level of satisfaction with one’s sexual life was generally high with three quarters or more of all partici-
pants reporting being satisfied. The percentage of MSM who reported being unsatisfied with their sex lives was 
generally lower than 25% across all cities. 
The level of “outness” and the perceived “homonegativity” differed substantially between the study areas. In 
Eastern European cities where homosexuality has been decriminalised relatively recently, men were less likely 
to be out regarding their sexual attraction to men. In this type of scenario, the use of the RDS method seemed 
to be very efficient in reaching more hidden MSM populations, particularly for MSM who had never tested for 
HIV/STIs. 
Introduction
In this Section a brief analysis of the sexual health indicators included in the Sialon II TLS survey are pre-
sented. Three sexual health indicators were measured including: sexual satisfaction; sexual safety, and; sexual 
autonomy. ‘Sexual satisfaction’ is presented by city, and then stratified by age and sexual practices, as these 
factors may potentially influence how MSM perceive their sexual satisfaction. This analysis was done in order 
to understand reasons for sexual dissatisfaction, which in turn may help to understand in which groups or at 
which level to intervene to reduce sexual dissatisfaction. A potential association with HIV-status would be in-
teresting to look at but was difficult to interpret meaningfully in the current sample due to very low numbers of 
HIV-positive men at the city level. The Section concludes by presenting the sexual health indicators on perceived 
‘sexual safety’ and ‘sexual autonomy’ which were only assessed in the RDS cities.
The indicators used were developed based on a comprehensive conceptual framework which sets out recom-
mendations for sexual health indicators (Toskin et al. 2013). This framework acknowledges that human sexuality 
is underpinned by core concepts of autonomy, well-being, and the fulfilment, promotion, and protection of human 
rights;  emphasising individual autonomy in relation to sexuality. It also refers to individuals’ rights to self-deter-
mination in sexual health. The framework recognises that concepts including sexual pleasure, intimacy, and social 
values in relation to sexuality, as well as a diverse range of gender identities are often overlooked in the design and 
implementation of programmes and policies (Hawkes et al. 2014). In line with these principles, HIV/STI prevention 
should aim at the promotion of safe, satisfying, responsible and autonomous sexual lives. 
The relationship between sexual well-being and sexual risk taking is complex. For instance, partner-related 
factors and sexual satisfaction have been found to be associated with gay male couples engaging in UAI (Da-
vidovich et al. 2006). Sexual risk behaviour (such as intentional condom-less sex among gay men in HIV risk 
contexts; Bauermeister et al. 2009) has been understood as an expression of sexual intimacy. However, other 
sexual health-related aspects such as how much people feel in control over their sexual health, operationalised 
as perceived sexual safety, may potentially contribute to less sexual risk taking (Robinson et al. 2002). 
Previously, sexual satisfaction has been operationalised as being happy with one’s sex life, and thus increas-
ing sexual happiness becomes a goal in itself for sexual health programmes (EMIS, 2013). The EMIS survey 
conducted among MSM found that sexual unhappiness is widespread among MSM, with the median value of 
the percentage of men being unhappy with their sex lives across the countries at 47%. Determinants of sexual 
unhappiness included: concealment of sexual identity; living in small settlements; having never been tested for 
HIV; having a medium level of education, and; being in the younger and older age groups. A majority of men also 
5.11 Sexual health
 160 The Sialon II Project. Report on a Bio-behavioural Survey among MSM in 13 European cities
reported that a reason for their sexual unhappiness included lacking a regular sexual partner (typically, 25% in 
each participating country stated being single as the reason for being unhappy; EMIS 2013). Against this back-
ground, assessing sexual satisfaction, safety and autonomy may thus provide a better understanding of HIV/STI 
prevention and risk behaviour in the current study population. 
Results
Sexual satisfaction
In both TLS and RDS cities, most participants reported high levels of satisfaction with their sex lives with 
little variation between cities (Table 5.11.1) in response to being asked: “How satisfied are you with your sex 
life?” (options provided were: “very satisfied; satisfied; somewhat unsatisfied; very unsatisfied; I prefer not to 
Table 5.11.1 Percentages of MSM reporting sexual satisfaction
City
Sexual 
satisfaction 
Point 
Estimate (%)
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
SE (%) Denominator
BARCELONA
Satisfied 82.9 77.9 87 0.9 2.3 312
Unsatisfied 17.1 13 22.1 0.9 2.3 74
BRATISLAVA
Satisfied 75.8 70.6 81.3 2 2.7 278
Unsatisfied 24.2 18.7 29.4 2 2.7 91
BRIGHTON
Satisfied 77.7 69.4 84.2 2.4 3.8 305
Unsatisfied 22.3 15.8 30.6 2.4 3.8 96
BRUSSELS
Satisfied 82.9 74 89.2 6.4 3.8 306
Unsatisfied 17.1 10.8 26 6.4 3.8 75
BUCHAREST
Satisfied 84.6 77 92.2 1.8 3.9 127
Unsatisfied 15.4 7.8 23 1.8 3.9 31
HAMBURG
Satisfied 76.2 68.1 82.7 3.3 3.7 284
Unsatisfied 23.8 17.3 31.9 3.3 3.7 109
LISBON
Satisfied 85.2 81.3 88.4 1.6 1.8 336
Unsatisfied 14.8 11.6 18.7 1.6 1.8 62
 LJUBLJANA
Satisfied 73.3 67.4 78.4 1.3 2.8 281
Unsatisfied 26.7 21.6 32.6 1.3 2.8 103
SOFIA
Satisfied 60.2 53.3 66.7 0.4 3.4 212
Unsatisfied 39.8 33.3 46.7 0.4 3.4 198
STOCKHOLM
Satisfied 74.6 66.7 81.1 3.9 3.7 253
Unsatisfied 25.4 18.9 33.3 3.9 3.7 92
VERONA
Satisfied 75.6 68.1 82.9 3.5 3.8 288
Unsatisfied 24.4 17.1 32 3.5 3.8 84
VILNIUS
Satisfied 77.8 71.8 83.4 1.8 3 239
Unsatisfied 22.2 16.7 28.3 1.8 3 59
WARSAW
Satisfied 71.1 65.2 76.3 1.4 2.8 281
Unsatisfied 28.9 23.7 34.8 1.4 2.8 104
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answer”). Across most cities, percentages of men reporting satisfaction with their sex lives ranged around 75% 
or above, except for Ljubljana and Warsaw (where 73.3% and 71.1% respectively reported satisfaction).  The 
highest percentages of men being satisfied with their sex lives in TLS cities were found in Lisbon with 85.2% 
followed by both Barcelona and Brussels with 82.9%, and in RDS cities in Bucharest with 84.6%. 
When looking at the percentages of men who reported being unsatisfied with their sex lives, there were consid-
erable differences between the cities. In TLS cities, the percentages of men reporting being unsatisfied with their 
sex lives ranged from as low as 14.8% in Lisbon and 17.1% in both Brussels and Barcelona, to a high of 39.8% in 
Sofia. With the exemption of the latter, fewer than one in four of all MSM included in the study reported being un-
satisfied with their sex lives. No clear differential pattern was evident between TLS cities and RDS cities. For RDS, 
percentages of MSM unsatisfied with their sex lives ranged from 15.4% in Bucharest to 24.4% in Verona. 
To aid visualisation, in the sub-sections that follow, data are presented as percentages of MSM who reported 
to be unsatisfied with their sex lives stratified by the respective variables (i.e. age and sexual practices).
Sexual dissatisfaction by age group
Increasing age has been identified as one of the important factors associated with being sexually unsatisfied 
in gay and heterosexual men alongside other factors such as psychological health, and expectations towards 
sexual relationships (Herdt et al. 2004). To stratify sexual dissatisfaction by age group the following age cat-
egorisations were used: younger than 30 years of age, 30-39 years of age, and above 40. Figure 5.11.1 shows 
the percentage of respondents in each city who reported being unsatisfied with their sex lives stratified by age. 
Among those who were unsatisfied with their sexual lives, MSM younger than 40 years reported the highest 
levels of sexual dissatisfaction in cities such as Sofia and Hamburg (47% and 32.7% respectively1). In contrast, 
1 However, the smaller sample sizes have to be taken into account when interpreting the data.
Figure 5.11.1 Percentages of MSM reporting sexual dissatisfaction by age groups (%)
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in cities such as Ljubljana and Vilnius (44.5% and 41.2% respectively) it was older participants (40≥ years) who 
reported to be unsatisfied with their sexual lives.  
Sexual dissatisfaction by type of sexual practice 
In this sub-section, the percentages of respondents who reported to be unsatisfied with their sex lives are 
stratified by city and by type of sexual practice (no anal intercourse=no AI; protected anal intercourse=PAI, and; 
unprotected anal intercourse=UAI; Figure 5.11.2). In many cities, the highest percentages of participants who 
were unsatisfied with their sex lives were also those who reported having had no AI. In cities including Brati-
slava, Brighton, Ljubljana, and Stockholm percentages were all about 40% for this sub-group with the highest in 
Sofia (56.9%). No clear trends were evident from the data with respect to a potential difference between partic-
ipants who reported PAI (red bars) versus those who reported UAI (green bars). In Sofia, participants generally 
reported higher levels of sexual dissatisfaction than in other cities, although this is likely to be due to a smaller 
sample size.
Perception of sexual safety and sexual autonomy (RDS only)
Due to the practical constraints of administering questionnaires in TLS venues, which required question-
naires to be as short as possible, only in RDS sites were questions on ‘sexual safety’ and ‘autonomy’ included. 
The item on sexual safety was operationalised as the ability to use condoms and asked for participants to 
indicate their agreement to the following statement: “In the last 12 months, I have been able to use condoms 
as often as I wanted to.” Similarly, sexual autonomy was measured by agreement to: “In the last 12 months, I 
have been able to refuse sexual intercourse and practices, I don’t want”. Participants rated both items on a four 
point-Likert scale ranging from “strongly disagree; rather disagree; rather agree; to strongly agree”. [1]
Figure 5.11.2 Percentages of MSM reporting sexual dissatisfaction by type of sexual practice (in %)
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With regards to perceived sexual autonomy (see Table 5.11.2), more than 85% of participants from all cities 
reported that they had always been able to refuse a condom as often as they wanted to. 86.5% of respondents from 
Bratislava, 91% from Bucharest, 87% from Verona, and 91.6% from Vilnius either strongly agreed or agreed to the 
given statement, suggesting that they perceived themselves to be in control of consensual sex. However, approxi-
mately 1 in 5 of participants from Verona and Bratislava reported not being able to refuse unwanted sexual activity. 
Table 5.11.2 Perception of sexual autonomy (RDS cities only)
City
Perception 
of sexual 
autonomy
Point 
Estimate (%)
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
SE (%) Denominator
BRATISLAVA
High 86.5 82.2 91 1.8 2.2 290
Low 13.5 9.1 17.8 1.8 2.2 44
BUCHAREST
High 91.0 83.7 98.4 2.5 3.8 131
Low 9.0 1.6 16.3 2.5 3.8 12
VERONA
High 87.0 82.2 91.9 2 2.5 273
Low 13.0 8.1 17.8 2 2.5 43
VILNIUS
High 91.6 88.1 95.4 1.6 1.9 266
Low 8.4 4.6 11.9 1.6 1.9 27
In terms of sexual safety (see Table 5.11.3), the percentages of participants who reported that they either 
strongly agreed or agreed that they had always been able to refuse sexual activity as often as they wanted to 
were high; ranging from 79.7% in Bratislava to 93.7% in Vilnius suggesting that more than three out of four men 
feel in control of their sexual behaviour.
Table 5.11.3 Perception of sexual safety (RDS cities only)
City
Perception of 
sexual safety 
Point 
Estimate (%)
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
SE (%) Denominator
BRATISLAVA
High 79.7 74.7 84.7 1.8 2.6 278
Low 20.3 15.3 25.3 1.8 2.6 70
BUCHAREST High 89.2 82.5 96 1.8 3.4 127
Low 15.4 4 17.5 1.8 3.4 17
VERONA
High 80.3 74 86.7 2.4 3.2 253
Low 19.8 13.3 26 2.4 3.2 66
VILNIUS
High 93.7 91 96.7 1.3 1.5 284
Low 6.3 3.3 9 1.3 1.5 22
Summary and conclusions
•	 Sialon II assessed a limited number of sexual health indicators guided by a comprehensive conceptual frame-
work for sexual health. The only indicator assessed at all data collection sites was sexual satisfaction; sexual 
safety and sexual autonomy were only assessed at in RDS cities. While sexual satisfaction has been concep-
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tualised as a complex construct consisting of emotional, relational, physical, and cultural dimensions (Štul-
hofer et al., 2014), the survey could not address all these aspects.  Such an objective was beyond the scope 
of SIALON II. However, in the context of this study, sexual satisfaction (as well as sexual safety and sexual 
autonomy for the RDS population) served as feasible and acceptable proxy measures for sexual well-being. 
•	 Reported levels of sexual satisfaction were generally high with three quarters or more of all participants 
generally reporting being satisfied with their sex lives (with the exception  of Sofia, where six out of ten 
men reported to be sexually satisfied). The percentage of MSM who reported being unsatisfied with their 
sex lives was generally lower than 25% across all cities. Such levels are markedly lower when compared to 
findings of the EMIS study, which found a median value of 47% of study participants being ‘unhappy’ about 
their sex lives. This could reflect a difference in wording as well as the influence of different data collection 
methods, for instance in settings where people socialise for seeking sex.
•	 The current findings are limited in that it was not possible to correlate the sexual satisfaction measured 
in TLS and RDS cities with context dependent variables (e.g. local social and/or sexual norms, availability 
of sexual health services, existing sexual health policies, legal contexts etc.) that may influence how freely 
MSM can live their sexual lives. Consequently, the current data should be subject to further secondary and 
more in-depth analysis that is impossible to present here. It could also be interesting with respect to a 
composite sexual health indicator (i.e. the three variables combined, currently only available for the RDS 
population), which may serve as a proxy measure of general sexual well-being in the target population.   
•	 While the overall sample size for the study was large, disaggregating sexual satisfaction by age and sexual 
practice at the city-level resulted in small numbers making it difficult to draw general conclusions. There-
fore, these findings have to be interpreted with caution and certainly cannot be generalised. Similarly, al-
though associations by HIV-status could be theoretically interesting to look at, the numbers were too small 
for further interpretation.  
•	 Looking at associations with age, the findings trends showed that participants tended to be more satisfied 
with their sexual lives when they were in the middle age group (30-40 years) compared to either the younger 
or the older age groups. This finding is consistent with EMIS findings. 
•	 With respect to associations with sexual practice, the results showed a potential impact of having had no 
anal intercourse and being unsatisfied. The findings are less clear with respect to protected vs. unprotected 
anal intercourse.  
•	 While perceptions of sexual autonomy generally were high across the RDS data collection sites, approxi-
mately 1 in 5 of the men in Verona and Bratislava reported not being able to refuse unwanted sexual activity. 
It has been suggested that not being in control of consensual sexual activity could be used as a proxy for 
coerced sex. Forced sex is known to increase vulnerability to numerous adverse health outcomes, including 
drug use, psychological morbidities, HIV, and other STIs (Bartholow et al. 1994). For comparison, preva-
lence for sexual assault has been estimated to be 2-3% for men, and 12-54% for gay and bisexual men in 
the US population (Rothman et al. 2011).
•	 Taken together, the findings on sexual satisfaction and sexual safety suggest that the majority of MSM who 
participated in the RDS study are currently enjoying safe sexual experiences, free of coercion and violence. 
•	 Future analysis should look at possible correlations between sexual well-being and actual STI/HIV preva-
lence, as well sexual risk-taking versus adoption of prevention behaviour. 
•	 In order to reduce the percentages of MSM who are unsatisfied with their sex lives, sexual health promotion 
and HIV/STI prevention programmes targeting MSM should integrate sexual well-being into their objec-
tives. Such programmes should be developed in participation with MSM concerned and should use attrac-
tive and appealing communication channels to adequately meet their needs. The role of internet-based in-
terventions including mobile phone applications in this respect should certainly be evaluated (ECDC 2015).
•	 In conclusion, the three sexual health indicators together (sexual satisfaction, perceived sexual safety, and 
autonomy) reflect a picture of MSM enjoying safe sexual experiences and being largely in control of their 
sexual lives. This could represent a promising starting point of future HIV/STI prevention and more com-
prehensive sexual health promotion.
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Summary
Levels of substance use across all cities were consistently high among the study participants. In most cit-
ies, participants who had ever injected drugs were more frequent or at a similar level in older MSM (≥25 years) 
compared to younger MSM (<25 years). 
The prevalence of substance use during last anal intercourse was high. Overall, the most common substance 
was alcohol, but it is worth noting that a high proportion of MSM use other drugs including illicit substances. 
The patterns of recreational drug use were highly variable across cities. Also there were no clear patterns by 
age regarding the frequency of use of different substances in different cities.
The use of party drugs (methamphetamine, MDMA, cocaine, GHB, and mephedrone) was associated with an 
increased likelihood of not using a condom, especially regarding sex with a non-steady partner. 
Introduction
This Section deals with the substance use among the Sialon II study population and its potential conse-
quences on sexual risk behaviours. In addition to the direct health risks related to the use of psychoactive sub-
stances, the patterns of use and the impact of substance use on sex risk behaviours are closely connected with 
HIV transmission risk. Several studies have found higher HIV prevalence among MSM, who reported substance 
use (Pines et al., 2014; Santos et al., 2014; Tieu et al., 2014; Vanden Berghe, Nöstlinger, and Laga, 2014; Wei, 
Guadamuz, Lim, Huang, and Koe, 2012; Woolf-King et al., 2013).
HIV is especially common among people who inject drugs (PWID). Injections with needles and syringes con-
taminated with blood of an infected person while sharing injecting equipment are well established modes of 
HIV transmission, currently accounting for 16.2% of newly diagnosed HIV cases in the WHO European Region 
(ECDC/WHO, 2015). Structural risk factors such as economic recession or political transition may decrease 
investment in preventive measures elevating risk for injection driven transmission among the PWID as demon-
strated by recent outbreaks in Greece and Romania (Niculescu et al., 2015; Paraskevis et al., 2013; Sypsa et al., 
2015). The patterns of using drugs by injection among MSM differ from the heterosexual population. MSM are 
more likely to inject amphetamine-type stimulants (e.g. methamphetamine) rather than opiates (Jin, Huriaux, 
Loughran, Packer, and Raymond, 2014). These drugs may be often used (injected) in the context of sex parties 
(‘slam parties’) due to their effect on prolonging sexual activity. There is evidence of an increase in drug use by 
injection in such situations in some subpopulations of MSM (Kirby and Thornber-Dunwell, 2013).
Moreover, non-injecting drug use has been shown to increase sexual risk behaviours (e.g. Folch et al., 2015). 
Studies indicate that during sexual encounters under the influence of drugs, MSM are less likely to use con-
doms (Boone, Cook, and Wilson, 2013; Tieu et al., 2014). Substance use has also been associated with higher 
cumulative sexual risk (Pines et al., 2014) and this sexual risk increased both with the number of substances 
used and the frequency of use (Santos et al., 2013).
Findings with regard to specific substances are variable to a certain degree. The evidence for association 
with risky sexual practices (different definitions) is the strongest for the stimulants use, especially metham-
phetamines (Santos et al., 2013; Vosburgh, Mansergh, Sullivan, Purcell, 2012; Woolf-King et al., 2013), and 
linked to sex parties (‘sexual marathons’) (Semple, Zians, Strathdee, Patterson, 2009). Alcohol use is not directly 
associated to HIV transmission risk, but was found to predict higher levels of risk behaviours (among HIV-neg-
ative or HIV-positive MSM) in some studies (Bruce, Kahana, Harper, Fernández, and ATN, 2013; Tieu et al., 
5.12 Substance use
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2014; Woolf-King et al., 2013); although not in others (Fendrich, Avci, Johnson, and Mackesy-Amiti, 2013). More 
evidence is available for the association of binge alcohol drinking and HIV risk (Vosburgh et al., 2012). Moreover 
age is possibly an effect modifier for the association with alcohol use, thus older MSM may have an increased 
risk	(Heath,	Lanoye,	&	Maisto,	2012;	Mustanski,	2008).	Additionally,	nitrites	(poppers)	and	erectile	dysfunction	
medications (EDM) are associated with increased odds of unprotected intercourse between sero-discordant 
sexual partners (Woolf-King et al., 2013) and combination of EDM and methamphetamines may be of especially 
high risk (Fisher, Reynolds, and Napper, 2010). 
Substance use is prevalent among MSM in Europe and elsewhere (The EMIS Network, 2013). This has been 
explained by higher reporting of depressive symptoms and other mental health problems, driven by both ex-
ternal and internal stigma, resulting in increased vulnerability for HIV and other STIs. These multiple health 
problems have been conceptualized within syndemic theory (Vanden Berghe et al., 2014), suggesting that the 
interaction between the different health problems results in an excess of disease burden. 
Whilst the majority of research on substance use among MSM comes from the US, relatively little is known 
about this issue in Europe, especially in Central and Eastern Europe. This Section presents data on the preva-
lence of injecting drug use (ever) among the MSM in European cities participating in Sialon II. In addition, data 
are presented on the percentages of participants using substances (e.g. alcohol, EDM, party drugs etc.) at the 
last episode of anal intercourse. This is essential in order to establish the importance of substance use for HIV/
STI transmission risk at the population level.
Results
MSM who have ever injected drugs by age
In both TLS and RDS cities, the Sialon II survey was designed to explore the level of drug use among par-
ticipants. Specifically, information on a participant’s lifetime history of taking illeg al drugs by injection was 
collected using the following item: 1) “Have you ever injected drugs? (Drugs injected for medical purposes or 
treatment of an illness do not count.)”. Possible responses included ‘yes’, ‘no’ and ‘I prefer not to answer’.[1] 
Overall the percentage of participants who reported ever having injected drugs varied from 1.2% in Brati-
slava and 2.9% in Sofia to 9.5% in Brussels, and 19.3% in Bucharest. In the majority of the cities, the percentage 
of older participants (≥25 years) reporting ever having injected drugs was higher or at a similar level as younger 
participants (<25 years). However, in Brussels, Ljubljana, Lisbon and Warsaw the situation was the opposite with 
the estimated frequency of injecting history higher in the younger (<25 years) rather than older age group (≥25 
years) respectively: 37.4% vs. 5.9%; 6.7% vs. 4.3%; 12.7% vs. 4.7%, and; 10.1% vs. 5.3% (Table 5.12.1). 
Table 5.12.1 Percentage of MSM who had at least once in their lifetime injected a drug (excluding medical indi-
cations), by age group
City Age
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Sample 
Size
BARCELONA
<25 1.3% 0.0% 4.0% 0.89 40
25+ 3.5% 0.4% 6.5% 1.57 356
Total 3.2% 0.3% 6.0% 1.66 396
BRATISLAVA
<25 1.6% 0.0% 3.8% 1.11 114
25+ 0.9% 0.0% 2.2% 1.56 276
Total 1.2% 0.1% 2.2% 1.27 390
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City Age
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Sample 
Size
BRIGHTON
<25 0.9% 0.0% 2.8% 0.80 62
25+ 5.2% 2.7% 7.6% 1.00 327
Total 4.5% 2.5% 6.4% 0.95 389
BRUSSELS
<25 37.4% 0.0% 81.4% 2.04 10
25+ 5.9% 0.4% 11.4% 1.28 117
Total 9.5% 1.3% 17.6% 1.59 127
BUCHAREST
<25 11.9% 0.0% 24.7% 1.89 45
25+ 21.4% 6.0% 36.7% 4.33 117
Total 19.3% 2.3% 36.3% 8.02 164
HAMBURG
<25 0.4% 0.0% 1.1% 0.37 39
25+ 3.7% 0.0% 8.4% 2.43 364
Total 3.3% 0.0% 7.5% 2.36 403
LISBON
<25 12.7% 0.0% 25.5% 1.26 35
25+ 4.7% 0.4% 9.1% 1.99 370
Total 5.5% 1.4% 9.7% 1.87 405
LJUBLJANA
<25 6.7% 0.6% 12.7% 1.16 118
25+ 4.3% 0.0% 8.7% 1.90 253
Total 4.8% 0.3% 9.4% 2.08 371
SOFIA
<25 2.4% 0.0% 5.6% 1.06 111
25+ 2.7% 0.6% 4.9% 1.12 269
Total 2.7% 0.2% 5.1% 1.49 380
STOCKHOLM
<25 7.1% 0.9% 13.2% 1.10 58
25+ 6.7% 1.4% 11.9% 1.61 249
Total 6.8% 3.2% 10.3% 1.27 307
VERONA
<25 0.0% - - - 104
25+ 3.1% 0.0% 8.6% 9.09 280
Total 2.1% 0.0% 7.7% 18.20 386
VILNIUS
<25 2.8% 0.1% 5.5% 0.69 82
25+ 3.9% 1.1% 6.7% 1.54 234
Total 3.6% 1.3% 5.8% 1.49 316
WARSAW
<25 10.1% 0.0% 20.3% 1.82 85
25+ 5.3% 0.0% 11.4% 2.35 306
Total 6.7% 0.0% 13.5% 2.76 391
MSM who have ever injected drugs by HIV status [2]
A history of drug injection was generally more common among HIV-positive participants with the exception of Sofia, 
Ljubljana, and Bratislava where no HIV-positive MSM reported to ever having injected drugs (Table 5.12.2). In several 
cities, including the three aforementioned cities, the sample size for HIV-positive MSM was small leading to unstable 
estimates for the percentage of injectors in the stratified analysis; thus findings must be interpreted cautiously.
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Among cities, where a sample size of above 30 HIV-positive MSM was available, the highest percentage of 
ever injectors among HIV-positive participants was observed in Bucharest (35.2%), Lisbon (16.5%), and Ham-
burg (14.1%; see Table 5.12.2). The exceptionally high percentage noted in the Bucharest sample was strongly 
affected by one chain recruited by the specific seed who was an injecting drug user and also had sex both with 
men and with women.
Table 5.12.2 Percentage of MSM who had at least once in their lifetime injected a drug (excluding for medical 
indications), by HIV status
City HIV status
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Sample 
Size
BARCELONA
HIV (-) 2.6% 0.3% 5.0% 1.36 334
HIV (+) 6.3% 0.0% 17.5% 1.73 60
BRATISLAVA
HIV (-) 1.2% 0.1% 2.3% 1.27 371
HIV (+) 0.0% - - - 19
BRIGHTON
HIV (-) 3.1% 0.3% 5.9% 1.46 316
HIV (+) 11.4% 2.4% 20.5% 1.19 64
BRUSSELS
HIV (-) 5.7% 0.0% 13.5% 1.91 113
HIV (+) 43.1% 0.0% 87.4% 1.87 11
BUCHAREST
HIV (-) 16.2% 3.0% 29.4% 4.52 133
HIV (+) 35.3% 9.1% 61.5% 2.46 31
HAMBURG
HIV (-) 2.6% 0.0% 5.2% 1.60 339
HIV (+) 14.1% 0.0% 41.8% 2.16 48
LISBON
HIV (-) 2.7% 0.0% 5.6% 1.55 299
HIV (+) 16.5% 0.0% 33.9% 1.90 69
LJUBLJANA
HIV (-) 5.0% 0.0% 10.3% 2.18 311
HIV (+) 0.0% 0.0% 0.0% 0.00 15
SOFIA
HIV (-) 3.0% 0.4% 5.7% 1.39 313
HIV (+) 0.0% 0.0% 0.0% 0.00 17
STOCKHOLM
HIV (-) 5.9% 1.9% 9.9% 1.48 286
HIV (+) 47.5% 0.0% 100.0% 1.46 15
VERONA
HIV (-) 1.3% 0.0% 6.9% 27.40 354
HIV (+) 9.7% 0.0% 26.3% 3.02 32
VILNIUS
HIV (-) 3.6% 1.3% 5.8% 1.46 308
HIV (+) 3.9% 0.0% 11.4% 0.35 8
WARSAW
HIV (-) 6.4% 0.0% 14.5% 3.17 338
HIV (+) 10.7% 0.8% 20.6% 0.87 52
MSM who have ever injected drugs by hepatitis status (RDS only)
In RDS cities, laboratory data from testing were also available for viral hepatitis B and C. History of injecting 
drug use was more common among participants with evidence of past or ongoing infection with HBV or HCV in 
Bucharest (30.3% in HBc-Ab positive MSM vs 13.3% in the negatives and 87.2% in HCV-Ab positive vs 1.3% in the 
negative) and Verona (11.6% in HBc-Ab positive MSM vs 0.2% in the negatives and 38.8% in HCV-Ab positive vs 
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0.2% in the negative), but not in Bratislava (none in HBc-Ab positive MSM vs 1.2% in the negatives and none in 
HCV-Ab positive vs 1.2% in the negative) and Vilnius (none in HBc-Ab positive MSM vs 3.9% in the negatives). In 
Bratislava and Vilnius, hepatitis B was less common and there were almost no (Bratislava) or no (Vilnius) MSM 
diagnosed with HCV-Ab (Table 5.12.3).
Table 5.12.3 Percentage of MSM who had at least once in their lifetime injected a drug (excluding for medical 
indications), by hepatitis B and C status 
City
Hepatitis 
status
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Sample Size
Hepatitis B: HbC-Ab
BRATISLAVA
HBc-Ab (-) 1.2% 0.1% 2.3% 1.37 372
HBc-Ab (+) 0.0% - - - 18
BUCHAREST
HBc-Ab (-) 13.6% 2.4% 24.7% 2.82 100
HBc-Ab (+) 30.3% 11.8% 48.7% 2.65 62
VERONA
HBc-Ab (-) 0.2% 0.0% 0.4% 0.27 326
HBc-Ab (+) 11.6% 0.0% 24.1% 2.78 60
VILNIUS
HBc-Ab (-) 3.9% 1.5% 6.3% 1.43 293
HBc-Ab (+) 0.0% - - - 23
Hepatitis C: HCV-Ab
BRATISLAVA
HCV-Ab (-) 1.2% 0.1% 2.3% 1.32 386
HCV-Ab (+) 0.0% - - - 4
BUCHAREST
HCV-Ab (-) 1.3% 0.4% 2.2% 0.19 122
HCV-Ab (+) 87.2% 74.0% 100.4% 1.66 40
VERONA
HCV-Ab (-) 0.2% 0.0% 0.5% 0.61 373
HCV-Ab (+) 38.8% 6.1% 71.5% 1.69 13
VILNIUS
HCV-Ab (-) 3.6% 1.3% 5.9% 1.51 316
HCV-Ab (+) - - - - 0
Substance use during the last anal intercourse with a male partner [3]
For TLS and RDS participants who indicated that they had previously had anal intercourse (AI) with a man, 
participants were asked to respond to one item assessing substance use during this last AI with a male part-
ner: “Before or during your last anal sexual intercourse, did you use the following?” Participants could re-
spond, ‘yes’, ‘no’, ‘I prefer not to answer’ for each item of the following list: alcohol; poppers; ecstasy; Viagra/
Camagra/Ciallis (erectile dysfunction medications or EDMs); hashish/marijuana; cocaine; amphetamine; GHB 
(gamma-hdroxybutyric acid); or other (‘specify’). 
With reference to Table 5.12.4, alcohol was the most frequent substance used during the last AI with between 
24.6% and 66.8% of participants reporting its use across TLS and RDS cities. There was a tendency for younger 
participants (<25 years) to use alcohol more than older participants (≥25 years), but not in all cities and the 
differences were small. 
In terms of EMD, reported use was less frequent than alcohol varying from 1.7% in Sofia and 1.8% in Ljubl-
jana to 14.5% in Brighton and 16.1% in Brussels (Table 5.12.4). These percentages were consistently higher 
in older participants (≥25 years). Among these older participants, the median value for EMD use was 5.4%, as 
compared to 1.4% for younger participants (<25 years). 12.4).
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Table 5.12.4 Percentage of MSM who used alcohol and who used EDM (e.g. Viagra) before or during the last anal 
sex, by age 
City Age
Alcohol EDM
Point 
Esti-
mate
95% 
Lower 
Bound
95% 
Upper 
Bound
Est. 
Design 
Effect
Sample 
Size
Point 
Esti-
mate
95% 
Lower 
Bound
95% 
Upper 
Bound
Est. 
Design 
Effect
Sample 
Size
BARCELONA
<25 49.0% 31.3% 66.6% 1.36 42 6.8% 0.0% 19.6% 1.96 42
25+ 32.8% 24.9% 40.7% 1.56 347 7.4% 3.2% 11.6% 1.48 347
Total 35.2% 28.1% 42.4% 1.50 389 7.3% 3.2% 11.4% 1.59 389
BRATISLAVA
<25 41.6% 31.0% 52.2% 1.89 117 1.1% 0.2% 2.1% 0.35 117
25+ 35.0% 27.7% 42.3% 2.26 276 7.0% 3.0% 10.9% 2.34 278
Total 37.0% 31.3% 42.7% 1.93 393 5.2% 2.5% 8.0% 2.16 395
BRIGHTON
<25 57.4% 39.7% 75.2% 1.36 61 14.9% 0.0% 32.2% 1.85 61
25+ 43.7% 31.6% 55.7% 2.20 324 14.4% 7.9% 21.0% 1.68 325
Total 45.6% 35.7% 55.5% 1.99 385 14.5% 9.2% 19.8% 1.50 386
BRUSSELS
<25 42.2% 17.0% 67.3% 1.96 48 3.7% 0.0% 9.3% 1.16 48
25+ 60.0% 50.5% 69.6% 1.75 321 18.3% 3.9% 32.7% 3.36 324
Total 57.3% 48.0% 66.6% 1.84 369 16.1% 3.6% 28.6% 3.35 372
BUCHAREST
<25 20.7% 8.6% 32.7% 1.09 46 0.0% - - - 41
25+ 47.6% 35.1% 60.1% 2.06 124 5.0% 0.6% 9.4% 1.19 111
Total 42.0% 32.0% 52.0% 1.89 172 4.0% -0.4% 8.3% 2.01 154
HAMBURG
<25 37.9% 12.7% 63.1% 1.66 36 2.3% 0.0% 6.7% 0.93 36
25+ 43.1% 35.1% 51.2% 1.53 346 4.1% 0.0% 8.7% 2.18 346
Total 42.6% 36.2% 48.9% 1.28 382 3.9% 0.0% 8.1% 2.18 382
LISBON
<25 35.1% 14.7% 55.5% 1.38 33 0.0% 0.0% 0.0% 0.00 33
25+ 30.0% 20.0% 40.1% 2.12 365 5.4% 2.2% 8.6% 1.37 364
Total 30.5% 22.2% 38.9% 1.85 398 4.9% 1.7% 8.0% 1.49 397
LJUBLJANA
<25 52.3% 42.3% 62.2% 0.90 114 0.4% 0.0% 1.1% 0.54 114
25+ 45.2% 31.1% 59.2% 2.44 259 2.2% 0.4% 4.0% 1.06 259
Total 46.7% 35.6% 57.8% 2.19 373 1.8% 0.4% 3.2% 1.05 373
SOFIA
<25 60.1% 41.2% 79.0% 1.99 115 1.5% 0.0% 4.3% 1.17 113
25+ 69.1% 63.8% 74.4% 1.02 296 1.8% 0.0% 5.0% 2.18 294
Total 66.8% 59.2% 74.5% 1.68 411 1.7% 0.0% 4.8% 2.45 407
STOCKHOLM
<25 38.3% 22.8% 53.9% 1.62 73 1.0% 0.0% 3.1% 1.03 73
25+ 37.6% 27.9% 47.2% 1.58 268 4.8% 1.2% 8.5% 1.35 267
Total 37.8% 27.5% 48.0% 1.99 341 3.7% 1.2% 6.2% 1.23 340
VERONA
<25 30.5% 17.5% 43.5% 2.55 104 1.4% -1.3% 4.1% 1.72 104
25+ 22.0% 15.4% 28.7% 2.36 289 5.1% 1.1% 9.2% 3.11 291
Total 24.6% 18.1% 31.0% 2.82 395 4.0% 1.0% 7.0% 2.91 398
VILNIUS
<25 55.2% 42.3% 68.0% 1.68 81 0.0% - - - 81
25+ 49.6% 42.2% 57.0% 1.61 236 5.8% 2.5% 9.1% 1.48 237
Total 51.0% 44.8% 57.2% 1.51 317 4.4% 1.9% 6.8% 1.39 318
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City Age
Alcohol EDM
Point 
Esti-
mate
95% 
Lower 
Bound
95% 
Upper 
Bound
Est. 
Design 
Effect
Sample 
Size
Point 
Esti-
mate
95% 
Lower 
Bound
95% 
Upper 
Bound
Est. 
Design 
Effect
Sample 
Size
WARSAW
<25 49.7% 33.2% 66.2% 1.81 88 2.4% 0.0% 5.5% 1.11 88
25+ 39.3% 33.3% 45.3% 1.02 295 7.4% 1.6% 13.1% 1.85 297
Total 42.3% 37.4% 47.3% 1.00 383 5.9% 2.0% 9.8% 1.65 385
Recreational drug use before or during the last anal intercourse [4]
Recreational drugs included: poppers, MDMA, cannabinoids, cocaine, amphetamine, ketamine/GHB, and 
mephedrone and they were further sub-classified into nitrites (poppers), cannabinoids (marihuana, hashish) 
and party drugs (as defined by the EMIS study: MDMA, cocaine, amphetamine, ketamine/GHB, and mephedrone 
(23)). With regards to Table 5.12.5, recreational drug use before or during the last AI varied across the cities. 
Estimates ranged from 7.5% of participants reporting use in Vilnius to over one third of respondents from Brigh-
ton, Brussels and Sofia. In the majority of cities, recreational drug use was more common among older partic-
ipants (>25 years) compared to younger participants (<25 years). The most commonly used recreational drug 
were nitrites (poppers) with a median value of 13.0% across cities. Variability was however substantial ranging 
from 3.8% in Verona and Vilnius to 25.8% in Brighton and 36.2% in Brussels. Cannabis use was less variable and 
in most cities ranged between 5% and 10% (Figure 5.12.1). Party drugs were used by 2.0% to 15% of MSM from 
different cities with an outlier of 32.3% in Brussels.
Table 5.12.5 Percentage of MSM who used a recreational drug before or during the last anal sex, by age
City Age
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Sample 
Size
BARCELONA
<25 13.3% 0.0% 31.5% 2.08 42
25+ 26.2% 17.9% 34.6% 1.76 348
Total 24.3% 14.0% 34.7% 2.42 390
BRATISLAVA
<25 21.3% 12.0% 30.6% 1.94 110
25+ 19.5% 13.4% 25.6% 2.19 264
Total 20.0% 15.0% 25.0% 2.02 374
BRIGHTON
<25 32.4% 9.7% 55.0% 1.84 61
25+ 35.0% 26.3% 43.7% 1.66 325
Total 34.6% 24.7% 44.5% 2.08 386
BRUSSELS
<25 20.7% 0.0% 42.1% 2.03 48
25+ 53.7% 45.3% 62.2% 1.53 323
Total 48.8% 39.4% 58.2% 1.85 371
BUCHAREST
<25 11.7% 0.7% 22.6% 1.24 40
25+ 21.4% 11.2% 31.6% 1.84 113
Total 19.5% 10.2% 28.8% 2.23 154
HAMBURG
<25 14.3% 0.0% 34.1% 1.80 36
25+ 27.6% 22.1% 33.0% 1.14 345
Total 26.2% 20.8% 31.5% 1.21 381
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City Age
Point 
Estimate
95% 
Lower Bound
95% 
Upper Bound
Estimated 
Design Effect
Sample 
Size
LISBON
<25 45.0% 19.1% 70.9% 1.68 33
25+ 22.0% 13.6% 30.4% 1.96 364
Total 24.3% 17.0% 31.7% 1.74 397
LJUBLJANA
<25 17.3% 9.0% 25.6% 0.99 113
25+ 22.6% 17.4% 27.9% 1.08 258
Total 21.5% 16.7% 26.3% 1.14 371
SOFIA
<25 47.4% 35.7% 59.1% 1.20 114
25+ 29.4% 15.6% 43.3% 2.71 295
Total 33.9% 22.5% 45.3% 2.48 409
STOCKHOLM
<25 9.5% 2.4% 16.6% 1.23 73
25+ 17.2% 11.4% 23.0% 1.22 267
Total 15.0% 10.3% 19.6% 1.22 340
VERONA
<25 21.9% 10.0% 33.9% 2.52 99
25+ 14.0% 5.8% 22.3% 4.98 281
Total 16.7% 8.0% 25.4% 6.51 383
VILNIUS
<25 7.1% 1.9% 12.3% 1.05 81
25+ 7.7% 3.5% 11.8% 1.77 233
Total 7.5% 4.2% 10.8% 1.54 314
WARSAW
<25 15.4% 5.9% 24.9% 1.44 88
25+ 20.0% 10.2% 29.7% 2.03 296
Total 18.6% 12.9% 24.4% 1.47 384
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Figure 5.12.1 Percentage (95% CI) of MSM using cannabis, poppers or party drugs, by city
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Associations of substance use and condom use during the last anal intercourse [5]
In both TLS and RDS cities, the use of party drugs (as defined by the EMIS study to include: MDMA, cocaine, 
amphetamine, ketamine/GHB, and mephedrone (23)) was associated with an increased risk of unprotected 
intercourse. 
In TLS cities for example, the percentage of participants using a condom during the last AI was 60.7% among 
those not using party drugs vs. 54.1% among those using drugs. Similarly differences in percentages were 
evident in RDS cities with 54.6% vs. 34.2% respectively (Figure 5.12.2). Important differences existed between 
the situations in which the intercourse was with a steady or a non-steady partner. Whilst substance use did 
not appear to impact on condom use in steady relationships, it was associated with unprotected intercourse in 
non-steady partners with a tendency of decreased condom use when using a substance. However, even in case 
of unprotected intercourse with non-steady partners, the association was significant only for the party drugs: 
78.9% vs 64.7% in the TLS and 69.2% vs 31.6% in the RDS and for the EDM in TLS settings.
Recruitment type: TLS
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Figure 5.12.2 Percentage of MSM using a condom during last anal sex, by whether substances were used/con-
sumed or not (aggregated, unweighted analysis, stratified by sampling method)
* denotes significantly different
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Figure 5.12.3 Percentage of MSM using a condom during last anal sex, by consuming/using or not substances 
and by partner type (aggregated, unweighted analysis, stratified by sampling method)
* denotes significantly different
Summary and conclusions
•	 Levels	of	substance	use	across	all	cities	were	consistently	high	among	study	participants.	Overall	2.9%	-	
9.4% of MSM reported ever having injected drugs. The estimates of injecting history tend to be higher for 
MSM than the available estimates for general population in the respective countries. In the data collected 
by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) national estimates for the 
prevalence of injecting drug use in Europe vary from 0.2 %to 5.9%. However, the methods used by studies 
reported to EMCDDA may differ for different countries and for different populations meaning it is difficult 
to compare with the findings from Sialon II (EMCDDA, 2014).
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•	 In	most	cities,	participants	who	had	ever	injected	drugs	were	more	frequent	or	at	a	similar	level	in	older	
MSM (≥25 years) compared to younger MSM (<25 years). This is consistent with accumulation of life-time 
experiences (maturation effect). The increase in the older age group is modest in some countries possibly 
reflecting the patterns of experimental drug use. Experimenting with drugs is more common among teen-
agers and young adults than among older age groups. Older participants (≥25 years) are therefore more 
likely to report such experiences which took place earlier in life. In six cities (Brussels, Bratislava, Lisbon, 
Ljubljana, Stockholm, and Warsaw) the patterns were the opposite with much more frequent estimated 
history of injecting in the younger age group. However, these data should be interpreted cautiously due 
to small sample sizes. These high percentages among younger participants (11.9% in Bucharest, 12.7% 
in Lisbon, 6.7% in Ljubljana, 7.1% in Stockholm and 10.1%, in Warsaw) should draw attention to possible 
increase in injecting incidence among MSM in these cities.
•	 The	history	of	injecting	drug	use	was	more	frequent	among	HIV,	HBc-Ab	and	especially	HCV-Ab	positive	
participants. It would be essential in further analysis to clarify if injecting drugs, even if only experimental 
or recreationally may have consequences on the spread of infections among MSM.
•	 The	prevalence	of	substance	use	during	last	anal	intercourse	was	high.	Overall,	the	most	common	sub-
stance was alcohol, but it is worth noticing that a high percentage of MSM use other drugs including illicit 
substances. The patterns of recreational drug use were highly variable across cities. Also there were no 
clear patterns by age regarding the frequency of use of different substances in different cities.
•	 Use	of	party	drugs	(methamphetamine,	MDMA,	cocaine,	GHB,	and	mephedrone)	was	associated	with	an	
increased likelihood of not using a condom, especially regarding sex with a non-steady partner. Previ-
ous research indicates that stimulant use (e.g. methamphetamine use) is associated with 2-fold to 6-fold 
increase in the odds of a detectable viral load (Blumenthal et al., 2014; Carrico, Woolf-King, Neilands, 
Dilworth, and Johnson, 2014). The detectable viral load implies a higher chance of transmission of HIV in 
the case of unprotected intercourse with a negative partner. Therefore party drug users may significantly 
contribute to onward transmission (Blumenthal et al., 2014).
•	 Substance	use	can	be	seen	as	part	of	so-called	syndemic	conditions	including	depression,	substance	use,	
violence, sexual stigma, and homelessness. Such syndemic conditions tend to act synergistically to in-
crease the HIV risk and a multi-faceted approach to mitigate this risk has been suggested previously (San-
tos et al., 2014; Vanden Berghe et al., 2014). 
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Endnotes
[1] To calculate lifetime history of taking illicit drugs by injection, the numerator included the number of participants who report every 
having used drugs by injection (i.e. those who answered ‘Yes’ to Question 35; excluding drug use for medical purposes. In the denominator, 
the number of participants of MSM who provided information on whether they had ever used drugs by injection (answered ‘Yes’ or ‘No’ to 
Question 35).
[2] To calculate estimates stratified by HIV status, the status was established based on the laboratory results in biological material (oral 
fluid or serum) collected in Sialon II.
[3] To calculate the percentage of participants who used a specific substance (e.g. alcohol, nitrites, ecstasy etc.), the numerators for 
these indicators were the number of MSM who reported using the substance during the last anal intercourse with another man (answered 
‘Yes’ to the respective item in Question 30). The denominators were the number of MSM who did not refuse to answer whether they used 
a substance during the last anal sex with another man (answered ‘Yes’, ‘No’ or no answer). Participants who indicated that they had never 
had anal intercourse (response to Question 26) were excluded. Importantly, it was necessary to impute missing values with ‘No’ as many 
participants interpreted Question 30 as a ‘checklist’ type question and not as a series of ‘Yes/No’ questions.
[4] To calculate the percentage of participants who used a recreational drug before or during the last anal intercourse, an indicator was 
constructed using the imputation described in [3]. Recreational drugs included: poppers, MDMA, cannabinoids, cocaine, amphetamine, 
ketamine/GHB, mephedrone. The numerator was the number of men who used any of the recreational drugs (answered ‘Yes’ to at least one 
of the respective items in Question 30). The denominator was the number of MSM who either reported having used any of the recreational 
drugs (the numerator) or did not refuse any of the items referring to the recreational drugs (answered ‘No’ or no answer). As in [3] partici-
pants who indicated that they had never had anal intercourse (response to Question 26) were excluded. Finally to calculate the percentage 
of participant who used a party drug we used the definition of party drug as defined by EMIS study (23). Thus, party drugs were defined as 
a subset of recreational drugs and included: MDMA, cocaine, amphetamine, ketamine/GHB, mephedrone. The indicator was calculated in 
an analogous way to the percentage of participants who used a recreational drug.
[5] To explore associations of substance use and condom use during the last anal intercourse, data were combined and used without 
weights, as a convenience sample to increase sample size for the description of associations.
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In this Chapter, an overview of the main results from the Sialon II survey is presented and discussed. The 
discussion considers both methodological issues as well as main insights from the study results. Finally, some 
comparisons between the former Sialon I and Sialon II project surveys are outlined.
Methodology
The methodology adopted for the Sialon II project incorporated the main approaches for monitoring and 
controlling the HIV epidemic in line with the indications in the literature and relevant international reports from 
ECDC, UNAIDS and WHO. A sound and structured surveillance system was elaborated accordingly, including 
the use of a common set of indicators. Ad-hoc prevention campaigns targeting MSM and focusing on testing 
promotion were also foreseen as an integral component of the project. 
Previous surveys have collected behavioural data using internet based recruitment methods but the con-
comitant collection of biological samples was not foreseen.  Furthermore, where bio-behavioural surveys have 
been carried out, different indicators and methodologies have been adopted, rendering any comparison of the 
results difficult.  
In terms of sampling methods, the implementation of a bio-behavioural survey using different sampling 
methods, namely Time-Location Sampling (TLS) and Respondent-Driven Sampling (RDS), has greatly improved 
the quality of the surveillance in terms of the validity and reliability of the data and has contributed to capacity 
building across participating countries. In addition, the use of these two different sampling methods – tailored 
according to both local needs and gay scene characteristics of each participating city – proved to be effective in 
different social contexts and across the different study sites. These different methods allowed researchers to 
enrol heterogeneous populations and to collect reliable information on behaviour patterns, prevention needs 
and sexual health in the MSM population, triangulating the behavioural data (risk behaviours, socio-ecological 
or contextual factors) and the biological information. 
The questionnaire, incorporating GARPR and ECDC indicators, developed and validated with the involvement 
of representatives of the gay communities of all cities,  represented a unique tool for collecting data according 
to a standardised approach. Such indicators were very useful for conducting this type of bio-behavioural survey 
6. Discussion
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targeting – in this case – MSM population and the results have provided countries with a clear and direct marker 
on the status of the epidemic in the MSM populations across cities. 
Given that the survey collected biological samples and linked behavioural information across 13 different Eu-
ropean countries, very specific and clear ethical and governance procedures were required and adopted in order 
to comply with all local, national, and European standards. Survey protocols and procedures were harmonised 
and tailored in order to minimise the risks of mistakes (including potential diagnostic mistakes) and ensuring 
the principle of privacy and confidentiality for all participants during the entire survey process.  For this purpose, 
a barcode system was developed with the twofold objective of ensuring anonymity of the participants while at 
the same time ensuring the anonymous traceability of each participant’s result. 
In addition, the Sialon II research protocols were also approved by the WHO Research Project Review Panel 
(RP2-WHO) and by the Research Ethics Review Committee (WHO-ERC) in February 2013, guaranteeing excel-
lence both from a scientific and ethical point of view. 
In terms of methodology, the Sialon II project has contributed to the harmonisation process of surveillance 
methods across participating countries initiated by ECDC and other International Agencies and has contributed 
to a more effective public health response at country and European level. The comparable data on behavioural 
and epidemiological indicators for MSM communities (ECDC and GARPR indicators) presented in this report 
represents an opportunity for local, European, and international Institutions, that can use the methodology ap-
plied in Sialon II to implement future surveys across different countries.  
Survey Results
The samples enrolled in the study cities present remarkable differences in the age composition and educa-
tional levels, which do not necessarily reflect the real difference in the cities’ MSM populations and which could 
potentially be attributed to the differences in the social segments of the MSM population reached by the Sialon 
II study. Also the migration patterns present marked differences which, together with the tourism patterns, 
should be taken into account in interpreting the estimates across the cities. In some cities the migrant popu-
lation represents a significant percentage (>20%) of the enrolled MSM compared to others where it appears to 
be almost absent. In line with other survey results, some cities manifest an important attraction factor for the 
MSM population probably due to the vast variety of gay venues on offer. These aspects have important repercus-
sions on the prevention policy and programmes that should be tailored to reach all the segments of the MSM 
population.  
The level of “outness” and the perceived “homonegativity” differed substantially between the study areas. In 
Eastern European cities where homosexuality has been decriminalised only recently, men were less likely to be 
out regarding their sexual attraction to men. In this type of scenario, the use of the RDS method seemed to be 
very efficient in reaching more hidden MSM populations particularly for never tested MSM. 
There are important differences between cities also when comparing the number of men reached by pre-
vention programmes (GARPR indicator 1.11). Even if most of the men in the TLS and RDS surveys knew where 
to go to get an HIV test, the percentage of men that had been given condoms during the last 12 months varied 
between the cities from less than half to almost all men. This is, therefore, an area where there seems to be 
room for improvement.
Differences between the cities regarding the extent of outreach activities and routines for providing condoms 
in health care settings and the type of venues sampled in the study vary considerably. It would appear, therefore, 
that the local context should be taken into consideration when developing strategies for condom distribution. 
Older participants (>25 years) tested more recently and more frequently than younger participants (<25 
years). This might indicate that a larger group of young MSM are potentially not aware of their HIV status. The 
majority of the participants reported having tested within the last two years (2012 -2014); this was particularly 
evident in younger participants (<25 years).
Anal intercourse without a condom in the previous six months was reported by approximately half of the 
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study participants, slightly more often by men living in the Central European study cities. In addition unpro-
tected anal intercourse was reported more frequently with steady partners compared to non-steady partners.
The association between age, condom use and partner type was not consistent across the study cities. In 
most cities, condom use with a steady partner was lower for younger men than for men 25 years and older, but 
sample sizes for younger men living in steady relationships were small for several cities. 
The effect of knowledge of HIV status on condom use differed by partner type: reported condom use was 
lowest among HIV negative respondents having anal sex with a steady partner and highest among HIV nega-
tive respondents having anal sex with a non-steady partner. Among respondents aware of being infected with 
HIV, condom use with steady partners was higher than among HIV negative men, however, condom use with 
non-steady partners was lower. Men unaware of being infected with HIV reported the lowest condom use with 
non-steady partners. The knowledge of HIV status had a greater impact on unprotected vaginal or anal inter-
course with female partners. Among men having sex with women, episodes of unprotected vaginal sex was 
high (almost a half) which would suggest the need to target this subpopulation group, particularly in Eastern 
European countries. 
The percentage of study participants reporting more than one UAI partner in the previous six months varied 
across cities with high frequency reported in almost all Eastern European cities. High numbers of partners 
with whom condomless AI was practiced were reported most frequently by study participants infected with HIV, 
regardless of whether they knew to be HIV infected or not. However, almost more than a half of the individuals 
unaware of being infected with HIV reported only one or no UAI partner in the previous six months.  
Reporting a STI diagnosis in the previous 12 months was also associated with a higher number of sex part-
ners in the previous six months: more than one third of all STIs reported were diagnosed in men reporting more 
than 10 partners, while among men without STIs less the one MSM over five reported more than 10 partners. 
As previously discussed, most MSM reported only having sex with male partners in the past six months. 
However, a minority of participants also reported sex with female partners (steady and non-steady) in the past 
six months. The percentage of behaviourally bi-sexual men varies considerably across cities but seems to be 
present in all study sites. This subgroup of MSM reported a high number of episodes of unprotected sex with 
women leading to a possible bridging effect for the HIV transmission. In terms of policy, these findings suggest 
that there may be important HIV prevention opportunities to tailor programmes in order to reach this subpop-
ulation of MSM particularly in those cases where MSM do not disclose their behavioural bi-sexuality to either 
their male or female partner. 
The last episode of anal sex is an important indicator suggested to estimate precisely the sexual behaviour 
and the associated risk. This was reported almost equally as often with a steady and a non-steady partner. 
Sexual roles during this last anal intercourse were found to be distributed equally between insertive, receptive, 
and both, with only minor variations between cities. The HIV serostatus concordance with the last steady anal 
sex partner was almost always assumed and also the HIV seroconcordance with non-steady anal sex partners 
was rarely established. Not knowing one’s own HIV status or the steady partner’s HIV status was most frequent 
in Central European cities. Condomless AI was considerably more frequent when the last anal sex partner was 
a steady partner compared to a non-steady partner.  
The majority of study participants in the RDS samples reported low levels of involvement in commercial sex 
with the exception of Bucharest. The majority of those who had been paid for sex reported that they had used a 
condom during anal sex the last time they were paid. The commercial sex with female partners was infrequent. 
Again the highest percentage was found in Bucharest. 
In terms of HIV prevalence, data suggested that this varies between 2% and 20%, with higher rates among 
individuals older than 25 years of age. A relevant proportion (ranging between 12% and 88%) of participants 
were unaware of being HIV-positive. This would suggest that it would be opportune to routinely offer to MSM 
periodical serological testing for HIV, syphilis, HBV, and HCV. In terms of viral load and treatment, consistent 
differences were reported across participating cities. In general, unsatisfactory treatment coverage and treat-
ment adherence were reported in the Eastern European cities. Among HIV positive MSM under treatment (ART), 
the percentage of participants with undetectable viral load was relatively high, suggesting good adherence and 
184 The Sialon II Project. Report on a Bio-behavioural Survey among MSM in 13 European cities
appropriate quality of treatment, whilst it should be noted that the continuum of care is quite different across 
cities. The lack or delay in diagnosis is a crucial factor in all areas. In several cities, the treatment coverage may 
be less than optimal even among the individuals who know they are HIV positive indicating potential challenges 
in linkage to care and continuity in care. This underlines the possible inequalities in access to preventive and 
medical services, which should be tackled in order to combat HIV in Europe. 
The level of satisfaction of the MSM sexual life was generally high with three quarters or more of all partic-
ipants generally reported to be satisfied. The percentage of MSM who reported being unsatisfied with their sex 
lives was generally lower than 25% across all cities. Such levels are markedly lower when compared to findings 
of the other studies. This could reflect a difference in wording as well as the influence of different data collection 
methods, for instance in settings where people socialise for seeking sex.
Levels of substance use across all cities were consistently high among the study participants. In most cit-
ies, participants who had ever injected drugs were more frequent or at a similar level in older MSM (>25 years) 
compared to younger MSM (<25 years). 
The prevalence of substance use during last anal intercourse was high. Overall, the most common substance 
was alcohol, but it is worth noticing that a high proportion of MSM use other drugs including illicit substances. 
The patterns of recreational drug use were highly variable across cities. Also there were no clear patterns by 
age regarding the frequency of use of different substances in different cities.
The use of party drugs (methamphetamine, MDMA, cocaine, GHB, and mephedrone) was associated with 
an increased likelihood of not using a condom, especially regarding sex with a non-steady partner. Substance 
use can be seen as part of so-called syndemic conditions including depression, substance use, violence, sexual 
stigma, and homelessness. 
In conclusion, when considering the main relevant findings, it should be underlined that a low level of testing 
uptake is reported in the survey. The high number of MSM who were tested for the first time in the context of 
this survey, in particular in the Eastern European survey cities and the high estimates of HIV positive partici-
pants unaware of their real serum-status, seem to suggest critical conditions in terms of future increase of the 
HIV epidemic. The situation seems to be particularly alarming in Eastern European cities, where a low level of 
condom use is reported, as well as a high level of perceived stigma. 
Comparisons between Sialon I and Sialon II
As already mentioned, the Sialon II project follows on from the Sialon project which was funded under the 
2003-2008 Public Health Programme (work plan 2007). It is not possible to compare precisely the findings from a 
statistical point of view, as in Sialon I only the TLS method was adopted whereas in Sialon II both the TLS and RDS 
methods were adopted. In addition, in the former Sialon un-weighted prevalence and estimates were produced, 
whereas in Sialon II the use of a weighting system (both in TLS and in RDS) was adopted. Furthermore, the partner 
network was more extensive in the Sialon II project. However, some general comparisons can be made as follows.
Estimates on HIV prevalence seem to be in line with previous project. Similar prevalence estimates were 
reported in Sialon I for four out of five cities that were included also in Sialon II i.e. Barcelona, Bratislava, 
Ljubljana, and Verona. In Barcelona and Ljubljana, the same sampling method was used and similar HIV prev-
alence estimates were observed when comparing Sialon II with Sialon I: 14% vs. 17% in Barcelona, 4% vs. 5% 
in Ljubljana, respectively. For Bratislava and Verona the sampling method was different in Sialon II compared 
to Sialon I. Nevertheless, the HIV prevalence estimates were similar: in Bratislava 4% vs. 6%, in Verona 10% vs. 
12%, respectively. Only in Bucharest, a higher prevalence was observed in Sialon II, which, as mentioned above, 
may be attributed to the high proportion of injecting drug user MSM included in the sample (Mirandola, 2009). 
Data on behavioural component (risky behaviours), testing and prevention programmes seem to confirm a 
critical situation especially in Eastern Europe, where the potential for further HIV transmission was evident in 
the former Sialon and it is confirmed – if not further corroborated – in Sialon II findings. 
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In general, the use of TLS (adopted in the former Sialon and in the majority of the participating cities in Sia-
lon II) as a sampling method confirmed to be feasible and efficient in cities where the gay scene is characterised 
by an adequate number of gay venues.  
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Overview
As a reminder from Chapter Two, the Sialon II project was undertaken within a Europe wide situation of ris-
ing HIV infections among MSM in many countries as indicated by both ECDC and the wider scientific literature. 
To respond effectively to the HIV epidemic(s), meaningful interventions of sufficient scale and intensity that 
target MSM specifically are required to ensure prevention and health promotion needs are assessed, identified, 
and responded to. However, what is also required is reliable and comparable data on epidemiological patterns 
of HIV within and between European countries. This is important to not only understand better the changing na-
ture and shape of HIV epidemics among MSM by harmonising HIV/STI surveillance in Europe, but also to share 
knowledge, experiences, and perhaps most importantly given the cross-border threat of HIV, develop and locate 
strategically HIV prevention activities at local, European and international levels.  
Set within this context, the overall objective of the Sialon II project was therefore to carry out HIV/STI sur-
veillance among MSM complemented by targeted and meaningful prevention. Specifically, the project had a 
series of ambitious objectives including: piloting of a bio-behavioural survey using TLS and RDS across thirteen 
European cities; estimating anti-HIV-Ab prevalence among MSM in cities where the TLS method was adopted, 
and anti-HIV-Ab, Syphilis, and HBV-HVC prevalence among MSM in cities where the RDS method was adopted; 
as well as identifying, describing, and analysing sexual risk behaviour patterns, prevention needs and sexual 
health in the MSM population. 
In this final Chapter of the report, some of the key conclusions based on the findings of the Sialon II survey 
are presented along with a series of broad recommendations to inform future policies and actions. It is beyond 
the scope of this current report to provide detailed and country specific conclusions and recommendations; 
however, these will be provided in future articles and other publications. 
Conclusions and recommendations
Data from the Sialon II survey have provided a wealth and diversity of insights regarding (as examples): ac-
cess to prevention programs and testing in each partner country, results on sexual behaviour amongst MSM 
7. Conclusions and recommendations
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in the last six months (with steady and non-steady partners) including condom use and “fisting”; as well as 
findings relating to commercial sex, HIV and other STIs, treatment and viral load, substance (mis)use, and 
sexual health (sexual satisfaction, sexual safety, and sexual autonomy). In doing so, the project has achieved its 
objectives comprehensively. 
However, of importance in this process have been two key factors contributing both to the scientific quality 
and to the validity of these achievements. First, in collaboration with the European Commission and with other 
project partners, namely ECDC, WHO, UNAIDS, members of MSM communities, and other stakeholders, the 
Sialon II project has contributed actively to the harmonisation of HIV/STI surveillance in Europe, in line with the 
most advanced survey methods adopted for the so-called “hard-to-reach populations”. Adoption of the Second 
Generation Surveillance Systems (SGSS) approach along with the use of common core indicators (GARPR; 1.11, 
1.12, 1.13, 1.14) has allowed the project to 1) gather robust, reliable, and valid bio-behavioural data on the HIV 
epidemic in each country among one of the most affected and ‘at risk’ populations of acquiring HIV and other 
STIs, in this case MSM; and 2) maintain the highest scientific and ethical standards in project design, imple-
mentation, and evaluation – and in doing so, provide a trustworthy source of relevant and comparable data for 
public health authorities (PHAs) and NGOs in each partner country to develop and inform HIV prevention strat-
egies and actions. 
Second, active involvement and participation of gay communities in all phases of the project (from planning, 
design, implementation, and evaluation) was a crucial factor in the successful implementation of the project. 
Members of various MSM communities were involved in different ways such as project partners, project par-
ticipants, as well as project stakeholders. Although adopting such a participatory approach to research can be 
challenging, it is important as it represents a move away from MSM as passive objects of scientific enquiry, and 
instead moves towards a view that MSM are social and cultural actors with a unique perspective and insight into 
their own realities. Moreover, participatory approaches have a number of advantages over more conventional 
methodologies where the target population are commonly excluded. In this case, the benefits of meaningful and 
systemic MSM participation were multiple and existed at both individual and project level. At an individual level, 
many representatives from the MSM community were involved directly in data collection, and in the process, 
thus benefited by developing new skills, knowledge, and experience in conducting epidemiological research as 
well as conducting prevention needs assessments, conducting outreach, and working with gay businesses. At 
a project level, benefits of MSM involvement were numerous and included (but were not limited to): informing 
project decision-making around appropriate and culturally sensitive actions and process;  refining the preven-
tion and communication strategies to be implemented at local/European level; identifying how best findings 
should be communicated and to which audiences, and; perhaps most importantly, helping ensure the project 
findings are as valid as they can be in representing MSM communities in Europe.
It should be noted that no virtual contexts (e.g. gay social network Internet profiles) were included in the Sia-
lon II survey. The EMIS survey, for instance, can represent an interesting and complementary survey, that can be 
further used in order to analyse differences, overlapping and “balancing” between different survey approaches 
and related estimates (EMIS, 2013). This would allow researchers, policy makers and NGO representatives in 
gaining an even better understanding also of contextual factors (e.g. virtual versus non-virtual settings) linked 
to risky behaviours and to the HIV-STIs epidemic, as well as new directions in both epidemiological research 
and prevention activities.   
From a policy and prevention perspective, the Sialon II project has confirmed the HIV epidemic among MSM in 
Europe with prevalence varying between 2% and 20% and has highlighted the range of different prevention needs 
among MSM living in the participating cities. For instance, the relatively high number of people unaware of their 
HIV status in certain cities calls for further epidemiological studies to better monitor the HIV epidemic, but also 
for prompt and concrete measures at multiple levels (community, policy, health sector) to reduce the number of 
undiagnosed HIV infected MSM. In addition, the use of GARPR indicators on prevention programmes (1.11 and 
1.13) provided comprehensive evidence on the need for more effective interventions, especially for young MSM.  
 Moreover, the available data on perceived homophobia suggests the need for adopting gay-friendly ap-
proaches across different cultural, political and social levels. In other words and in line with the ecological sys-
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tem theory (Bronfenbrenner, 1979), at the level of legislation (macro-level) for instance, laws related to same-
sex partnerships legally recognising  same-sex marriage or civil unions might improve the acceptability of 
homosexual relations at the population level. At the hospital setting level (e.g. Infectious Diseases Department), 
that is, at meso-level, providing specific training to the health care staff (counsellors, medical doctors, nurses) 
could improve a gay-friendly and sympathetic attitude among the personnel, which may facilitate health seek-
ing behaviours in MSM communities.     
This latter point of needing to tackle homophobia (and stigma) should not be underestimated and is essen-
tial for improving policy and prevention initiatives at local and European level. Societal rejection and criminal-
isation of homosexuality leading to homophobia is a structural determinant associated with HIV risk in MSM 
(Mayer et al., 2013) that must be addressed. For instance, it is well known that the internalized homophobia 
(generally defined as the experience of negative feelings toward oneself as a consequence of internalizing neg-
ative attitudes towards homosexual people that can be common in a given community) is often associated with 
an increased risk for HIV acquisition and transmission. This is partially due to increased risk behaviours (related 
to factors such a low self-esteem, a low perceived control over sexual risk-taking) (Ross, 2013) and partially to 
a decreased engagement in prevention and care. 
In Sialon II, perceived discrimination or “homonegativity” which is linked directly to the frequency with which 
MSM openly declare their sexuality (so-called “outness”) were both investigated in the survey. In many study 
sites, particularly in Central and Eastern European countries where homosexuality has been decriminalised 
relatively recently, the level of perceived negative attitudes was very high with men less likely to be ‘out’ than 
from Western European countries. Similarly, other findings from Sialon II also indicate societal homophobia. For 
instance, although overall HIV testing uptake across Sialon II cities was generally low (with quite a high number 
of participants having “never tested”), this was particularly the case in Eastern European survey cities. Similarly, 
in these same cities, there were a high number of HIV positive participants who were not aware of their real 
HIV-status, evidence of low condom use, and poor treatment coverage for HIV positive individuals. 
The segmentation and the complexity of the MSM population which this project has contributed to iden-
tifying, provides also useful indications regarding the necessity to design targeted HIV prevention and health 
promotion interventions by subgroups. Despite the fact that MSM engage in similar behaviours and practices, 
the term defines a transmission method, without in reality recognising the diverse identities, behaviours, and 
cultures, which are included. To design an effective and comprehensive strategy to achieve a HIV transmission 
reduction therefore requires a clear understanding of different MSM subcultures. 
Broadly, young MSM (<25 years) presented a particularly vulnerable subgroup of MSM, for example, because 
they may have experienced bullying and social exclusion at school and at home, and may still be economically 
dependent on their family. Together these factors can render this subgroup as particularly prone to depression 
and other mental health conditions, risky behaviours including voluntary exposure to HIV, substance (mis)use, 
and in some cases suicide ideations and behaviours (Mayer et al., 2013). In the Sialon II survey, UAI was frequent 
among younger MSM together with the use of drugs and the high perceptions of homonegativity, that is, the 
perception of negative attitude towards MSM. A comprehensive approach to sexual risky behaviour reduction 
therefore, should be complemented by the inclusion of actions addressing social exclusion, homophobia and 
discrimination and vulnerability of young MSM. 
Other subgroups reached through the Sialon II survey, such as the commercial sex workers and the MSM 
who have sex with female partners, can be particularly relevant in terms of a bridging effect where these specific 
populations can serve as a bridge for transmitting the HIV infections into non-high risk populations. For these two 
subgroups, data were collected only through the RDS survey. In terms of commercial sex with other male partners 
or with female partners, data points to low levels of involvement in this activity, with the exception of Bucharest. 
With regards to sexual intercourse with female partners (steady or non-steady), again, data suggests that a mi-
nority of participants engaged in this behaviour in the past six months. However, the percentage of behaviourally 
bisexual men seems to be present in all study sites, even if a considerable variation is reported. The high number 
of episodes of unprotected sex with women represents an alarming issue that needs to be addressed also in terms 
of prevention actions tailored to reach these very specific – but not irrelevant – subpopulations. 
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Other subgroups identified in Sialon II include high numbers of MSM attending venues from other European 
countries included migrants (non-native or non-resident MSM) and tourists. This raises a number of issues: 
1) MSM may experience multiple marginalisation on both ethnic and sexual identity grounds which can render 
them  particularly exposed to higher risk; 2) Although reasons for the presence of non-native born MSM differ 
from city to city, migration driven by economic reasons is one of the most common phenomena meaning that 
such sub-populations of MSM may, once again, be increasingly vulnerable; 3) Finally, tourism may also have 
contributed to the presence of non-native born MSM in the Sialon II survey cities. Given the presence of tourists 
is often limited to short periods, the opportunities for intervention is limited when compared to the resident 
MSM population. 
The above issues all suggest that inclusion and prevention policies/actions need to take the heterogeneity of 
MSM populations into account including young MSM, those from (minority) ethnic backgrounds, migrants, com-
mercial sex workers, MSM who have sex with female partners and tourists. These issues also suggest that gay 
venues where MSM were recruited (in TLS) need to be embraced as potential settings for health particularly for 
‘mobile’ MSM. In other words, as shown by the Everywhere Project (Sherrriff and Gugglberger, 2014), structural 
and community level interventions that embrace gay businesses as settings for HIV and other health promotion 
and public health interventions, can provide an important base to reduce HIV transmission and in doing so, 
target strategically different subgroups of MSM (e.g. resident and non-resident MSM). 
Conceptualising gay venues as settings for health can also be useful for supporting condom distribution as 
a simple cost effective preventative measure. Despite this, Sialon II findings suggest that condom distribution 
programmes and/or interventions appear to remain difficult if not impossible to implement consistently and 
sustainably in many study cities: in many cases, lack of economic resources for the local NGOs or Institutions 
seems to represent a crucial barrier. A European-wide comprehensive condom distribution strategy at multiple 
levels (e.g. associations/NGOs, gay venues) needs to be developed and promoted, as basic and cost-effective 
strategy for reducing the transmission. Together with the Everywhere project framework and subsequent co-
operation of business owners, such a strategy may help to maximize the impact of condom distribution, the 
resources used, and the synergic scaling up of single actions into larger and broader prevention frameworks.
In a similar way to condom distribution, increasing the uptake of HIV testing also remains a challenge in 
many European countries. However, community based testing (such as via gay venues) using point-of-care 
rapid HIV testing represent an important solution given it can be implemented easily by NGOs in Europe with 
the direct involvement and supervision of local public health services. Initially developed for low-middle income 
countries this strategy is becoming more and more relevant when a “Test and Treat” policy is adopted by PHAs. 
Testing policies integrated with access to ART represent an important milestone in the prevention of infec-
tion both because of its efficiency in economic terms and also because it focuses on synergy between treatment 
and prevention. The number of non-diagnosed infections is alarming in some countries (as demonstrated by the 
Avidity Index). Testing promotion, whether in a clinic or by means of a rapid test, is a pressing need, especially in 
the Central and Eastern European cities that participated in the Sialon II survey. However, testing expansion de-
pends on normalising HIV testing, that is, making the HIV testing process more like that for other screening and 
diagnostic tests (ECDC, 2010), and for this specific policy actions must be adopted by national/regional PHAs. 
However, as noted earlier, policy actions must also address the social determinants of low uptake of testing for 
HIV and other STIs such as homophobia and stigma. The EC in its Communication to the European Parliament 
and in its successive working staff document has adopted a clear policy in line with the need to expand the HIV 
testing and linkage to care (EC, 2009, 2013). 
Moreover, the findings on co-infections including HIV-syphilis, HIV-HBV, and HIV-HCV underline the impor-
tance of periodical serological testing which should be actively offered to the MSM population.  
The “Test and Treat” approach is part of the broad bio-medical prevention strategy described in a recent re-
view by Ho et al (Simon, 2016). This strategy aims at decreasing the risk of HIV transmission by reducing the risk 
associated with the exposure to the HIV virus of other STIs agents. Interventions that are part of the bio-medical 
approach could be the treatment of STIs, the use of ART among HIV infected individuals to decrease the risk of 
HIV transmission (effective treatment and resulting low level of viral load – treatment as prevention or TasP), the 
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short term use of ARTs by HIV-negative individuals after accidental exposure to HIV (post-exposure prophylaxis; 
PEP) and the regular assumption of ART by HIV negative individuals to reduce the transmission probability dur-
ing intercourse with potentially infected partners (pre-exposure prophylaxis; PrEP). 
Among other biomedical interventions, Sialon II data suggest that PEP is available in all participating cities 
for medical staff in case of accidental exposure to HIV. Less clear however, is whether this policy is applied in all 
cities for MSM accidentally exposed to a potential HIV positive partner during a sexual contact. The possibility 
of PEP should be pursued by the local NGOs together with the relevant PHAs. 
With regard to PrEP the picture is even less clear. PrEP with consistent condom use currently constitutes an 
as yet unknown tool with regard to the efficacy of reducing the probability of infection. However despite growing 
evidence of efficacy in clinical trials, it is still not clear if the same benefit can be transferred “sic et simpliciter” 
to everyday life. In addition in many European countries a clear policy on the PrEP use has not yet been estab-
lished waiting for more evidence on real life efficacy and safety. According to Beaten (Baeten, 2013) “As with 
all prevention strategies, PrEP is only effective if used, and maximum PrEP benefits, at both individual and 
population levels, will likely be achieved by combining PrEP with other effective HIV prevention interventions”. 
Despite these current uncertainties, this approach may become in the future a further instrument to be used 
to try to control the HIV epidemic.        
Considering the results of the Sialon II survey, it is clear that in addition to tackling homophobia, promoting 
testing, and improving condom distribution networks, more effort also needs to be directed towards the sup-
pression of viral load and improving care patterns for those already infected with HIV (in all cities but partic-
ularly in Central and Eastern European cities). Such a measure is essential to increase the life expectancy of 
HIV infected MSM and to reduce the probability of onward transmission. The substantial and effective viral load 
suppression of HIV infected individuals can lead to viral load suppression at a community level and to a subse-
quent reduction of the HIV transmission probability per single sexual act. However even in the most optimistic 
forecast it will take years to have an appreciable impact in lowering community viral load for MSM.
With regard to risk behaviour, it is necessary to intensify the use of campaigns that are aimed at highlighting 
the risks of transmission linked not only to the lack of condom use, but also to the concomitant use of drugs 
during sex, particularly those defined as party drugs. Information alone is not sufficient for behaviour change 
but it does constitute an important base upon which additional interventions can be developed. In recent years, 
HIV has received less and less attention from the media with the result that the problem has faded from the 
public view including public health commissioners, and often among the gay community too. However, “new” 
MSM become sexually active every day and the need for cultural and socially relevant information alongside 
wider interventions is therefore ever present.
Finally, the findings of Sialon II survey represent a valid contribution to the pool of epidemiological research 
that has been undertaken to date in the area of HIV/STI prevention among MSM. However, at the same time, a 
more in-depth knowledge of how the HIV/STIs epidemic is evolving among MSM is still of crucial importance. 
A better understanding of the different components (such as contextual factors, risky and healthy behaviours) 
together with reliable data in line with the Second Generation Surveillance System still remain the cornerstones 
of any effective intervention. 
Recommendations in brief
MSM community
•	 Promote and where possible provide low-threshold, community-based voluntary HIV and STI testing and 
counselling, in order to reduce barriers and to increase access to testing; 
•	 Prioritize the fight against stigma and discrimination (particularly faced by HIV positive MSM), to be in-
cluded as one of the main topics in information/prevention campaigns, ensuring that the MSM perspective 
is properly considered; 
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•	 Organise the community for scale up of biomedical HIV prevention strategies, in order to increase accept-
ability and access to these new strategies;
•	 Advocate with Public Health Institutions for the availability and expansion of access to PrEP and PEP for HIV; 
•	 Promote and empower networks of MSM or gay associations across different EU and neighbouring coun-
tries, in order to support those countries where the gay community is still invisible and hence prevention 
activities are poorly developed.   
National and regional authorities 
•	 Conduct nation-wide bio-behavioural surveys, in line with the Second Generation Surveillance System, 
including a prevention component to gauge the numbers of undiagnosed and new diagnosis and to curtail 
the epidemic;
•	 Carry out modelling of the data from a statistical point of view to identify the prevention needs and the pre-
vention components to be included in order to maximise the impact of public health interventions;
•	 Identify and target sub-groups for prevention activities, especially in case of limited funding;
•	 Foresee adequate funding to ensure continuity of prevention activities;
•	 Collaborate with gay venue owners and settings for the promotion of sexual health initiatives for MSM; 
•	 Specifically, foresee a comprehensive condom and lubricant distribution strategy which includes a frame-
work for condom distribution in gay venues as a simple cost effective preventative measure (including 
practical information on how to use condom and lubricant);
•	 Collaborate with mobile app owners to gauge interest in reaching out to the community with testing re-
minders, stigma reduction strategies and educating the community on new prevention technologies such 
as PrEP, etc.
•	 Consider the widespread use of Rapid (and possibly self-testing) Tests for HIV and Syphilis as part of a 
public health strategy to address issues such as: low levels of testing, poor rates of test collection results, 
higher transmission rates in early stage of infection;
•	 Invest in testing policies integrated with access to antiretroviral treatment (ART)  which represent an im-
portant milestone in the prevention of infection both because of its efficiency in economic terms and also 
because it focuses on synergy between treatment and prevention;
•	 Foresee “test and treat” policies as described above as part of a broader strategy to ensure targeted care 
for all MSM living with HIV including ART, regular STI screening and treatment; individual counselling, 
sexual health promotion and access to peer-support groups. Activities in this regard should be planned 
and implemented in close collaboration with the MSM community;  Guarantee that the Post Exposure Pro-
phylaxis is available not only for health care staff, but also for the MARPs, particularly the MSM community, 
according to well-defined procedures developed in partnership with the gay community; 
•	 Guarantee that the Pre-Exposure Prophylaxis is considered as an option in the HIV prevention package, 
in line with the growing scientific evidence on this matter. In any case, PrEP availability should be tailored 
according to the local contexts;
•	 Include in the testing policies, strategies to actively encourage periodical serological testing to MSM in 
order to address the problem of STI co-infections (Syphilis, HBV and HCV), and considering – when appro-
priate –  self-testing; 
•	 Engage with and create an enabling environment (e.g. funding, medical support services) for NGOs to pur-
sue prevention activities as those best placed to reach MSM;
•	 Promote and strengthen the increase of vaccination campaigns for Hepatitis A and B and consider vacci-
nation for human papilloma virus (HPV);
•	 Put in place cross-cutting policy actions (e.g. health, education, social care etc.) with appropriate resource 
allocation and with the cooperation of multiple stakeholders (MSM communities, NGOs, public sector or-
ganisations including educational institutions) in order to promote social integration and to address stigma 
and discrimination toward the MSM community. 
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EU Institutions  
•	 Prioritise additional research in the area of HIV among MSM, with a view also to linking different financing 
mechanisms	(e.g.	Public	Health	Programme,	Horizon2020,		European	Fundamental	Rights	&	Citizenship	
(FRC) programme) in order to maximise the projects impact;
•	 Foresee a wide participation of Member States with adequate funding mechanisms, in particular Member 
States from Central Eastern Europe where the identified problems appear to more pressing (e.g.  low level 
of testing, low level of prevention actions, less resources in terms of clinical testing, high level of risk be-
haviour, higher level of stigma, higher number of bisexuals) which could be related to stigma); 
•	 Prioritise exchange of expertise and capacity among Member States in terms of survey design and imple-
mentation as well as with regard to prevention activities, in particular as a means to ensuring the use of 
standardized data collection methodologies so as to have comparable data; 
•	 Promote multidisciplinary actions under existing financing mechanisms (e.g. Public Health Programme, 
Horizon2020,		European	Fundamental	Rights	&	Citizenship	(FRC)	programme)	in	order	to	better	address	
issues of stigma and discrimination, as main enabling or disabling factors of access to HIV test; 
•	 Ensure the involvement of MSM community representatives in the planning and programming of funding 
for HIV prevention actions; 
•	 Foresee a Europe-wide information campaign, with a particular focus on awareness of one’s own HIV and 
STI status.,  to get the issue of HIV prevention back in the public eye and on national governments’ agenda; 
•	 Foster  a  scientific debate on the potential impact of new available tools (e.g. PrEP) at community level 
(e.g. in terms of epidemic patterns and cost-effectiveness), ensuring that the evidence of such a debate is 
considered in current and evolving prevention strategies. 
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Overview of the most relevant Sialon II 
deliverables
Report on a bio-behavioural survey
The Report includes a detailed description of the main results from the  
bio-behavioural survey implemented in 13 EU countries
Report on recent HIV infections among MSM in Sialon II
The Report includes the results from the Avidity Index Calculation exercise 
performed in RDS countries on HIV positive samples
City Profiles
The document presents a list of recommendations on HIV prevention gaps 
and opportunities for health promotion among MSM in the participating cities
Capacity building
in combining targeted prevention
with meaningful HIV surveillance
among MSM
Recent HIV Infections  among MSM in Sialon II
Results from the Avidity Index Component
of the Sialon II RDS survey
The Sialon II project was funded under the European Commission’s (EC) Public Health Programme 2008-2013 (Work Plan 2010).
For more information: http://www.sialon.eu/en/home/
Capacity building in combining targeted prevention
with meaningful HIV surveillance among MSM
REPORT ON A
BIO-BEHAVIOURAL SURVEY
City Profiles
Recommendations on HIV prevention gaps 
and opportunities for Health Promotion 
among Men who have Sex with Men
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Prevention Report
The Report includes a detailed description of the main prevention
outcomes, strategies and actions implemented in Sialon II
Prevention materials
Scratch-card for prevention, 
Prevention Info-pack with testing information and condom+lube
Avidity Index Workshop DVD
The DVD includes a 1-hour training video on how to perform 
the Avidity Index Calculation for HIV
The Sialon II project was funded under the European Commission’s (EC) Public Health Programme 2008-2013 (Work Plan 2010).
For more information: http://www.sialon.eu/en/home/
RAINBOW
HOUSE
Per il sesso anale usa sempre 
lubricanti a base di acqua o silicone. 
Non usare quelli a base oleosa come 
unguenti, lozioni, olio per bambini, 
poiché possono danneggiare
il condom.
Il sessso anale senza condom è la pratica più a rischio sia 
per te sia per il tuo partner, con o senza eiaculazione, a 
causa di possibili micro-lesioni
nel retto e/o sul pene. 
POSTI DOVE SI PUO’ FARE IL TEST A VERONA
L’obiettivo generale del progetto SIALON II è di ottenere informazioni 
valide e attendibili sulla prevalenza HIV, i comportamenti a rischio e i 
fattori culturali tra gli MSM (uomini che fanno sesso con uomini), 
combinando una prevenzione specifica per gli MSM con un sistema 
europeo di monitoraggio ad hoc dell’infezione. L’intero progetto è 
stato sviluppato in collaborazione con le associazioni gay locali in 
Belgio, Bulgaria, Germania, Italia, Repubblica Slovacca, Spagna, Lituania, 
Polonia, Portogallo, Slovenia, Svezia, Romania e Regno Unito.
Questo pacchetto informativo, assieme al suo contenuto, è stato 
concepito dalle associazioni gay dei paesi partecipanti e distribuito 
nell’ambito di una campagna europea di prevenzione.
www.sialon.eu
TEST HIV
DAY HOSPITAL  MALATTIE INFETTIVE – OSP. POLICLINICO G.B. ROSSI (B. go Roma)
Nuovo Edicio Sud – Piazzale L. A. Scuro, 10 – 045 8128253/256
lun – ven 10:00 – 15:00
Anonimo e gratuito. Anche test HIV rapido (in 15 min si ha il risultato).
TEST HIV, SIFILIDE ED EPATITI
GRUPPO C – Centro Medicina Preventiva - Via Germania, 20 – 045 8622232/35
lun - ven 8:30-12:30
Riservato e gratuito. Non serve impegnativa, ma attualmente viene richiesto codice scale. 
ALTRE IST (in particolare condilomi)
DAY HOSPITAL DERMATOLOGIA-VENEREOLOGIA – OSP. CIVILE MAGGIORE (B. go Trento)
P. le A. Stefani, 1 – 045 8122570
lun – ven 8:00 – 9:00 (meglio alle 8:00, il medico visita al massimo 8 persone)
Anonimo e gratuito.
TESTED FOR HIVIN THE LAST 12 MONTHSAccording to a recent European study called EMIS, 
what percentage of European gay men received the 
results of an HIV test in the last 12 months?
54,2 % □
33,9 % □
75,7 % □
The right answe
r is: 33,9%
There are large 
differences bet
ween European
 
countries in Hiv
 testing rates a
mong gay men
.
When the perc
entage of gay m
en receiving an
 Hiv 
test in the last 
12 months is lo
w, many Hiv inf
ections 
are diagnosed l
ate. More men b
eing unaware o
f 
their HIV statu
s causes an incr
ease in Hiv infe
ctions 
and is an obstac
le for early trea
tment.
Ask the SIALON
 volunteer for m
ore informatio
n
or go to WWW
.SIALON.EU.
For information
, please call:
Stick the code h
ere
Prevention
Report
Deliverable 8
Compiled by Work-Package 8
Societal/Policy Level
Community
Peers
Service Provision
Individuals
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Training module for data collectors
The Manual includes training materials for data collection through Time-Location 
Sampling and for Respondent-Driven Sampling methods
Training module for lab technicians
The Manual includes lab methods and testing algorithms for bio-behavioural 
survey using Time-Location Sampling and Respondent-Driven Sampling
Prevention Manual and Training
The Manual includes the main results from the Sialon II Formative Research 
and a specific Prevention Training for data collectors
The Sialon II project was funded under the European Commission’s (EC) Public Health Programme 2008-2013 (Work Plan 2010).
For more information: http://www.sialon.eu/en/home/
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Prevention Manual and Training 
Formative Research Report 
Sandra Dudareva-Vizule, Ulrich Marcus 
Robert Koch Institut, Berlin 
 
Prevention Training Manual 
Peter de Grot, Wim Vanden Berghe 
Institut of Tropical Medicine, Antwerp 
 
Training Module for Coordinators and Data Collectors 1 
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Training Module for Coordinators and 
Data Collectors 
 
Manual for Data Collectors in TLS studies 
Cinta Folch, Laia Ferrer 
CEEISCAT, Spain 
Sampling Manual in TLS studies 
Laia Ferrer, Alexandra Montoliu 
CEEISCAT, Spain 
Manual for Data Collectors in RDS studies  
Lorenzo Gios, Michele Breveglieri, Martina Furegato,  
Massimo Mirandola 
Azienda Ospedaliera Universitaria Integrata, Italy 
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